Form 8-K

8-K — Westin Acquisition Corp

Accession: 0001213900-26-082408

Filed: 2026-07-29

Period: 2026-07-22

CIK: 0002076192

SIC: 6770 (BLANK CHECKS)

Item: Entry into a Material Definitive Agreement

Item: Changes in Control of Registrant

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — ea0299262-8k425_westin.htm (Primary)

EX-2.1 — BUSINESS COMBINATION AGREEMENT, DATED AS OF JULY 22, 2026, BY AND AMONG WESTIN ACQUISITION CORP., FIRST CHOICE HEALTHCARE SOLUTIONS, INC., AND FIRST CHOICE ACQUISITION CORP (ea029926201ex2-1.htm)

EX-10.1 — PARENT SUPPORT AGREEMENT, DATED AS OF JULY 22, 2026, BY AND AMONG WESTIN ACQUISITION CORP., FIRST CHOICE HEALTHCARE SOLUTIONS, INC. AND THE OTHER PARENT SUPPORTING SHAREHOLDERS THERETO (ea029926201ex10-1.htm)

EX-10.2 — COMPANY SUPPORT AGREEMENT DATED AS OF JULY 22, 2026, BY AND AMONG WESTIN ACQUISITION CORP., FIRST CHOICE HEALTHCARE SOLUTIONS, INC. AND THE OTHER COMPANY SUPPORTING SHAREHOLDERS THERETO (ea029926201ex10-2.htm)

EX-10.3 — FORM OF LOCK-UP AGREEMENT (ea029926201ex10-3.htm)

EX-10.4 — FORM OF REGISTRATION RIGHTS AGREEMENT (ea029926201ex10-4.htm)

EX-10.5 — SHARE TRANSFER AGREEMENT, DATED AS OF JULY 25, 2026, BY AND BETWEEN WESTIN VENTURES HOLDINGS LTD. AND EU ASIA HOLIDAYS PTE. LTD (ea029926201ex10-5.htm)

EX-99.1 — PRESS RELEASE, DATED AS OF JULY 22, 2026 (ea029926201ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0299262-8k425_westin.htm · Sequence: 1

false

Singapore

0002076192

00-0000000

0002076192

2026-07-22

0002076192

wstn:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareAndOneRightEntitlingHolderToReceiveOnesixth16OfOneClassOrdinaryShareMember

2026-07-22

0002076192

wstn:ClassOrdinarySharesParValue0.0001PerShareMember

2026-07-22

0002076192

wstn:RightsEachEntitlingHolderToReceiveOnesixth16OfOneClassOrdinaryShareMember

2026-07-22

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):

July 22, 2026

Westin Acquisition Corp.

(Exact name of registrant as specified in its charter)

Cayman Islands

001-42926

N/A

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

Suite 1165-L

3 Coleman Street #03-24

Singapore 179804

(Address of principal executive offices)

+65 9488 4425

(Registrant’s telephone number, including

area code)

Not Applicable

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Securities Exchange Act of 1934:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one right entitling the holder to receive one-sixth (1/6) of one Class A ordinary share

WSTNU

The Nasdaq Stock Market LLC

Class A ordinary shares, par value $0.0001 per share

WSTN

The Nasdaq Stock Market LLC

Rights, each entitling the holder to receive one-sixth (1/6) of one Class A ordinary share

WSTNR

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Business Combination Agreement

On July 22, 2026, Westin Acquisition

Corp., a Cayman Islands exempted company (“Parent”), entered into a Business Combination Agreement (the “Business

Combination Agreement”) with First Choice Healthcare Solutions, Inc., a Delaware corporation (the “Company”),

and First Choice Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”). Pursuant

to the Business Combination Agreement, and subject to the terms and conditions that are set forth therein, on the day that is one (1)

Business Day prior to the Closing Date, Parent will de-register from the Registrar of Companies in the Cayman Islands and transfer by

way of continuation out of the Cayman Islands and into the State of Nevada so as to migrate to and domesticate as a Nevada corporation

(the “Domestication”), with the Parent being referred to at and after the effective time of the Domestication as “Wellgevity

360, Inc.” or “PubCo.” Immediately following the Domestication, Merger Sub will merge with and into the Company, with

the Company surviving the merger as a wholly owned subsidiary of PubCo (the “Merger”). The Domestication, the Merger,

and the other transactions contemplated by the Business Combination Agreement are to be collectively referred to herein as the “Business

Combination” or the “Transactions.” The closing of the Transactions is referred to as the “Closing,”

and the date on which the Closing occurs is referred to herein as the “Closing Date.” Capitalized terms used but not

otherwise defined herein shall have the meanings ascribed to them in the Business Combination Agreement.

The Company and its subsidiaries

are engaged in providing healthcare services and developing and operating functional health, longevity and regenerative medicine clinics

and related healthcare businesses. Concurrently with the execution of the Business Combination Agreement, the Company entered into binding

agreements to acquire all of the outstanding equity interests of Pointe Medical Services, LLC, Point Medical Pharmacy, Inc., Live Well

Drugstore, LLC and Live Well Drugstore, Inc. (collectively, the “Pointe Med Entities”), and the acquisitions of the

Pointe Med Entities are expected to be consummated substantially concurrently with the Closing.

Consideration to Company Securityholders

The Business Combination

values the Company at an equity value of up to approximately $650 million. Pursuant to the Business Combination Agreement, the aggregate

merger consideration will consist of a number of shares of PubCo Common Stock equal to the Equity Value divided by the Redemption Price

(the “Aggregate Merger Consideration”). The Aggregate Merger Consideration

will be allocated among the holders of Company Securities in accordance with the Business Combination Agreement and the Closing Consideration

Spreadsheet.

At or prior to the Closing,

PubCo will deposit the Aggregate Merger Consideration with the Exchange Agent for the benefit of the holders of Company Securities entitled

to receive the applicable portion thereof. At the Merger Effective Time, each outstanding share of Company Common Stock (other than Excluded

Shares and Dissenting Shares) and each outstanding share of Company Preferred Stock, if any, will be converted into the right to receive

the applicable Per Share Merger Consideration in accordance with the Business Combination Agreement and the Closing Consideration Spreadsheet.

Company Equity Awards, if any, will be treated in accordance with the Business Combination Agreement.

The Domestication

One Business Day prior to the Closing Date, Parent

will deregister from the Register of Companies in the Cayman Islands and transfer by way of continuation out of the Cayman Islands and

into the State of Nevada so as to migrate to and domesticate as a Nevada corporation. Concurrently, Parent will file its Articles of Incorporation

with the Secretary of State of the State of Nevada and adopt the bylaws of PubCo.

Immediately prior to the Domestication,

to the extent any Parent Units remain outstanding and unseparated, each such Parent Unit will be automatically separated into its component

securities (the “Unit Separation”), and the holder thereof will be deemed to hold one Parent Class A Ordinary Share

and one Parent Public Right entitling the holder to receive one-sixth (1/6) of one Parent Class A Ordinary Share. Immediately following

the Unit Separation, all Parent Units will be canceled and cease to exist.

Upon the Domestication becoming

effective (the “Domestication Effective Time”), (i) each issued and outstanding Parent Class A Ordinary Share will

automatically convert into one validly issued, fully paid and nonassessable share of PubCo Common Stock; (ii) each outstanding Parent

Right will automatically become a right to receive PubCo Common Stock on the same terms and conditions in effect immediately prior to

the Domestication; and (iii) Parent will continue as PubCo without interruption of its corporate existence.

The Merger

Immediately following the

Domestication, Merger Sub will merge with and into the Company, with the Company surviving the Merger as the Surviving Corporation and

a wholly owned subsidiary of PubCo. The Closing will occur on the second (2nd) Business Day following the satisfaction or waiver

(to the extent permitted by applicable Law) of the conditions set forth in the Business Combination Agreement, unless otherwise agreed

by the parties in writing.

Pursuant to the Business Combination

Agreement and in accordance with the Delaware General Corporation Law (“DGCL”), at the Merger Effective Time: (i) Merger

Sub will merge with and into the Company; (ii) the separate corporate existence of Merger Sub shall cease; and (iii) the Company shall

survive the Merger as the Surviving Corporation and become a wholly owned subsidiary of PubCo.

Merger Consideration

At the Merger Effective Time,

each outstanding share of Company Common Stock (other than Excluded Shares and Dissenting Shares) will be canceled and converted into

the right to receive the applicable Per Share Merger Consideration. Each outstanding share of Company Preferred Stock, if any, will be

converted into the right to receive the applicable Per Share Merger Consideration in accordance with the Closing Consideration Spreadsheet

and the Company’s organizational documents.

The Business Combination Agreement

also provides for the treatment of outstanding Company Equity Awards in accordance with the terms thereof.

PIPE Investment

The Business Combination

Agreement contemplates that, prior to or concurrently with the Closing, PubCo may enter into one or more subscription agreements with

certain investors (the “PIPE Investors”), pursuant to which the PIPE Investors

would agree, subject to the terms and conditions set forth therein, to purchase at the Closing shares of PubCo Preferred Stock having

an aggregate stated value of up to $12,500,000 for an aggregate purchase price of up to $10,000,000 (the “PIPE

Investment”). As of the date of this prospectus, no subscription agreements have been executed, and there can be no assurance

that the PIPE Investment will be completed on the contemplated terms, or at all.

Representations, Warranties and Covenants

The Business Combination Agreement

contains customary representations, warranties and covenants of the parties for a transaction of this nature. Among other things, the

Company is required to provide financial statements and other information necessary for the preparation of the registration statement

on Form S-4 and to cooperate with Parent in the preparation of the required pro forma financial statements. The parties have also agreed

to customary interim operating covenants, non-solicitation obligations, obligations to use reasonable best efforts to obtain the required

governmental and third-party approvals and consents, and other customary covenants pending the Closing.

Registration Statement / Proxy Statement

As promptly as reasonably

practicable after the date of the Business Combination Agreement, Parent will prepare and file with the SEC a registration statement on

Form S-4, which will include a proxy statement/prospectus, to register the securities to be issued in connection with the Business Combination

and to solicit the approval of Parent’s shareholders. Parent and the Company have agreed to cooperate in the preparation, review,

amendment and completion of the Registration Statement and other required SEC filings, including responding to SEC comments and furnishing

information required in connection therewith.

Conditions to Closing

The obligations of the parties

to consummate the Business Combination are subject to the satisfaction or waiver (to the extent permitted by applicable Law) of certain

customary closing conditions, including, without limitation: (i) the absence of any Law or Order that makes the Business Combination illegal

or otherwise restrains, enjoins or prohibits the consummation of the Domestication, the Merger or any of the other Transactions; (ii)

the effectiveness under the Securities Act of the Registration Statement, with no stop order suspending its effectiveness being in effect

and no proceedings seeking such suspension having been initiated or threatened by the SEC; and (iii) approval for listing on the applicable

national securities exchange of the shares of PubCo Common Stock to be issued in connection with the Business Combination, subject to

official notice of issuance.

The obligations of Parent

and Merger Sub to consummate the Business Combination are further subject to additional conditions, including, among other things: (i)

the Company’s performance and compliance in all material respects with its covenants, agreements and obligations under the Business

Combination Agreement; (ii) the accuracy of the Company’s representations and warranties, subject to the bring-down standards set

forth in the Business Combination Agreement; (iii) no Company Material Adverse Effect having occurred since the date of the Business Combination

Agreement that is continuing; (iv) receipt by Parent of a certificate executed by an executive officer of the Company certifying compliance

with specified closing conditions; (v) delivery of a FIRPTA certificate and related IRS notice; (vi) termination of certain specified

contracts prior to the Closing; (vii) receipt of the Company Stockholder Approval; (viii) receipt of all required Company consents; (ix)

the absence of any unresolved adverse written communication from the DEA or any other applicable Governmental Authority that would materially

and adversely affect the Company’s business or regulatory engagement; (x) execution and delivery of the Lock-Up Agreement by the

Lock-Up Stockholders; (xi) timely filing of specified outstanding Tax Returns; and (xii) the substantially simultaneous consummation of

the acquisitions of the Pointe Med Entities pursuant to the applicable acquisition agreements.

The obligations of the Company

to consummate the Business Combination are subject to additional conditions, including, among others: (i) Parent’s and Merger Sub’s

performance and compliance in all material respects with their respective covenants, agreements and obligations under the Business Combination

Agreement; (ii) the accuracy of Parent’s and Merger Sub’s representations and warranties, subject to the bring-down standards

set forth in the Business Combination Agreement; (iii) no Parent Material Adverse Effect having occurred since the date of the Business

Combination Agreement that is continuing; (iv) receipt by the Company of a certificate executed by an authorized executive officer of

Parent certifying compliance with specified closing conditions; (v) effectiveness of PubCo’s articles of incorporation; (vi) execution

and delivery of the Registration Rights Agreement and the Lock-Up Agreement; (vii) compliance by the Parent Supporting Shareholders with

the Parent Support Agreement; and (viii) receipt of the Parent Shareholder Approval.

Termination

The Business Combination Agreement

may be terminated in certain customary circumstances, including, without limitation: (i) by the mutual written consent of Parent and the

Company; (ii) by either Parent or the Company if the Closing has not occurred on or before March 31, 2027, which date will be automatically

extended to April 30, 2027 if the SEC has not declared the Registration Statement effective on or prior to February 28, 2027, subject

to certain exceptions; (iii) by either Parent or the Company if any Governmental Authority has issued a final, nonappealable Order permanently

restraining, enjoining or otherwise prohibiting the consummation of the Business Combination; (iv) by either party for certain uncured

breaches by the other party that would result in the failure of a closing condition, subject to the notice and cure provisions set forth

in the Business Combination Agreement; (v) by Parent if the Company Stockholder Written Consent is not obtained or delivered within 24

hours after execution of the Business Combination Agreement, provided that Parent delivers notice of its intention to terminate within

five Business Days after such deadline; and (vi) by either Parent or the Company if the Parent Shareholder Approval is not obtained at

the Parent Shareholder Meeting.

Effect of Termination

If the Business Combination

Agreement is terminated in accordance with its terms, it will become void and have no further force or effect, without liability on the

part of any party to any other party, except as otherwise expressly provided in the Business Combination Agreement; provided, however,

that no such termination will relieve any party from liability arising out of or incurred as a result of such party’s Willful Breach

of the Business Combination Agreement or Fraud.

Governance

Following the Closing, the

initial board of directors of PubCo is expected to consist of five directors: one independent director designated by the Sponsor; three

independent directors designated by the Company, after consultation with Parent; and the Company’s Chief Executive Officer. At least

a majority of the board will qualify as independent directors. The Company will designate the initial Chairperson of the board from among

the directors designated by the Company and the Company’s Chief Executive Officer.

Timeframes for Filing and Closing

As promptly as reasonably

practicable after the date of the Business Combination Agreement, Parent will prepare and file the Registration Statement on Form S-4

in accordance with the terms of the Business Combination Agreement.

The foregoing description

of the Business Combination Agreement and the Transactions does not purport to be complete and is qualified in its entirety by reference

to the full text of the Business Combination Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K (this

“Current Report”) and is incorporated herein by reference. The Business Combination Agreement contains representations,

warranties and covenants made by the respective parties solely for the purposes of the Business Combination Agreement and as of specified

dates. The assertions embodied in those representations, warranties and covenants were made solely for purposes of the contract among

the parties and are subject to important qualifications and limitations agreed to by the parties in connection with negotiating the Business

Combination Agreement. The Business Combination Agreement is being filed to provide investors with information regarding its terms and

is not intended to provide any other factual information about Parent, Merger Sub or the Company.

In particular, the representations,

warranties and covenants contained in the Business Combination Agreement may be subject to contractual standards of materiality that differ

from those applicable to investors and should not be relied upon as characterizations of the actual state of facts or condition of Parent,

Merger Sub or the Company.

Other Agreements

The Business Combination Agreement

contemplates or was entered into in connection with the following additional agreements and instruments:

Parent Support Agreement

Concurrently with the execution

of the Business Combination Agreement, the Sponsor and certain other Parent shareholders entered into a Parent Support Agreement pursuant

to which they agreed, among other things, not to transfer or redeem their Parent Ordinary Shares, to vote in favor of the Business Combination

and to waive certain anti-dilution and similar protections.

The foregoing description of the Parent Support Agreement does not purport to be complete and is qualified in its entirety by reference

to the Parent Support Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report and is incorporated herein by reference.

Company Support Agreement

Concurrently with the execution of the Business Combination Agreement, certain Company stockholders entered into Company Support Agreements

pursuant to which they agreed, among other things, to vote their Company securities in favor of the Business Combination and comply with

certain restrictions on the transfer of their Company securities, in each case subject to the terms and conditions set forth therein.

The foregoing description of the Company Support Agreement does not purport to be complete and is qualified in its entirety by reference

to the form of Company Support Agreement, a copy of which is filed as Exhibit 10.2 to this Current Report and is incorporated herein by

reference.

Form of Lock-Up Agreement

In connection with the Closing, the Sponsor and certain stockholders of the Company will enter into Lock-Up Agreements pursuant to which

they will agree, subject to customary exceptions, not to transfer the shares of PubCo Common Stock issued to them in connection with the

Transactions until the earlier of (i) six months after the Closing and (ii) the completion of certain change-of-control transactions involving

PubCo.

The foregoing description

of the form of Lock-Up Agreement does not purport to be complete and is qualified in its entirety by reference to the form of Lock-Up

Agreement, a copy of which is filed as Exhibit 10.3 to this Current Report and is incorporated herein by reference.

Registration Rights Agreement

In connection with the Closing, PubCo, the Sponsor, the SPAC Holders and the Company Holders will enter into an Amended and Restated Registration

Rights Agreement (the “Amended and Restated Registration Rights Agreement”), which will amend and restate in its entirety

the Registration Rights Agreement, dated November 3, 2025, among Parent, the Sponsor and the other parties thereto. Pursuant to the Amended

and Restated Registration Rights Agreement, PubCo will be required, within thirty (30) calendar days following the Closing Date, to file

a resale shelf registration statement on Form S-1 or, if then eligible, Form S-3, covering the resale of the registrable securities held

by the Sponsor, the SPAC Holders and the Company Holders, including the Founder Shares, Private Placement Shares, Working Capital Loan

Shares and Merger Shares. PubCo will be required to use commercially reasonable efforts to cause the resale shelf registration statement

to become effective as promptly as practicable and to remain continuously effective until no registrable securities remain outstanding.

The holders will also have certain underwritten takedown, demand registration, block trade and piggyback registration rights, in each

case subject to the thresholds, limitations, underwriter cutbacks, suspension rights, transfer restrictions and other terms set forth

in the Amended and Restated Registration Rights Agreement. PubCo will bear the expenses of registrations effected pursuant to the Amended

and Restated Registration Rights Agreement, other than applicable underwriting discounts, selling commissions, transfer taxes and similar

selling expenses attributable to a holder’s sale of registrable securities. The Amended and Restated Registration Rights Agreement

will become effective upon the Closing and will be void ab initio if the Business Combination Agreement is terminated prior to the Closing.

The

foregoing description of the Amended and Restated Registration Rights Agreement does not purport to be complete and is qualified in its

entirety by reference to the form of Amended and Restated Registration Rights Agreement, a copy of which is filed as Exhibit 10.4 to this

Current Report and is incorporated herein by reference.

Item 5.01 Changes in Control of Registrant

Sponsor Share Transfer

Westin Investment Co. Ltd.,

the sponsor of Parent (the “Sponsor”), was wholly owned by Westin Ventures

Holdings Ltd., a British Virgin Islands company (“Westin Ventures” or the “Transferor”), whose sole shareholder

is Mr. Kok Peng Na. On July 25, 2026, Westin Ventures and EU Asia Holidays Pte. Ltd., a Singapore company (“EU

Asia” or the “Transferee”), entered into a Share Transfer Agreement

(the “Share Transfer Agreement”), pursuant to which Westin Ventures transferred

to EU Asia all of the issued and outstanding shares of the Sponsor for consideration consisting of $1.00 and other good and valuable

consideration. EU Asia’s sole shareholder is Mr. Hanjie Ong. As a result of the transfer, EU Asia became the sole shareholder of

the Sponsor, and Mr. Ong became the ultimate controlling person of the Sponsor.

The Share Transfer Agreement did not result in

a transfer of any securities of Parent held directly by the Sponsor. The Sponsor continues to hold directly 2,012,500 Class B ordinary

shares of Parent and 235,000 private placement units of Parent, representing beneficial ownership of approximately 27.9% of Parent’s

outstanding ordinary shares based on 8,055,000 ordinary shares outstanding as of May 15, 2026. As a result of the transfer, EU Asia and

Mr. Ong may each be deemed to share voting and dispositive power over the Parent securities held directly by the Sponsor. The Share Transfer

Agreement does not provide for any change to Parent’s directors or executive officers.

The foregoing description of the Share Transfer

Agreement does not purport to be complete and is qualified in its entirety by reference to the Share Transfer Agreement, a copy of which

is filed as Exhibit 10.5 to this Current Report and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure

On July 22, 2026, Parent and the Company issued

a joint press release announcing the execution of the Business Combination Agreement. A copy of the press release is furnished as Exhibit

99.1 to this Current Report and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, shall

not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section,

nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, except as expressly set

forth by specific reference in such filing.

Additional Information and Where to Find

In connection with the proposed

Business Combination, Westin intends to prepare and file with the SEC a registration statement on Form S-4 (the “Registration Statement”),

which will include a preliminary proxy statement/prospectus. After the Registration Statement is declared effective, Westin will mail

a definitive proxy statement/prospectus relating to the Business Combination to its shareholders as of a record date to be established

for voting on the Business Combination. The Registration Statement, including the proxy statement/prospectus contained therein, will contain

important information about the Business Combination and the other matters to be voted upon at the Westin shareholder meeting. This Current

Report does not contain all the information that should be considered concerning the Business Combination and other matters and is not

intended to provide the basis for any investment decision or any other decision in respect of such matters. Westin, the Company and their

respective affiliates may also file other documents with the SEC regarding the Business Combination. Westin’s shareholders and other

interested persons are advised to read, when available, the Registration Statement, including the preliminary proxy statement/prospectus

contained therein, any amendments thereto, the definitive proxy statement/prospectus and other documents filed in connection with the

Business Combination, as these materials will contain important information about Westin, the Company and the Business Combination. Shareholders

will also be able to obtain free copies of such documents, once available, without charge, at the SEC’s website located at www.sec.gov

or by directing a request to Westin Acquisition Corp., Suite 1165-L, 3 Coleman Street #03-24, Singapore 179804.

Participants in the Solicitation

The Company, Parent, Merger

Sub and their directors and executive officers and other persons may be deemed to be participants in the solicitations of proxies from

Parent’s shareholders in connection with the proposed Business Combination and the other matters to be presented at the shareholder

meeting. A list of the names of the Parent’s directors and executive officers and a description of their interests in Parent is

contained in Parent’s Registration Statement on Form S-1, as amended from time to time, which was filed with the SEC and declared

effective on November 3, 2025, and is available free of charge at the SEC’s website located at www.sec.gov or by directing a request

to Westin Acquisition Corp., Suite 1165-L, 3 Coleman Street #03-24, Singapore, 179804. Additional information regarding the participants

in the proxy solicitation and a description of their direct and indirect interests by security holdings or otherwise, will be contained

in the proxy statement/prospectus relating to the Business Combination when it becomes available.

Forward-Looking Statements

This Current Report on Form

8-K contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation

Reform Act of 1995. Westin’s and the Company’s actual results may differ from their expectations, estimates and projections

and, consequently, readers should not rely on these forward-looking statements as predictions of future events. Words such as “expect,”

“estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,”

“plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”

“potential,” “might,” “continues” and similar expressions are intended to identify such forward-looking

statements. These forward-looking statements include, without limitation, Westin’s and the Company’s expectations with respect

to future performance and anticipated financial impacts of the Business Combination, the satisfaction of the closing conditions to the

Business Combination and the timing of the completion of the Business Combination. These forward-looking statements involve significant

risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside

the control of Westin and the Company and are difficult to predict. Factors that may cause such differences include, but are not limited

to: (1) the occurrence of any event, change or other circumstance that could give rise to the termination of the Business Combination

Agreement; (2) the outcome of any legal proceedings that may be instituted against Westin or the Company following the announcement of

the Business Combination Agreement and the Transactions; (3) the inability to complete the Business Combination, including due to a failure

to obtain the Parent Shareholder Approval, the Company Stockholder Approval or satisfy other closing conditions; (4) delays in obtaining

or the inability to obtain necessary regulatory approvals; (5) the inability to obtain or maintain the listing of PubCo Common Stock on

Nasdaq following the Business Combination; (6) the risk that the Business Combination disrupts current plans and operations; (7) the ability

to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition and the combined

company’s ability to grow, manage growth profitably and retain key employees; (8) costs related to the Business Combination; (9)

changes in applicable Laws or regulations; (10) the possibility that the Company or the combined company may be adversely affected by

other economic, business or competitive factors; and (11) other risks and uncertainties to be identified in the Registration Statement

to be filed by Westin relating to the Business Combination, including those under “Risk Factors” therein, and in other filings

made with the SEC by Westin and the Company. Westin and the Company caution that the foregoing list of factors is not exclusive. Readers

are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date made. Neither Westin nor

the Company undertakes any obligation to update or revise publicly any forward-looking statements to reflect any change in expectations

or any change in events, conditions or circumstances on which any such statement is based, except as required by applicable Law. The information

contained on any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this Current Report.

No Offer or Solicitation

This Current Report on Form

8-K shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business

Combination, or an offer to sell or the solicitation of an offer to buy any securities. No offering of securities shall be made except

by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom,

nor shall any sale of securities be effected in any state or jurisdiction in which such offer, solicitation or sale would be unlawful

prior to registration or qualification under the securities Laws of any such jurisdiction. Neither the SEC nor any securities commission

of any other U.S. or non-U.S. jurisdiction has approved or disapproved of the Business Combination contemplated hereby or determined that

this Current Report is accurate or complete. Any representation to the contrary is a criminal offense.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

2.1†*

Business Combination Agreement, dated as of July 22, 2026, by and among Westin Acquisition Corp., First Choice Healthcare Solutions, Inc., and First Choice Acquisition Corp.

10.1

Parent Support Agreement, dated as of July 22, 2026, by and among Westin Acquisition Corp., First Choice Healthcare Solutions, Inc. and the other Parent Supporting Shareholders thereto.

10.2

Company Support Agreement dated as of July 22, 2026, by and among Westin Acquisition Corp., First Choice Healthcare Solutions, Inc. and the other Company Supporting Shareholders thereto.

10.3

Form of Lock-Up Agreement.

10.4†

Form of Registration Rights Agreement.

10.5

Share Transfer Agreement, dated as of July 25, 2026, by and between Westin Ventures Holdings Ltd. and EU Asia Holidays Pte. Ltd.

99.1

Press Release, dated as of July 22, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

†

Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.

Certain portions of these exhibits have been redacted pursuant to Item 601(b)(2)(ii) or 601(b)(10)(iv) of Regulation S-K. The Company hereby agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon request.

SIGNATURE

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

WESTIN ACQUISITION CORP.

Date: July 28, 2026

By:

/s/ Kok Peng Na

Name:

Kok Peng Na

Title:

Chief Executive Officer and Chairman

EX-2.1 — BUSINESS COMBINATION AGREEMENT, DATED AS OF JULY 22, 2026, BY AND AMONG WESTIN ACQUISITION CORP., FIRST CHOICE HEALTHCARE SOLUTIONS, INC., AND FIRST CHOICE ACQUISITION CORP

EX-2.1

Filename: ea029926201ex2-1.htm · Sequence: 2

Exhibit 2.1

BUSINESS COMBINATION AGREEMENT

dated

July 22,

2026

by and among

First Choice Healthcare Solutions,

Inc.,

Westin Acquisition Corp.,

and

First Choice Acquisition Corp.

TABLE OF CONTENTS

Page

ARTICLE I DEFINITIONS

1.1

Certain Definitions

1.2

Further Definitions

1.3

Construction

ARTICLE II THE DOMESTICATION AND THE MERGER

2.1

The Domestication

2.2

The Merger

2.3

Closing

2.4

Directors and Officers of PubCo and the Surviving Corporation

2.5

Taking of Necessary Action; Further Action

2.6

Appraisal Rights

2.7

Transaction Expenses

ARTICLE III CONSIDERATION TO COMPANY SECURITYHOLDERS

3.1

Conversion of Company Securities

3.2

Appointment of Exchange Agent

3.3

Exchange of Shares

3.4

Closing Consideration Spreadsheet

3.5

No Fractional Shares

3.6

Withholding

3.7

No Further Ownership Rights in Company Securities

ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY

4.1

Corporate Existence and Power

4.2

Authorization

4.3

Governmental Authorization

4.4

Hart-Scott-Rodino Act

4.5

Non-Contravention

4.6

Capitalization

4.7

Corporate Records

4.8

Subsidiaries

4.9

Consents

4.10

Financial Statements

4.11

Books and Records

4.12

Internal Accounting Controls

4.13

Absence of Certain Changes

4.14

Properties; Title to the Company’s Assets

4.15

Litigation

4.16

Material Contracts

4.17

Permits

4.18

Compliance with Laws

4.19

Intellectual Property

TABLE OF CONTENTS CONTINUED

Page

4.20

Accounts

Payable; Affiliate Loans

4.21

Employees;

Employment Matters

4.22

Withholding

4.23

Employee

Benefits

4.24

Real

Property

4.25

Tax Matters

4.26

Environmental

Laws

4.27

U.S.

Nuclear Regulatory Matters.

4.28

Finders’

Fees

4.29

Powers

of Attorney and Suretyships

4.30

Directors

and Officers

4.31

Anti-Corruption

Laws, Anti-Money Laundering Laws and Sanctions

4.32

Insurance

4.33

Party Transactions

4.34

Top Customers,

Vendors, and Suppliers

4.35

No Undisclosed

Liabilities

ARTICLE V REPRESENTATIONS AND WARRANTIES

OF PARENT AND MERGER SUB

5.1

Corporate

Existence and Power

5.2

Authorization

5.3

Governmental

Authorization

5.4

HSR

5.5

Non-Contravention

5.6

Finders’

Fees

5.7

Capitalization

5.8

Information

Supplied

5.9

Trust

Account

5.10

Parent

SEC Documents and Financial Statements

5.11

Certain

Business Practices

5.12

Anti-Money

Laundering Laws

5.13

Affiliate

Transactions

5.14

Litigation

5.15

Expenses,

Indebtedness and Other Liabilities

5.16

Tax Matters.

5.17

Parent

Benefit Arrangements

5.18

Business

Activities; Contracts and Liabilities

5.19

No Undisclosed

Liabilities

5.20

PIPE

Investment

5.21

Internal

Accounting Controls

ARTICLE VI COVENANTS OF THE PARTIES

6.1

Conduct

of Business

6.2

Exclusivity

6.3

Access

to Information

6.4

Notices

of Certain Events

TABLE OF CONTENTS CONTINUED

Page

6.5

Cooperation with Registration

Statement, Proxy Statement/Prospectus; Other Filings

6.6

Company Financial Statements

and Financial Information

6.7

Reasonable Best Efforts;

Further Assurances; Governmental Consents

6.8

Confidentiality

6.9

Directors’ and Officers’

Indemnification and Liability Insurance

6.10

Sponsor Indemnification

6.11

Certain Tax Matters

6.12

Litigation

6.13

Regulatory Authority Communications

ARTICLE VII COVENANTS OF THE COMPANY

7.1

Commercially Reasonable

Efforts to Obtain Consents

7.2

Company Stockholder Approval

7.3

No Parent Securities Transactions

ARTICLE VIII COVENANTS OF PARENT

8.1

Stock Exchange Listing

8.2

PubCo Equity Incentive

Plan and PubCo ESPP

8.3

Trust Account

8.4

PIPE Investment

8.5

Adoption of Registration

Statement

8.6

Section 16 Matters

8.7

Obligations of Merger Sub

ARTICLE IX CONDITIONS TO CLOSING

9.1

Condition to the Obligations

of the Parties

9.2

Conditions to Obligations

of Parent and Merger Sub

9.3

Conditions to Obligations

of the Company

9.4

Frustration of Conditions

9.5

Waiver of Conditions

ARTICLE X TERMINATION

10.1

Termination Without Default

10.2

Termination Upon Default

10.3

Effect of Termination

ARTICLE XI MISCELLANEOUS

11.1

Notices

11.2

Amendments; No Waivers;

Remedies

11.3

Arm’s Length Bargaining;

No Presumption Against Drafter

11.4

Publicity

11.5

Expenses

11.6

No Assignment or Delegation

iii

TABLE OF CONTENTS CONTINUED

Page

11.7

Governing Law

11.8

Waiver of Jury Trial

11.9

Submission to Jurisdiction

11.10

Counterparts; Facsimile Signatures

11.11

Entire Agreement

11.12

Severability

11.13

Further Assurances

11.14

Third Party Beneficiaries

11.15

Waiver

11.16

Non-Recourse

11.17

Non-Survival of Representations and Warranties

11.18

No Other Representations; No Reliance

11.19

Conflicts and Privilege

EXHIBITS

Exhibit

Form

of PubCo AOI

Exhibit

Form

of PubCo Bylaws

Exhibit

Form

of Parent Support Agreement

Exhibit

Form

of Subscription Agreement

Exhibit

Form

of Company Support Agreement

Exhibit

Form

of Lock-Up Agreement

Exhibit

Form

of Registration Rights Agreement

Exhibit

Form

of Company Stockholder Written Consent

Exhibit

Form

of PubCo Equity Incentive Plan

Exhibit

Form

of PubCo Employee Stock Purchase Plan

SCHEDULES

Company Schedules

Parent Schedules

BUSINESS COMBINATION AGREEMENT

This BUSINESS COMBINATION

AGREEMENT, dated as of July 22, 2026 (this “Agreement”), is entered into by and among First Choice Healthcare Solutions,

Inc., a Delaware corporation (the “Company”), Westin Acquisition Corp., a Cayman Islands exempted company, which shall

de-register from the Register of Companies in the Cayman Islands and transfer by way of continuation out of the Cayman Islands and into

the State of Nevada so as to migrate to and domesticate as a Nevada corporation on the day that is one Business Day prior to the Closing

Date (prior to the Domestication Effective Time, “Parent”, and at and after the Domestication Effective Time, “Wellgevity

360, Inc.” or “PubCo”), and First Choice Acquisition Corp., a Delaware corporation (“Merger Sub”).

W I T N E S S E T H:

A. The

Company and the Company Subsidiaries (as identified on Schedule A) are engaged in the business of providing healthcare services and developing

and operating functional health, longevity and regenerative medicine clinics and related healthcare businesses,(the “Business”);

B. Parent

is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share

exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, and Merger Sub

is a wholly-owned Subsidiary of Parent formed for the sole purpose of effecting the Merger;

C. Prior

to the Domestication, to the extent any Parent Units remain outstanding and unseparated, the Parent Ordinary Shares and Parent Public

Rights comprising each such issued and outstanding Parent Unit shall be automatically separated (the “Unit Separation”)

and the holder of each Parent Unit shall be deemed to hold one (1) Parent Class A Ordinary Share and one right entitling the holder to

receive one-sixth (1/6) of one Class A Ordinary Share immediately following the Unit Separation, all Parent Units shall automatically

be canceled and shall cease to exist, and the holders of Parent Units immediately prior to the Unit Separation shall cease to have any

rights with respect to such Parent Units except as provided herein;

D. On

the day that is one Business Day prior to the Closing Date (which shall also be the calendar day immediately prior to the Closing Date)

and subject to the conditions of this Agreement, Parent shall de-register from the Register of Companies in the Cayman Islands and transfer

by way of continuation out of the Cayman Islands and into the State of Nevada so as to migrate to and domesticate as a Nevada corporation

in accordance with the Parent Articles, the applicable conversion provisions of Chapter 92A of the Nevada Revised Statutes, as amended

(the “NRS”), and Part 12 of the Companies Act (Revised) of the Cayman Islands (the “Cayman Companies Act”)

(the “Domestication”);

E. Concurrently

with the Domestication, Parent shall file articles of incorporation with the Secretary of State of the State of Nevada substantially in

the form attached hereto as Exhibit A (the “PubCo COI”) and adopt bylaws substantially in the form attached

hereto as Exhibit B (the “PubCo Bylaws”) in each case, with such changes as may be agreed to in writing by Parent

and the Company;

F. immediately

following the Domestication, which shall occur on the Closing Date, Merger Sub will merge with and into the Company (the “Merger”),

with the Company surviving the Merger as a wholly-owned Subsidiary of PubCo;

G. Contemporaneously

with the execution of, and as a condition and an inducement to Parent and the Company entering into this Agreement, the Parent Supporting

Shareholders are entering into and delivering a support agreement, substantially in the form attached hereto as Exhibit C (the

“Parent Support Agreement”), pursuant to which such Parent Supporting Shareholders have agreed (i) not to transfer

or redeem any Parent Ordinary Shares held by such Parent Supporting Shareholder, (ii) to vote in favor of this Agreement and the Domestication,

the Merger and the other Transactions at the Parent Shareholder Meeting, and (iii) to waive any rights of anti-dilution or similar protection

with respect to the Parent Ordinary Shares in connection with the Transaction, in each case upon the terms and subject to the conditions

set forth therein;

H. Each

of the parties hereto intends that, for U.S. federal income tax purposes, (i) the Domestication qualifies as a “reorganization”

within the meaning of Section 368(a)(1)(F) of the Code and the Treasury Regulations promulgated thereunder (the “Domestication

Intended Tax Treatment”), (ii) the Merger qualifies as a “reorganization” within the meaning of Section 368(a) of

the Code and the Treasury Regulations promulgated thereunder, to which each of Parent, Merger Sub, and the Company are parties under Section

368(b) of the Code (the “Merger Intended Tax Treatment” and, together with the Domestication Intended Tax Treatment,

the “Intended Tax Treatment”), and (iii) this Agreement constitutes a “plan of reorganization” within the

meaning of Sections 354, 361 and 368 of the Code and within the meaning of Treasury Regulations Section 1.368-2(g) and 1.368-3(a);

I. Contemporaneously

with the closing of, and as a condition and an inducement to Parent and the Company entering into this Agreement, the Company has agreed

to enter into subscription agreements (collectively, the “Subscription Agreements”), with the PIPE Investors,

pursuant to which the PIPE Investors have agreed, subject to the terms and conditions set forth therein, to subscribe for and purchase,

at the Closing, shares of PubCo Preferred Stock with a stated value of $12,500,000 at a purchase price of $10,000,000 for an aggregate

cash amount of $10,000,000 (the “PIPE Investment”);

J. Prior

to or at Closing, certain executives of the Company may enter into employment or retention agreements with PubCo, if mutually agreed by

the Parties.

K. Concurrently

with the execution and delivery of this Agreement, each of the Company Stockholders party thereto has entered into a Company Support Agreement

(each, a “Company Support Agreement”), substantially in the form attached hereto as Exhibit E, pursuant to which

each such Company Stockholder has agreed, among other things, to vote in favor of this Agreement and the Domestication, the Merger and

the other Transactions at the Company Stockholder Meeting;

L. Concurrently

with the execution of this Agreement, the Company has entered into a binding agreement to purchase all of the capital stock of Pointe

Medical Servies, LLC , Point Medical Pharmacy, Inc. Live well Drugstore, LLC.and Live well Drugstore, Inc. , collectively the “Pointe

Med Entities” The acquisition of the Pointe Med Entities (the “Point Med Acquisition”) will be consummated concurrently

with the Closing of the Transaction.

M. In

connection with the Transactions, concurrently with the Closing, Sponsor and each Company Stockholder holding fiver percent (5%) or more

of the outstanding equity securities of the Company immediately prior to the Closing will enter into and deliver a lock-up agreement substantially

in the form attached hereto as Exhibit F (the “Lock-Up Agreements”);

N. In

connection with the Transactions, concurrently with the Closing, PubCo, Sponsor, [the holders of Parent Class B ordinary shares] and certain

Company Stockholders to be mutually agreed by the Company and Parent will enter into an amended and restated registration rights agreement

substantially in the form attached hereto as Exhibit G (the “Registration Rights Agreement”);

O. The

Board of Directors of the Company has unanimously (i) approved and declared advisable this Agreement, the Additional Agreements to which

the Company is or will be party, the Merger and the other Transactions, in each case, on the terms and subject to the conditions set forth

herein or therein, (ii) determined that this Agreement and such transactions are fair to, and in the best interests of, the Company and

the Company Securityholders, and (iii) resolved to recommend that the Company Stockholders approve the Merger and such other transactions

and adopt this Agreement and the Additional Agreements to which the Company is or will be a party;

P. The Board of

Directors of Parent (including any required committee or subgroup of such board) has (i) approved and declared advisable this

Agreement, the Additional Agreements to which Parent is or will be party, the Domestication, the Merger and the other Transactions,

in each case, on the terms and subject to the conditions set forth herein or therein, (ii) determined that this Agreement and such

transactions are fair to, and in the best interests of, Parent and the Parent Shareholders, and (iii) resolved to recommend that the

Parent Shareholders approve the Merger and such other transactions and adopt this Agreement and the Additional Agreements to which

Parent is or will be a party;

Q. The

Board of Directors of Merger Sub has unanimously (i) approved and declared advisable this Agreement, the Additional Agreements to which

Merger Sub is or will be party, the Merger and the other Transactions, in each case, on the terms and subject to the conditions set forth

herein or therein, (ii) determined that this Agreement and such transactions are fair to, and in the best interests of, Merger Sub and

its sole stockholder, and (iii) resolved to recommend that the sole stockholder of Merger Sub approve the Merger and such other transactions

and adopt this Agreement and the Additional Agreements to which Merger Sub is or will be a party; and

R. Parent, as

the sole stockholder of Merger Sub, has (i) approved and declared advisable this Agreement, the Additional Agreements to which

Merger Sub is or will be party, the Merger and the other Transactions, in each case, on the terms and subject to the conditions set

forth herein or therein, and (ii) determined that this Agreement and such transactions are fair to, and in the best interests of,

Merger Sub.

In consideration

of the mutual covenants and promises set forth in this Agreement, and other good and valuable consideration, the receipt and sufficiency

of which are hereby acknowledged, the parties hereto hereby agree as follows:

ARTICLE

DEFINITIONS

I.1 Certain Definitions. For purposes

of this Agreement:

“Action”

means any action, litigation, suit, claim, hearing, proceeding or investigation, including any audit, claim or assessment for Taxes or

otherwise, by or before any Authority.

“Additional

Agreements” means the Parent Support Agreement, the Company Support Agreement, the Company Stockholder Written Consent, the

Registration Rights Agreement, the Subscription Agreements, the Lock-Up Agreement and each other agreement, instrument and certificate

required by, or contemplated in connection with, this Agreement to be executed by any of the parties hereto as contemplated by this Agreement,

in each case only as is applicable to the relevant party or parties hereto who is or are a party to such Additional Agreement, as indicated

by the context in which such term is used.

“Affiliate”

means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by or under common Control with

such Person, whether through one or more intermediaries or otherwise. “Affiliate” shall also include, with respect to

any individual natural Person, (a) such Person’s spouse, parent, lineal descendant, sibling, aunt, uncle, niece, nephew,

mother-in-law, father-in-law, sister-in-law or brother-in-law, or (b) a trust for the benefit of such Person and/or the individuals

described in the foregoing clause (a), or of which such Person is a trustee.

“Aggregate

Fully Diluted Company Shares” means the sum, without duplication, of (a) the aggregate number of shares of Company Common

Stock that are issued and outstanding immediately prior to the Merger Effective Time; plus (b) the aggregate number of shares

of Company Common Stock that are issuable upon, or subject to, the exercise or settlement of Company Options (whether or not then

vested or exercisable), in each case, that are outstanding immediately prior to the Merger Effective Time; plus (c) the

aggregate number of shares of Company Preferred Stock (on an as converted to Company Common Stock basis) that are issued and

outstanding immediately prior to the Merger Effective Time.

“Aggregate

Merger Consideration” means the number of shares of PubCo Common Stock equal to the quotient obtained by dividing (a)

the Equity Value by (b) the Redemption Price.

“Aggregate

Parent Closing Cash” means an amount equal to the sum of (a) the aggregate cash proceeds available for release to Parent

from the Trust Account in connection with the Transactions (net of the Parent Redemption Amount but for the avoidance of doubt, prior

to the payment of any Transaction Expenses); plus (b) the aggregate cash proceeds actually received by Parent on the Closing Date

in respect of the PIPE Investment; plus (c) any cash or cash equivalents held by Parent outside of the Trust Account as of immediately

prior to the Domestication Effective Time; plus (d) any cash or cash equivalents held by the Company and the Company Subsidiaries

as of immediately prior to the Merger Effective Time; plus (e) the aggregate amount of any Permitted Company Financing proceeds

received by the Company on or prior to the Closing Date.

“Anti-Corruption

Laws” means the U.S. Foreign Corrupt Practices Act of 1977, as amended, and any other applicable anti-bribery or anti-corruption

Laws.

“Anti-Money

Laundering Laws” means all applicable Laws relating to money laundering, terrorist financing or similar financial crimes.

“Authority”

means any nation or government, any state, province, county, municipal or other political subdivision thereof, any governmental, regulatory,

quasi-judicial or administrative body, agency or authority, any court or judicial authority, any arbitrator (public or private), any public,

private or industry regulatory authority, whether international, national, foreign, federal, state or local, or any other body or administrative,

regulatory or quasi-judicial authority, agency, department, board, commission or instrumentality of any federal, state, local or foreign

jurisdiction.

“Books and

Records” means all books and records, ledgers, employee records, customer lists, files, correspondence and other records of

every kind (whether written, electronic or otherwise embodied) owned or controlled by a Person in which a Person’s assets, liabilities,

obligations, business or its transactions are otherwise reflected.

“Business

Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York City,

New York or the Cayman Islands are authorized to close for business.

“Change

of Control Payments” means any and all sale, retention or change-of-control payments or bonuses, or any other similar payments,

bonuses, compensation, benefits or amounts, owing, due or payable by or on behalf of the Company or the Company Subsidiaries solely or

partially in connection with the consummation of the Transactions, whether pursuant to any Contract or applicable Laws or otherwise, whether

or not payable at the Closing.

“COBRA”

means collectively, the requirements of Sections 601 through 606 of ERISA and Section 4980B of the Code.

“Code” means the

Internal Revenue Code of 1986, as amended.

“Company Bylaws”

means the bylaws of the Company, in effect on the date hereof.

“Company Capital

Stock” means the Company Common Stock and the Company Preferred Stock.

“Company

Certificate of Incorporation” means the Amended and Restated Certificate of Incorporation of the Company, as amended and as

in effect on the date hereof.

“Company Common

Stock” means common stock of the Company, par value $0.0001 per share.

“Company

Equity Incentive Plan” means the Pubco.Equity Incentive Plan, as amended from time to time.

“Company

Financial Statements” means the Company 2024 and 2025 Audited Financial Statements, Company 2026 Balance Sheet, Company 2026

Statement of Operations and Cash Flows, Company PCAOB Audited Financial Statements, Company Unaudited Interim Financial Statements, the

Point Med 2024 and 2025 Audited Financial statement and the Point Med Unaudited Interim Financial Statements.

“Company

Fundamental Representations” means the representations and warranties of the Company set forth in Sections 4.1 (Corporate

Existence and Power), 4.2 (Authorization), 4.5(a) (Non-Contravention), the last sentence of Section

4.5 (Non-Contravention), 4.6 (Capitalization), 4.8 (Subsidiaries), [and 4.28 (Finders’

Fees)].

“Company

Intervening Event” means any Event that, individually or in the aggregate, is materially adverse to the consummation of the

Transactions (a) was not known or reasonably foreseeable to Parent’s Board of Directors as of the date hereof (or if known or reasonably

foreseeable, the consequences or magnitude of which were not known or were not known or reasonably foreseeable as of the date hereof)

and that becomes known to Parent’s Board of Directors after the date hereof and prior to the receipt of approval of the Parent Shareholder

Approval and (b) that does not relate to or regard an Alternative Transaction. Notwithstanding the foregoing, the amount of redemptions

from the Trust Account pursuant to the Redemption shall not be deemed to be a Company Intervening Event.

“Company

Option” means each option to purchase Company Common Stock granted, and that remains outstanding, under the Company Equity Incentive

Plan or otherwise.

“Company Preferred

Stock” means preferred stock of the Company, par value $0.0001 per share.

“Company

Schedules” means the disclosure schedules of the Company (including disclosures with respect to any of the Company Subsidiaries)

delivered to Parent by the Company concurrently with entering into this Agreement, and the term “Company Schedule” shall refer

to the specified section of the Company Schedules, unless otherwise specified.

“Company

Securities” means the Company Common Stock, the Company Preferred Stock, and the Company Options.

“Company

Securityholder” means, as at any particular reference time, each Person who holds Company Securities.

“Company

Stockholders” means, as at any particular reference time, the holders of Company Capital Stock.

“Company

Transaction Expenses” means all fees, costs, expenses, obligations and liabilities of the Company and the Company Subsidiaries

incurred in connection with, or otherwise related to, the Transactions, the negotiation, execution and preparation of this Agreement and

the Additional Agreements and the performance and compliance with this Agreement and the Additional Agreements and conditions contained

herein and therein, including the fees, expenses and disbursements of legal counsel, reserves evaluators, auditors and accountants, due

diligence expenses, advisory and consulting fees (including financial advisors) and expenses, other third-party fees, any and all filing

fees payable by or on behalf of the Company and the Company Subsidiaries to Authorities in connection with the Transactions, any and all

Change of Control Payments and the employer portion of payroll Taxes payable as a result of the foregoing amounts, and all severance payments,

retirement payments or similar payments or success fees payable by or on behalf of the Company or any of the Company Subsidiaries in connection

with the consummation of the Transactions and the employer portion of payroll Taxes payable as a result of the foregoing amounts.

“Consideration

Ratio” means the quotient obtained by dividing (a) the Aggregate Merger Consideration by (b) the Aggregate Fully Diluted Company

Shares.

“Contracts”

means all contracts, subcontracts, agreements, leases (including Real Property Leases, equipment leases, car leases and capital leases),

subleases, licenses, sublicenses, Permits, powers of attorney, commitments, bonds, notes, indentures, deeds of trust, mortgages, debt

instruments, client contracts, statements of work (SOWs), sales and purchase orders and other instruments or obligations of any kind,

in each case whether oral or written (including any amendments and other modifications thereto), to which the Company or any Company Subsidiary

is a party or by which it or any of its assets are bound.

“Control”

of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies

of such Person, whether through the ownership of voting securities, by contract, or otherwise. “Controlled”, “Controlling”

and “under common Control with” have correlative meanings. Without limiting the foregoing, a Person (the “Controlled

Person”) shall be deemed Controlled by any other Person (i) owning beneficially, as meant in Rule 13d-3 under the Exchange Act,

securities entitling such Person to cast 50% or more of the votes for election of directors or equivalent governing authority of the Controlled

Person or (ii) entitled to be allocated or receive 50% or more of the profits, losses, or distributions of the Controlled Person.

“Data

Protection Laws” means all Laws worldwide relating to the processing, privacy or security of Personal Information and all

regulations or guidance issued thereunder, including to the extent applicable, the EU General Data Protection Regulation (EU)

2016/679 and all laws implementing it, HIPAA, the regulations set forth in 42 C.F.R. Part 495 and 45 C.F.R. Parts 160, 164 and 170,

the HITECH Act, Section 5 of the Federal Trade Commission Act, the FTC Red Flag Rules, the CAN SPAM Act and associated regulations

set forth in 16 C.F.R. Part 316, state data breach notification laws, state data privacy laws including the California Consumer

Privacy Act, as amended, state data security laws, state consumer protection Laws, and any law concerning requirements for website

and mobile application privacy policies and practices, or any outbound commercial communications (including email marketing,

telemarketing and text messaging), tracking and marketing.

“DGCL” means Delaware

General Corporation Law.

“Enforceability

Exceptions” means bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar Laws affecting creditors’

rights generally, and general principles of equity (regardless of whether enforceability is considered in a proceeding at law or in equity).

“Environmental

Laws” means all Laws that prohibit, regulate or control any Hazardous Material or any Hazardous Material Activity, including

the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, the Resource Recovery and Conservation Act of 1976,

the Federal Water Pollution Control Act, the Clean Air Act, the Hazardous Materials Transportation Act and the Clean Water Act.

“Equity

Interest” means, with respect to any Person, any capital stock of, or other ownership, membership, partnership, rights of first

refusal or first offer, voting, joint venture, equity interest, preemptive right, stock appreciation, phantom stock, profit participation

or similar rights in, such Person or any indebtedness, securities, options, warrants, call, subscription or other rights or entitlements

of, or granted by, such Person that are convertible into, or are exercisable or exchangeable for, or give any person any right or entitlement

to acquire any such capital stock or other ownership, partnership, voting, joint venture, equity interest, preemptive right, stock appreciation,

phantom stock, profit participation or similar rights, in all cases, whether vested or unvested, of such Person or any similar security

or right that is derivative or provides any economic benefit based, directly or indirectly, on the value or price of any such capital

stock or other ownership, partnership, voting, joint venture, equity interest, preemptive right, stock appreciation, phantom stock, profit

participation or similar rights, in all cases, whether vested or unvested.

“Equity

Value” means equity value of the Company as determined pursuant to Section 3.1, approximately up to $650 million.

“ERISA”

means the Employee Retirement Income Security Act of 1974, as amended.

“ERISA Affiliate” means each entity, trade

or business that is, or was at the relevant time, a member of a group described in Section 414(b), (c), (m) or (o) of the Code or

Section 4001(b)(1) of ERISA that includes or included the Company or any Company Subsidiary, or that is, or was at the relevant

time, a member of the same “controlled group” as the Company or any Company Subsidiary pursuant to Section 4001(a)(14)

of ERISA.

“Exchange Act” means

the Securities Exchange Act of 1934.

“Excluded

Shares” means (i) any shares of Company Capital Stock held by the Company as treasury shares and (ii) any shares of Company

Capital Stock held by Parent, Merger Sub or any wholly owned Subsidiary of Parent or the Company immediately prior to the Merger Effective

Time.

“Hazardous

Material” means any material, emission, chemical, substance or waste that has been designated by any Authority to be radioactive,

toxic, hazardous, a pollutant or a contaminant.

“Hazardous

Material Activity” means the transportation, transfer, recycling, storage, use, treatment, manufacture, removal, remediation,

release, exposure of others to, sale, labeling, or distribution of any Hazardous Material or any product or waste containing a Hazardous

Material, or product manufactured with ozone depleting substances, including any required labeling, payment of waste fees or charges (including

so-called e-waste fees) and compliance with any recycling, product take-back or product content requirements.

“HIPAA”

means the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and

Clinical Health Act.

“HSR Act”

means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

“Indebtedness”

means with respect to any Person and its Subsidiaries, (a) all obligations of such Person for borrowed money, or with respect to

deposits or advances of any kind (including amounts by reason of overdrafts and amounts owed by reason of letter of credit

reimbursement agreements), including with respect thereto, all interests, fees and costs, (b) all obligations of such Person and its

Subsidiaries evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person and its Subsidiaries

under conditional sale or other title retention agreements relating to property purchased by such Person and its Subsidiaries, (d)

all obligations of such Person and its Subsidiaries issued or assumed as the deferred purchase price of property or services (other

than accounts payable to creditors for goods and services incurred in the ordinary course of business consistent with past

practice), (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent

or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the obligations secured

thereby have been assumed, (f) all obligations of such Person and its Subsidiaries under leases required to be accounted for as

capital leases under U.S. GAAP, (g) all guarantees by such Person, (h) all liability of such Person and its Subsidiaries with

respect to any hedging obligations, including interest rate or currency exchange swaps, collars, caps or similar hedging

obligations, (i) any unfunded or underfunded liabilities pursuant to any pension or nonqualified deferred compensation plan or

arrangement, (j) any premiums, prepayment fees or other penalties, fees, costs or expenses associated with payment of any

Indebtedness of such Person and its Subsidiaries and (k) any agreement to incur any of the same. For informational purposes, with

respect to the Company or any Company Subsidiary, Indebtedness shall include any grants or loans that are not carried as tangible

liabilities on the Company Financial Statements on a stand-alone basis (whether or not such liabilities are included in the

footnotes to the Company Financial Statements).

“Independent

Director” means, with respect to any corporation or company, a member of the Board of Directors of such corporation or company

that qualified as an independent director under the rules of the SEC and Nasdaq rules.

“Intellectual

Property Rights” means all intellectual property, including any and all rights, title, and interest therein or thereto, in

any jurisdiction throughout the world, including in or to the following: (a) all technology (including patented, patentable and

unpatented inventions and unpatentable proprietary or confidential information, systems or procedures), designs, licenses, and

processes; (b) trademarks, service marks, logos, corporate and trade names, trade dress, brand names, slogans, registrations thereof

or applications for registration therefor, and all other indicia of source or origin, together with all goodwill symbolized by or

associated with any of the foregoing; (c) patents, patent applications, invention disclosures, including all continuations,

continuations-in-part, divisionals, reissues, re-examinations, interferences, substitutions, provisionals, and extensions thereof;

(d) trade secrets, know-how, inventions, procedures, customer lists, supplier lists, business plans, formulae, discoveries, methods,

manuals and systems, techniques, ideas, designs, models, concepts, creations, technical information, confidential business

information and other proprietary information; (e) copyrights, copyrightable materials, copyright registrations, applications for

copyright registration, marks works and design rights, Software, data bases, u.r.l.s., and any other works of authorship, computer

programs, technical data and information and other intellectual property, and all embodiments and fixations thereof and related

documentation and registrations and all additions, improvements and accessions thereto, and all moral rights or similar attribution

rights; (f) internet domain names, social media accounts, and IP addresses; (g) rights recognized under applicable Law that are

equivalent or similar to any of the foregoing; and (h) all rights with respect to the foregoing, including all causes of action,

judgements, settlements, claims and demands related thereto, and rights to prosecute and recover damages for any past, present or

future infringements, dilutions, misappropriation and other violations thereof.

“IPO”

means the initial public offering of Parent pursuant to a final prospectus dated November 5, 2025.

“Knowledge

of Parent” or similar terms (whether or not capitalized) means the actual knowledge (after reasonable inquiry) of Kok Peng Na

(Chairman and Chief Executive Officer) and Stanney Patrick Majawit (Chief Financial Officer).

“Knowledge

of the Company” or “to the Company’s Knowledge” or similar terms (whether or not capitalized) means

the actual knowledge (after reasonable inquiry) of Lance Friedman (Chief Executive Officer), Barbara Sher (Chief Operating Officer) and

Joseph Clemente (Chief Financial Officer).

“Law”

means any federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code, edict,

decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order that is or has

been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority

of any Authority.

“Lien”

means, with respect to any property or asset, any mortgage, lien, license, deed of trust, pledge, charge, security interest or encumbrance

of any kind in respect of such property or asset, any option, right of first offer or right of first refusal in respect of such property

or asset, or any conditional sale or voting agreement or proxy, including any agreement to give any of the foregoing.

“Lock-Up Stockholders”

has the meaning set forth on Parent Schedule [ ].

“Material

Adverse Effect” means any change, circumstance, condition, development, effect, event, occurrence or state of facts (each,

an “Event”) that (i) has had, or would reasonably be expected to have, individually or in the aggregate a

material adverse effect upon the business (including the Business), assets, liabilities, results of operations or condition

(financial or otherwise), of the Company or any Company Subsidiary or (ii) does or would reasonably be expected to, individually or

in the aggregate, prevent, materially delay or materially impede the ability of the Company or any Company Subsidiary to consummate

the Transactions; provided, however, that with respect to the foregoing clause (i) in no event would any of the

following, alone or in combination, be deemed to constitute, or be taken into account in determining whether there has been or will

be, a “Material Adverse Effect”: (a) any change in general economic or political conditions; (b) changes in conditions

generally affecting the industries in which the Company or any Company Subsidiary operates; (c) any change in market, business,

financial, commodity, credit, debt, securities, derivatives or capital market conditions in the United States or in any other

country or region in the world, including inflation, supply chain disruptions, labor shortages, interest, foreign exchange or

exchange rates, tariffs, trade wars and any suspension of trading in securities (whether equity, debt, derivative or hybrid

securities) generally on any security exchange or over-the-counter market; (d) acts of war (whether or not declared), armed

hostilities or terrorism, or the escalation or worsening thereof; (e) the taking of any action expressly required by this Agreement;

(f) any changes in applicable Laws or accounting rules (including U.S. GAAP) or the interpretation thereof, in each case effected

after the date hereof; (g) the announcement of this Agreement or the consummation of the Transactions (but in each case only to the

extent attributable to such announcement or consummation) (provided, that the exception in this subclause (g) shall

not apply to any representation or warranty contained in Sections 4.3, 4.5 or 4.9 or to the determination of

whether any inaccuracy in such representations or warranties would reasonably be expected to have a Material Adverse Effect for

purposes of Section 9.2(b)); (h) any natural disaster, epidemic, pandemic, or change in climate or act of God; or (i) any

failure by the Company or any Company Subsidiary to meet any internal or published projections, forecasts or revenue or earnings

predictions (it being understood that the underlying facts giving rise to such failure may constitute, or be taken into account in

determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect if such facts are not otherwise

excluded under this definition); provided, further, that any Event referred to in subclauses (a), (b), (c), (d), (f)

and (h) above may be taken into account in determining whether there has been or will be a Material Adverse Effect to the

extent such Event has a disproportionate adverse effect on the Company or any Company Subsidiary relative to similarly situated

companies in the same industry in which the Company or any Company Subsidiary conducts its operations.

“Nasdaq” means The

Nasdaq Global Market.

“Order”

means any decree, order, judgment, writ, award, injunction, stipulation, determination, award, rule or consent of or by an Authority.

“Other Filings”

means any filings to be made by Parent required under the Exchange Act, Securities Act or any other United States federal, foreign or

blue sky Laws, other than the Registration Statement and the other Offer Documents.

“Owned IPR”

means any and all Intellectual Property owned (or purported to be owned), in whole or in part, by the Company or any Company Subsidiary,

and includes Owned Software.

“Owned Software”

means any and all proprietary Software owned (or purported to be owned), in whole or in part, by the Company or any Company Subsidiary.

“Parent

Articles” means the Amended and Restated Memorandum and Articles of Association of Parent, as amended and as in effect as of

the date hereof.

“Parent

Fundamental Representations” means the representations and warranties of Parent set forth in Sections 5.1 (Corporate

Existence and Power), 5.2 (Authorization), 5.5 (Non-Contravention), 5.6 (Finders’ Fees)

and 5.7 (Capitalization).

“Parent

Material Adverse Effect” means any Event that (i) has had, or would reasonably be expected to have, individually or in the

aggregate a material adverse effect upon the business, assets, liabilities, results of operations or condition (financial or

otherwise), of Parent or Merger Sub or (ii) does or would reasonably be expected to, individually or in the aggregate, prevent,

materially delay or materially impede the ability of Parent or Merger Sub to consummate the Transactions; provided, however,

that with respect to the foregoing clause (i) in no event would any of the following, alone or in combination, be deemed to

constitute, or be taken into account in determining whether there has been or will be, a Parent Material Adverse Effect: (a) any

change in general economic or political conditions; (b) changes in conditions generally affecting the industries in which Parent or

Merger Sub operates; (c) any changes in financial, banking or securities markets in

general, including any disruption thereof or any change in prevailing interest rates; (d) acts of war (whether or not declared),

armed hostilities or terrorism, or the escalation or worsening thereof (but only to the extent such escalation or worsening thereof

was not reasonably foreseeable); (e) the taking of any action expressly required by this Agreement; (f) any changes in applicable

Laws or accounting rules (including U.S. GAAP) or the interpretation thereof, in each case effected after the date hereof; (g) the

announcement of this Agreement or the consummation of the Transactions (but in each case only to the extent attributable to such

announcement or consummation), provided, that the exception in this subclause (g) shall not apply to any

representation or warranty contained in Sections 5.3 or 5.5 or to the determination of whether any inaccuracy in such

representations or warranties would reasonably be expected to have a Parent Material Adverse Effect for purposes of Section

9.2(b); (h) any natural disaster, epidemic, pandemic, or change in climate or act of God.

“Parent

Class A Ordinary Shares” means, prior to the Domestication, the Class A Ordinary Shares, $0.0001 par value per share, of Parent.

“Parent

Class B Ordinary Shares” means, prior to the Domestication, the Class B Ordinary Shares, $0.0001 par value per share, of Parent.

“Parent

Rights” means, prior to the Domestication, rights entitling the holder to 1/6 of one Class A Ordinary Share of Parent.

“Parent

Schedules” means the disclosure schedules of Parent delivered to the Company by Parent concurrently with entering into this

Agreement, and the term “Parent Schedule” shall refer to the specified section of the Parent Schedules, unless otherwise specified.

“Parent Shareholders”

means the shareholders of Parent prior to the Closing.

“Parent Shareholder Approval” means approval of [ ].

“Parent

Transaction Expenses” means all fees, costs, expenses, obligations and liabilities, in each case of the Parent Parties (including

any such fees, costs, expenses, obligations or liabilities incurred by Sponsor or its Affiliates or Parent’s directors or officers,

in each case on behalf of the Parent Parties and that the Parent Parties are liable for), incurred in connection with, or otherwise related

to, the Transactions, the investigation or pursuit of prospective business combinations other than the Transactions, the negotiation,

execution and preparation of this Agreement and the Additional Agreements and the performance and compliance with this Agreement and the

Additional Agreements and conditions contained herein and therein, including the fees, expenses and disbursements of legal counsel, reserves

evaluators, auditors and accountants, due diligence expenses, advisory and consulting fees (including financial advisors) and expenses,

other third-party fees, any and all deferred underwriting fees, and any and all filing fees payable by Parent to Authorities in connection

with the Transactions. For the avoidance of doubt, Parent Transaction Expenses shall not include any Company Transaction Expenses.

“Parent

Units” means the units issued in Parent’s IPO, each comprising one Parent Class A Ordinary Share and Right.

“Permit”

means each license, franchise, permit, order, approval, consent, waiver, concession, exemption or other similar authorization

required to be obtained and maintained by the Company or any Company Subsidiary under applicable Law to carry out or otherwise

affecting, or relating in any way to, the Business.

“Permitted

Liens” means (a) all defects, exceptions, restrictions, easements, rights of way and encumbrances with respect to Real Property

in the public record that do not adversely affect the operation of the Real Property or the conduct of business thereon; (b) mechanics’,

carriers’, workers’, repairers’ and similar statutory Liens arising or incurred in the ordinary course of business consistent

with past practice for amounts (i) that are not delinquent, (ii) that are not material to the Business or the operations and financial

condition of the Company or any Company Subsidiary so encumbered, either individually or in the aggregate, (iii) not resulting from a

breach, default or violation by the Company or any Company Subsidiary of any Contract or Law, (iv) for which adequate accruals or reserves

have been established on the Company Financial Statements or Parent Financial Statements, as the case may be, in accordance with U.S.

GAAP, and (v) that could not result in the loss of all or any portion of the Real Property or create a default under any Lien; (c) Liens

for Taxes not yet due and payable or which are being contested in good faith by appropriate proceedings and for which adequate accruals

or reserves have been established on the Company Financial Statements or Parent Financial Statements, as the case may be, in accordance

with U.S. GAAP; and (d) the Liens set forth on Company Schedule 1.1(b).

“Person”

means any natural person, sole proprietorship, corporation, company, partnership (including a general partnership, limited partnership

or limited liability partnership), limited liability company, association, joint venture, trust, unincorporated association or other entity

or organization, including a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof

or any other Authority.

“Personal

Information” means any data or information, on any media that, alone or in combination with other data or information, can,

directly or indirectly, be associated with or be reasonably used to identify an individual natural Person or household (including any

part of such Person’s name, physical address, telephone number, email address, financial account number or credit card number, government

issued identifier (including social security number and driver’s license number), user identification number and password, billing

and transactional information, medical, health or insurance information, date of birth, educational or employment information, vehicle

identification number, IP address, cookie identifier, or any other number or identifier that identifies an individual natural Person,

or such Person’s vehicle, browser or device), or any other data or information that constitutes personal data, protected health

information, personally identifiable information, personal information or similar defined term under any Data Protection Law.

“PIPE Investors”

means those certain investors participating in the PIPE Investment pursuant to the Subscription Agreements.

“Plan”

means each “employee benefit plan” within the meaning of Section 3(3) of ERISA and all other compensation and benefits plans,

policies, programs, or arrangements, and each other stock purchase, stock option, restricted stock, equity-based, severance, retention,

employment (other than any employment offer letter in such form as previously provided to Parent that is terminable “at will”

without any contractual obligation on the part of the Company or any Company Subsidiary to make any severance, termination, change of

control, or similar payment), change-of-control, bonus, incentive, deferred compensation, employee loan, fringe benefit and other employee

benefit plan, agreement, program, policy, commitment or other arrangement, whether or not subject to ERISA, whether formal or informal,

oral or written, in each case, that is sponsored, maintained, contributed or required to be contributed to by the Company or any Company

Subsidiary, or under which the Company or any Company Subsidiary has any current or potential liability.

“PubCo Common

Stock” means, following the Domestication, the common stock of PubCo, par value $0.0001 per share.

“PubCo Rights” means,

following the Domestication, the Rights of PubCo.

“Real Property”

means, collectively, all real properties and interests therein (including Real Property Leases and rights to use), together with all buildings,

fixtures, trade fixtures, plant and other improvements located thereon or attached thereto; all rights arising out of use thereof (including

air, water, oil and mineral rights); and all subleases, franchises, licenses, permits, easements and rights-of-way which are appurtenant

thereto.

“Redemption”

means the redemption of such number of Parent Class A Ordinary Shares, at the Redemption Price, in connection with the Transactions, which

an eligible holder of Parent Class A Ordinary Shares has elected to redeem, and has not withdrawn such election, all as determined in

accordance with the Parent Articles and the Trust Agreement.

“Redemption

Price” means an amount equal to the price at which each Parent Class A Ordinary Share initially issued as part of the Parent

Units may be redeemed pursuant to the Redemption, as determined in accordance with the Parent Articles and the Trust Agreement.

“Registration

Statement” means the registration statement on Form S-4 filed in connection with the Transactions, including the combined Proxy

Statement/Prospectus included therein, whether in preliminary or definitive form, and any amendments or supplements thereto.

“Regulatory

Authority” means any Governmental Entity responsible for granting approvals, licenses, clearances, permits or authorizations

required by applicable Law in connection with the business activity of the Company (including the Company Subsidiaries) or Parent, including

the U.S. Securities and Exchange Commission, Nasdaq and any applicable antitrust, foreign investment review or export control authority,

and any foreign equivalents of any of the foregoing.

“Representatives”

means, with respect to any Person, such Person’s Affiliates and the respective officers, directors, managers, consultant, employees,

independent contractors, advisors (including financial advisors, counsel and accountants), representatives, agents and other legal representatives

of such Person or its Affiliates.

“Required

Company Consents” means the Company Consents set forth on Company Schedule 1.1(c).

“Required

Parent Proposals” means the Merger Proposal, the Domestication Proposal, the Charter Amendment Proposal, the Stock Issuance

Proposal, the Equity Incentive Proposal and the Name Change Proposal.

“Sarbanes-Oxley Act”

means the Sarbanes-Oxley Act of 2002.

“SEC” means the Securities and Exchange Commission.

“Securities Act”

means the Securities Act of 1933.

“Software”

means any and all (a) software, firmware, middleware, computer programs, operating systems, applications, and other code, including

APIs, tools, compilers, files, scripts, architecture, algorithms, heuristics, data, data compilations, data files, databases,

protocols, specifications, user interfaces, menus, buttons, icons and other items, as well as foreign language versions, fixes,

upgrades, updates, enhancements and past and future versions and releases, in each case, including all source code, object code or

human readable code; (b) deep learning, machine learning and other artificial intelligence technologies; and (c) manuals, notes,

comments or documentation for or related to any of the foregoing.

“Sponsor”

means Westin Investment Co. Ltd, a Cayman Islands limited liability company.

“Stock Exchange”

means the Nasdaq Stock Market, New York Stock Exchange, NYSE American or another national securities exchange as mutually determined by

Parent and the Company prior to the Closing.

“Subsidiary”

means, with respect to any Person, any other Person of which at least fifty percent (50%) of the capital stock or other equity or voting

securities of such other Person are Controlled or owned, directly or indirectly, by such Person.

“Surviving

Corporation Bylaws” means the bylaws of the Surviving Corporation, in form and substance reasonably acceptable to Parent and

the Company.

“Surviving

Corporation Charter” means the articles of incorporation of the Surviving Corporation, in form and substance reasonably acceptable

to Parent and the Company.

“Tangible

Personal Property” means all tangible personal property and interests therein with a book value or fair market value of greater

than [fifty thousand dollars ($50,000)], including machinery, computers and accessories, furniture, office equipment, communications equipment,

automobiles, laboratory equipment and other equipment owned or leased by the Company or any Company Subsidiary, and other tangible property,

including the items listed on Company Schedule 4.14(a).

“Tax(es)”

means any U.S. federal, state or local or non-U.S. tax, charge, fee, levy, custom, duty, deficiency or other assessment of any kind or

nature imposed by any Taxing Authority (whether disputed or not, whether payable directly or by withholding and whether or not requiring

the filing of a Tax Return), including any income (net or gross), gross receipts, net worth, severance, stamp, premium, environmental,

capital stock, value added, inventory, profits, windfall profit, sales, use, goods and services, ad valorem, franchise, license, withholding,

employment, social security, workers compensation, unemployment compensation, employment, payroll, transfer, excise, import, Real Property,

personal property, intangible property, occupancy, recording, minimum, alternative minimum, escheat, unclaimed property, estimated and

other Taxes, together with any interest, penalty, additions to tax or additional amount imposed with respect thereto and shall include

any liability for such amounts as a result of (a) being a transferee or successor or member of a combined, consolidated, unitary or affiliated

group, or (b) a contractual obligation to indemnify any Person (other than any commercial agreement entered into in the ordinary course

of business and the principal purpose of which is not Taxes).

“Tax Return”

means any return, information return, declaration, claim for refund or credit, report or any similar statement, and any amendment thereto,

including any attached schedule and supporting information, whether on a separate, consolidated, combined, unitary or other basis, that

is filed or required to be filed with any Taxing Authority in connection with the determination, assessment, collection or payment of

a Tax or the administration of any Law relating to any Tax.

“Taxing

Authority” means the Internal Revenue Service and any other Authority responsible for the collection, assessment or imposition

of any Tax or the administration of any Law relating to any Tax.

“Transaction

Expenses” means the Company Transaction Expenses and Parent Transaction Expenses.

“Transactions”

means the transactions contemplated by this Agreement (including the transactions contemplated by any Additional Agreement) to occur at

or immediately prior to or at the Closing, including the Domestication and the Merger.

“Transfer

Taxes” means all transfer, documentary, sales, use, stamp, registration, excise, recording, value added and other such similar

Taxes and fees (including any penalties and interest) that become payable in connection with or by reason of the execution of this Agreement

and the Transactions.

“Treasury

Regulations” means the regulations promulgated under the Code by the United States Department of the Treasury (whether in final

or temporary form), as the same may be amended from time to time.

“U.S. GAAP” means

U.S. generally accepted accounting principles, consistently applied.

I.2 Construction.

(a) References

to particular sections and subsections, clauses and subclauses, schedules, and exhibits not otherwise specified are cross-references to

sections and subsections, schedules, and exhibits of this Agreement. Captions are not a part of this Agreement, but are included for convenience

only.

(a) The

words “herein,” “hereof,” “hereunder,” and words of similar import refer to this Agreement as a whole

and not to any particular provision of this Agreement; and, unless the context requires otherwise, “party” means a party signatory

hereto. The words “on the date hereof” and any words of similar import refer to the date of this Agreement.

(b) Any

use of the singular or plural, or the masculine, feminine or neuter gender, includes the others, unless the context otherwise requires;

the word “including” means “including without limitation”; the word “or” means “and/or”;

the word “any” means “any one, more than one, or all”; and, unless otherwise specified, any financial or accounting

term has the meaning of the term under United States generally accepted accounting principles as consistently applied heretofore by the

Company and the Company Subsidiaries.

reference in this Agreement to “PubCo” shall also mean Parent to the extent the matter relates to the pre-Domestication

period and any reference to “Parent” shall also mean “PubCo” to the extent the matter relates to the post-Domestication

period (including, for the purposes of this Section 1.3(d), the Domestication Effective Time).

(d) Any

reference in this Agreement to “Surviving Corporation” shall also mean the Company to the extent the matter relates to the

pre-Closing period and any reference to “Company” shall also mean “Surviving Corporation” to the extent the matter

relates to the post-Closing period (including, for the purposes of this Section 1.3(e), the Merger Effective Time).

(e) Unless

otherwise specified, any reference to any agreement (including this Agreement), instrument, or other document includes all schedules,

exhibits, or other attachments referred to therein, and any amendments thereto, and any reference to a statute or other law means such

law as amended, restated, supplemented or otherwise modified from time to time and includes any rule, regulation, ordinance or the like

promulgated thereunder, in each case, as amended, restated, supplemented or otherwise modified from time to time. References to “$”

or “dollar” or “US$” shall be references to United States dollars. The word “day” means calendar day

unless Business Day is expressly specified.

(f) The

Company Schedules and the Parent Schedules have been arranged, for purposes of convenience only, in separate sections and subsections

corresponding to the sections and subsections of this Agreement. Any information set forth in any section or subsection of the Company

Schedules or Parent Schedules, as applicable, shall be deemed to be disclosed for purposes of other sections and subsections of this Agreement,

shall be deemed to be incorporated by reference in each of the other sections and subsections of the Company Schedules or Parent Schedules,

as applicable, as though fully set forth in such other sections and subsections (whether or not specific cross-references are made) only

to the extent the relevance of such information is reasonably apparent from the face of such disclosure. No reference to or disclosure

of any item or other matter in the Company Schedules or Parent Schedules, as applicable, shall be construed as an admission or indication

that such item or other matter is material, that such item is outside the ordinary course of business or not consistent with past practice,

or that such item or other matter is required to be referred to or disclosed in the Company Schedules or Parent Schedules, as applicable.

The information set forth in the Company Schedules or Parent Schedules, as applicable, is disclosed solely for purposes of this Agreement,

and no information set forth therein shall be deemed to be an admission by any party to any third party of any matter whatsoever, including

any violation of Law or breach of any Contract. The information set forth in the Company Schedules or Parent Schedules, as applicable,

that are not required by this Agreement to be so reflected are set forth solely for informational purposes.

(g) If

any action is required to be taken or notice is required to be given within a specified number of days following a specific date or event,

the day of such date or event is not counted in determining the last day for such action or notice. If any action is required to be taken

or notice is required to be given on or before a particular day which is not a Business Day, such action or notice shall be considered

timely if it is taken or given on or before the next Business Day.

(h) The

phrases “provided,” “delivered,” or “made available,” when used in this Agreement, shall mean that

the information referred to has been posted in the “data room” (virtual) hosted by Box and established by the Company or its

Representatives and to which, and to the extent to which, Parent and its Representatives have had access prior to 10:00 a.m. Eastern Time

on the day prior to the date of this Agreement.

ARTICLE II

THE DOMESTICATION AND THE MERGER

II.1 The Domestication.

(a) On

the Business Day immediately preceding the Closing Date, Parent shall deregister as an exempted company incorporated under the laws of

the Cayman Islands and continue into the State of Nevada pursuant to Part XII of the Companies Act (As Revised) of the Cayman Islands

and Chapter 92A of the Nevada Revised Statutes (the “Domestication”).

(b) In connection with the Domestication, Parent shall:

(i) file Articles of Domestication with the Nevada Secretary of State;

(ii) file Articles of Incorporation substantially in the form attached hereto as Exhibit A;

(iii) adopt the Bylaws attached hereto as Exhibit B;

(iv) thereafter

continue its corporate existence as a Nevada corporation under the name “Wellgevity 360].”

(i) each

issued and outstanding Parent Class A Ordinary Share shall automatically convert into one validly issued, fully paid and non-assessable

share of PubCo Common Stock;

(ii) each

outstanding Parent Right shall automatically become a Right exercisable for PubCo Common Stock upon the same terms and conditions in effect

immediately prior to the Domestication;

(iii) Parent

shall thereafter continue as PubCo without interruption of its corporate existence.

(d) The

Domestication shall not affect any rights, privileges, obligations or liabilities of Parent existing immediately prior to the Domestication

Effective Time, all of which shall continue as obligations of PubCo.

II.2 The Merger.

Subject to the terms and conditions of this Agreement, immediately following the Domestication Effective Time, Merger Sub, a Delaware

corporation and wholly owned subsidiary of PubCo, shall merge with and into the Company in accordance with Section 251 of the Delaware

General Corporation Law (the “DGCL”), with the separate corporate existence of Merger Sub ceasing and the Company

surviving the Merger as a wholly owned subsidiary of PubCo (the “Surviving Corporation”).

(a) Merger.

Upon the terms and subject to the conditions of this Agreement and in accordance with the DGCL, at the Closing:

(i) Merger Sub shall merge with and into the Company;

(ii) the separate corporate existence of Merger Sub shall cease;

(iii) the Company shall survive the Merger as the Surviving Corporation; and

(iv) the Surviving Corporation

shall become a wholly owned subsidiary of PubCo.

(b) Effect

of the Merger. At the Merger Effective Time, the effect of the Merger shall be as provided in this Agreement, the Certificate of

Merger and the applicable provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, pursuant to

the Merger, at the Merger Effective Time, (i) the Company Securityholders shall be entitled to the consideration described in, and

in accordance with the provisions of, ARTICLE III and (ii) all the property, rights, privileges, agreements, powers and

franchises, debts, liabilities, duties and obligations of the Company and Merger Sub shall become the property, rights, privileges,

agreements, powers and franchises, debts, liabilities, duties and obligations of the Surviving Corporation, which shall include the

assumption by the Surviving Corporation of any and all agreements, covenants, duties and obligations of the Company and the Merger

Sub set forth in this Agreement to be performed after the Closing.

Documents of the Surviving Corporation. At the Merger Effective Time, by virtue of the Merger, the Company Certificate of Incorporation

and the Company Bylaws, in each case as in effect immediately prior to the Merger Effective Time, shall cease and shall be amended and

restated in their entireties to be the Surviving Corporation Charter and the Surviving Corporation Bylaws, respectively, until thereafter

supplemented or amended in accordance with their terms and the DGCL.

II.3 Closing. Unless this Agreement

is earlier terminated in accordance with ARTICLE X, the closing of the transactions contemplated by this Agreement (the “Closing”)

shall take place remotely on the second (2nd) Business Day after the satisfaction or waiver (to

the extent permitted by applicable Law) of the conditions set forth in ARTICLE IX (other than those conditions that by their terms

are to be satisfied at the Closing, but subject to the satisfaction or waiver thereof), or at such other time, date and location as Parent

and Company agree in writing. The parties hereto may participate in the Closing via the exchange of signature pages via email or other

electronic means. The date on which the Closing actually occurs is hereinafter referred to as the “Closing Date”.

II.4 Directors and Officers of PubCo and

the Surviving Corporation.

(a) Following

the Domestication and Prior to the Merger. Effective as of the Closing, the Board of Directors of PubCo shall consist of the number

of directors determined by the Parties prior to the Closing in accordance with this Agreement and the applicable governance documents

of PubCo.

(b) Following

the Merger. The parties hereto will take all requisite action such that, immediately after the Merger Effective Time:

(i) PubCo’s

Board of Directors will initially consist of five directors, as follows: (A) one (1) director who qualifies as an Independent Director

will be designated by the Sponsor; (B) three directors who each qualify as Independent Directors will be designated by the Company after

consultation with Parent; and (C) one director will be the Company’s Chief Executive Officer; provided, that the chairman of PubCo’s

Board of Directors shall be designated by the Company from among the directors designated pursuant to clauses (B) and (C); provided,

that at least a majority of PubCo’s Board of Directors shall qualify as Independent Directors. The initial director designees are

set forth on Company Schedule 2.4(b)(i), with such individuals holding such office until their respective successors are duly appointed

and qualified or until their earlier death, resignation or removal. If any Person designated pursuant to this Section 2.4(b)(i)

is not duly elected at the Parent Shareholder Meeting, the parties hereto shall take all necessary action to fill any such vacancy on

PubCo’s Board of Directors with such Person or an alternative Person designated in accordance with this Section 2.4(b)(i).

(ii) The

individuals identified on Company Schedule 2.4(b)(ii) will be the officers of PubCo, with such individuals holding the titles set

forth opposite their names until their respective successors are duly appointed and qualified or until their earlier death, resignation

or removal.

(iii) The

officers and directors of PubCo immediately after the Merger Effective Time will also serve as the officers and directors of the Surviving

Corporation immediately after the Merger Effective Time, with such individuals holding such office until their respective successors are

duly appointed and qualified or until their earlier death, resignation or removal.

II.5 Taking of Necessary Action; Further

Action. If, at any time after the Closing, any further action is necessary or desirable to carry out the purposes of this Agreement

and to vest the Surviving Corporation with full right, title and interest in, to and under, or possession of, all assets, property, rights,

privileges, powers and franchises of the Company and the Merger Sub, the officers and directors of the Surviving Corporation are fully

authorized in the name and on behalf of the Company and the Merger Sub, to take all lawful action necessary or desirable to accomplish

such purpose or acts, so long as such action is not inconsistent with this Agreement.

II.6 Appraisal

Rights. Notwithstanding anything to the contrary contained herein, any shares of Company Capital Stock that are issued and

outstanding immediately prior to the Merger Effective Time and in respect of which appraisal rights shall have been perfected, and

not waived, withdrawn or lost, in accordance with the DGCL in connection with the Merger and that are owned by a holder who complies

in all respects with Section 262 of the DGCL (such shares, “Dissenting Shares”) shall not be converted into the

right to receive the Per Share Merger Consideration, but shall instead be converted into the right to receive such consideration as

may be determined to be due with respect to any such Dissenting Shares pursuant to the DGCL. At the Merger Effective Time, (a) all

Dissenting Shares shall be cancelled, extinguished and cease to exist and (b) the holders of Dissenting Shares shall be entitled

only to such rights as may be granted to them under the DGCL. Each holder of Dissenting Shares who, pursuant to the DGCL, becomes

entitled to payment thereunder for such shares shall receive payment therefor in accordance with the DGCL (but only after the value

therefor shall have been agreed upon or finally determined pursuant to such provisions). If, after the Merger Effective Time, any

Dissenting Shares shall lose their status as Dissenting Shares, then (i) the right of such holder to be paid the fair value of such

shares shall cease, (ii) any such shares shall immediately be deemed to have converted, as of the Merger Effective Time, into the

right to receive the applicable portion of the Aggregate Merger Consideration (upon the terms and conditions of this Agreement) in

respect of such shares as if such shares never had been Dissenting Shares, and (iii) PubCo shall issue and deliver (or cause to be

issued and delivered) to the holder thereof, in accordance with the terms and conditions set forth in this Agreement, the applicable

portion of the Aggregate Merger Consideration as if such shares never had been Dissenting Shares. The Company shall give Parent

prompt written notice (and in any event within two (2) Business Days) of any demands received by the Company for appraisal of shares

of Company Capital Stock, attempted withdrawals of such demands and any other instruments served pursuant to the DGCL and received

by the Company relating to rights to be paid the fair value of Dissenting Shares, and Parent shall have the right to participate in

and, following the Merger Effective Time, direct all negotiations and proceedings with respect to such demands. Prior to the Merger

Effective Time, the Company shall not, except with the prior written consent of Parent (such consent not to be unreasonably

withheld, conditioned, or delayed), (x) make any payment or offer to make any payment with respect to, or settle or compromise or

offer to settle or compromise, any claim or demand in respect of any Dissenting Shares, (y) waive any failure to timely deliver a

written demand for appraisal or otherwise comply with the provisions under Section 262 of the DGCL or (z) agree or commit to do any

of the foregoing.

II.7 Transaction

Expenses. Except as otherwise expressly provided in this Agreement, Parent shall be responsible for and shall pay all Parent

Transaction Expenses, and the Company shall be responsible for and shall pay all Company Transaction Expenses. Notwithstanding the

foregoing, if Parent is required to deposit, contribute or otherwise fund any amounts to extend the deadline by which Parent must

consummate its initial business combination pursuant to its Organizational Documents, applicable Law or any agreement governing such

extension (including any contributions to Parent’s trust account or payments made in connection with obtaining shareholder

approval for any such extension), the Company shall reimburse Parent for the full amount of such extension funding within three (3)

Business Days with reasonable supporting documentation evidencing such payment. Such extension funding shall not constitute Parent

Transaction Expenses for purposes of this Agreement and shall instead be borne solely by the Company.

Not less than three

(3) Business Days prior to the Closing Date, each of Parent and the Company shall deliver to the other Party a good faith written statement

setting forth, in reasonable detail, all unpaid Transaction Expenses expected to be outstanding as of the Closing, together with copies

of all material invoices, engagement letters, statements, wire instructions and such other supporting documentation as the other Party

may reasonably request. Each Party shall use commercially reasonable efforts to cause all invoices relating to its respective Transaction

Expenses incurred through the Closing Date to be submitted on or prior to the Closing Date and shall not knowingly withhold or defer the

submission of any such invoice for the purpose of causing such expense to become an obligation of PubCo following the Closing. Following

the Closing, PubCo shall pay only those unpaid Transaction Expenses reflected on the final Closing Funds Flow Memorandum or otherwise

approved in writing by Parent and the Company prior to the Closing. Each Party shall remain solely responsible for any Taxes imposed upon

such Party with respect to its respective Transaction Expenses, including any employment Taxes, withholding Taxes or similar Taxes arising

from any bonuses, change in control payments or other compensatory payments payable by such Party, and shall timely prepare, file and

furnish all applicable IRS Forms W-2, Forms 1099 and any other required federal, state or local Tax forms or information returns relating

thereto. Each Party shall cooperate in good faith in the preparation of the Closing Funds Flow Memorandum and shall promptly provide such

additional documentation relating to its Transaction Expenses as may be reasonably requested by the other Party, PubCo or the auditors

in connection with the preparation of the financial statements or any post-Closing audit.

ARTICLE

III

CONSIDERATION TO

COMPANY SECURITYHOLDERS

III.1 Conversion of Company Securities.

Subject to the terms and conditions of this Agreement, at the Merger Effective Time, by virtue of the Merger and without any further

action on the part of Parent, PubCo, Merger Sub, the Company or any holder of Company Securities:

(a) each

issued and outstanding share of Company Common Stock (other than Excluded Shares and Dissenting Shares) shall automatically be cancelled

and converted into the right to receive the applicable portion of the Aggregate Merger Consideration, as determined pursuant to this Article

III and the Closing Consideration Spreadsheet (the “Per Share Merger Consideration”):

(b) each

outstanding share of Company Preferred Stock, if any, shall be converted into the right to receive such portion of the Aggregate Merger

Consideration as set forth in the Closing Consideration Spreadsheet and in accordance with the Company’s Organizational Documents:

issued and outstanding share of common stock of Merger Sub shall automatically be converted into one (1) validly issued, fully paid and

non-assessable share of common stock of the Surviving Corporation; and

(d) all

shares of Company Capital Stock held in the treasury of the Company immediately prior to the Merger Effective Time shall automatically

be cancelled without any conversion or payment therefor.

III.2 Treatment

of Company Equity Awards. At the Merger Effective Time, each outstanding Company Equity Award shall be treated as set forth

on Schedule 3.2. Prior to the Closing, the Company shall take all actions reasonably necessary to effect the treatment of the Company

Equity Awards contemplated by this Agreement, including obtaining any required approvals from its Board of Directors, compensation committee

and, if required, the holders of such Company Equity Awards. Following the Closing, PubCo shall honor the obligations assumed pursuant

to this Section 3.2 in accordance with the applicable award agreements and the terms of this Agreement.

III.3 Exchange of Shares.

(a) Exchange

Procedures. At or prior to the Closing, PubCo shall deposit with the Exchange Agent the Aggregate Merger Consideration for the benefit

of the holders of Company Securities entitled to receive the Per Share Merger Consideration pursuant to this Agreement. As soon as reasonably

practicable following the Merger Effective Time (and in any event within five (5) Business Days thereafter), the Exchange Agent shall

deliver to each holder of Company Securities a letter of transmittal in customary form and such instructions as may be reasonably necessary

to surrender such holder’s Company Securities in exchange for the applicable Per Share Merger Consideration. Upon receipt of a duly

completed letter of transmittal and such other customary documentation as the Exchange Agent may reasonably require, PubCo shall cause

the Exchange Agent to issue to such holder the applicable Per Share Merger Consideration in book-entry form, subject to applicable withholding

Taxes. Until surrendered in accordance with this Section 3.3, each Company Security shall represent only the right to receive the applicable

Per Share Merger Consideration.

(b) Distributions

with Respect to Unexchanged Company Capital Stock. No dividends or other distributions declared after the Merger Effective Time with

respect to PubCo Common Stock issuable pursuant to this Article III shall be paid to any holder until such holder has surrendered its

Company Securities in accordance with this Section 3.3, after which such holder shall be entitled to receive all such unpaid dividends

or distributions, without interest, subject to applicable Law.

to Per Share Merger Consideration. The Per Share Merger Consideration shall be adjusted to reflect appropriately the effect of any

stock split, subdivision, reverse stock split, stock dividend, reorganization, recapitalization, reclassification, combination, consolidation,

exchange of shares or other like change with respect to Parent outstanding securities or Company Capital Stock occurring on or after the

date of this Agreement and prior to the Merger Effective Time.

(d) Unclaimed

Merger Consideration. Any portion of the Aggregate Merger Consideration remaining undistributed to the former holders of Company Common

Stock (and any other Company Securities entitled to receive Merger Consideration) one (1) year following the Merger Effective Time shall

be delivered to PubCo, and any former holder of Company Securities who has not theretofore complied with this Article III shall thereafter

look solely to PubCo (subject to applicable abandoned property, escheat or similar Laws) as a general unsecured creditor for payment of

the Per Share Merger Consideration to which such holder is entitled, without any interest thereon. Notwithstanding anything herein to

the contrary, none of PubCo, Parent, the Surviving Corporation, the Exchange Agent or any of their respective Affiliates shall be liable

to any Person for any portion of the Aggregate Merger Consideration delivered to a Governmental Authority pursuant to any applicable abandoned

property, escheat or similar Law.

III.4

Closing Consideration Spreadsheet. No later than two (2) Business Days prior to the Closing Date, the Company shall deliver to

Parent a certificate (the “Closing Consideration Spreadsheet”), certified by the Chief Executive Officer and Chief Financial

Officer of the Company, setting forth, as of immediately prior to the Merger Effective Time: (a) the name of each holder of Company Securities

and the number and class of Company Securities held by such holder; (b) the calculation of the Aggregate Merger Consideration, the Per

Share Merger Consideration and any other amounts payable pursuant to this Agreement; (c) the treatment of any Company Equity Awards,

if any; and (d) such other information reasonably requested by Parent or the Exchange Agent to effect the transactions contemplated by

this Agreement. Parent shall be entitled to rely conclusively upon the Closing Consideration Spreadsheet in making the distributions

contemplated by this Article III, absent manifest error. The Company shall remain solely responsible for the accuracy and completeness

of the Closing Consideration Spreadsheet.

III.5 No Fractional Shares. No fractional

shares of PubCo Common Stock, or certificates or scrip representing fractional shares of PubCo Common Stock, will be issued upon the

conversion of the Company Capital Stock pursuant to the Merger, and any such fractional shares or interests therein will not entitle

the owner thereof to vote or to any rights of a stockholder of PubCo. Any fractional shares of PubCo Common Stock will be rounded down

to the nearest whole number of shares of PubCo Common Stock and no cash or other consideration shall be paid in lieu of any fractional

share.

I.2 Withholding. Notwithstanding any

other provision to this Agreement, Parent, Merger Sub, the Company, and the Surviving Corporation (and their respective affiliates and

Representatives) shall be entitled to deduct and withhold from any amount payable pursuant to this Agreement such amounts that are required

to be deducted or withheld under the applicable tax law. To the extent that amounts are so deducted and withheld and paid or remitted

over to the appropriate Authorities, such amounts shall be treated for all purposes under this Agreement as having been paid to the Person

in respect of which such deduction and withholding was made. Notwithstanding the foregoing, Parent, Merger Sub, the Company and the Surviving

Corporation shall use commercially reasonable efforts to provide recipients of consideration with a reasonable opportunity to provide

documentation establishing exemptions from or reductions of such withholdings. In the case of any such payment payable to employees of

the Company in connection with the Merger treated as compensation, the parties hereto shall cooperate to pay such amounts through the

Company’s payroll to facilitate applicable withholding.

I.3 No Further Ownership Rights in Company

Securities. At the Merger Effective Time, the stock transfer books of the Company shall be closed and thereafter there shall be no

further registration of transfers of shares of the Company Securities. From and after the Merger Effective Time, the holders of Company

Securities outstanding immediately prior to the Merger Effective Time (including any stock certificates evidencing such shares) shall

cease to have any rights with respect thereto except the right to receive the applicable Merger Consideration pursuant to this Article

III and such other rights, if any, as may be provided under this Agreement or applicable Law.

ARTICLE IV1

REPRESENTATIONS AND

WARRANTIES OF THE COMPANY

Except as set forth

in the Company Schedules, the Company hereby represents and warrants to Parent and Merger Sub as of the date of this Agreement and as

of the Closing Date (except for representations and warranties that are made as of a specific date, which are made only as of such date):

IV.1 Corporate Existence and Power.

(a) The

Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware. The Company

has all power and authority, corporate and otherwise, and all governmental Permits, required to own, lease or otherwise hold, and operate,

all of its properties and assets and to carry on the Business as presently conducted and as proposed to be conducted. The Company is duly

licensed or qualified to do business and in good standing in each jurisdiction where such qualification is required, except where the

failure to be so qualified or in good standing would not reasonably be expected to have a Material Adverse Effect. The Company has made

available to Parent true, correct and complete copies of its Organizational Documents, each of which is in full force and effect, and

the Company is not in material violation thereof.

(b) Each

Subsidiary of the Company (each a “Company Subsidiary” and collectively, the “Company Subsidiaries”)

is duly formed or organized, validly existing and in good standing under the Laws of the jurisdiction of organization, has the requisite

organizational power and authority to own, lease and operate its properties and conduct its business as presently conducted, and is duly

qualified to do business where required, except where the failure to be so qualified or in good standing would not reasonably be expected

to have a Material Adverse Effect. The Company has made available to Parent true, correct and complete copies of the Organizational Documents

of each Company Subsidiary, each of which is in full force and effect. On Closing, the Company will own 100% of the capital stock of each

of the Subsidiaries.

IV.2

Authorization. The Company has all requisite corporate power and authority to execute and deliver this Agreement and each Additional

Agreement to which it is or will be a party and, subject to obtaining the Company Stockholder Approval, to consummate the Transactions.

The execution, delivery and performance of this Agreement and the Additional Agreements by the Company and the consummation of the Transactions

have been duly authorized by all necessary corporate action on the part of the Company, other than the Company Stockholder Approval,

and no other corporate proceedings are necessary to authorize this Agreement or the Transactions. The Board of Directors of the Company

has duly approved this Agreement and the Transactions and resolved to recommend that the Company’s stockholders approve this Agreement,

subject to applicable Law and the fiduciary duties of the Board of Directors. This Agreement has been duly executed and delivered by

the Company and, assuming the due authorization, execution and delivery by the other parties hereto, constitutes a valid and binding

obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions.

IV.3 Governmental

Authorization. Except for (a) compliance with the applicable requirements of the Securities Act, the Exchange Act and applicable

state securities Laws, (b) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware and the

Articles of Merger with the Secretary of State of the State of Nevada, (c) receipt of the Company Stockholder Approval, (d) approval

of the listing of the shares of PubCo Common Stock to be issued in connection with the Transactions on the applicable national

securities exchange, and (e) such other consents, approvals, filings or notices the failure of which to obtain or make would not

reasonably be expected to have a Material Adverse Effect or materially impair the Company’s ability to consummate the

Transactions, no consent, approval, order or authorization of, or registration, declaration or filing with, any Governmental

Authority is required in connection with the execution, delivery or performance of this Agreement by the Company or the consummation

of the Transactions.

IV.4 Non-Contravention. Assuming the

receipt of the Company Stockholder Approval and the consents, approvals, filings and notices referred to in Section 4.3, neither the

execution, delivery or performance of this Agreement or any Additional Agreement by the Company, nor the consummation of the Transactions,

will: (a) conflict with or violate the Organizational Documents of the Company or any Company Subsidiary; (b) violate any applicable

Law or Order applicable to the Company or any Company Subsidiary; or (c) result in any breach of, constitute a default under, or give

rise to any right of termination, cancellation or acceleration under any Material Contract, except, in the case of clauses (b) and (c),

where such conflict, violation, breach, default, termination, cancellation or acceleration would not reasonably be expected to have a

Material Adverse Effect or materially delay or prevent the consummation of the Transactions.

IV.5 Capitalization. The authorized,

issued and outstanding Company Securities are accurately set forth in Schedule 4.5, which includes, as of the date of this Agreement:

(a) the authorized and outstanding shares of Company Capital Stock, by class or series; (b) all outstanding Company Equity Awards, if

any, including the number of shares subject thereto and the applicable exercise or purchase price, if any; (c) all outstanding securities

convertible into or exercisable for Company Capital Stock, if any; and (d) the record holders thereof, to the extent required to determine

the Merger Consideration.

Except as set forth

on Schedule 4.5, there are no outstanding (i) shares of Company Capital Stock, (ii) Company Equity Awards, (iii) securities convertible

into or exchangeable for Company Capital Stock, (iv) options, warrants, rights, calls, subscriptions or other rights to acquire Company

Capital Stock, or (v) obligations of the Company or any Company Subsidiary to issue, redeem, repurchase or otherwise acquire any Company

Securities.

All outstanding

shares of Company Capital Stock have been duly authorized and validly issued and are fully paid and non-assessable and were issued in

compliance with applicable Law and the Company’s Organizational Documents.

IV.6 Corporate Records. All material

proceedings of the Board of Directors of the Company, including all committees thereof, of the equivalent governing body of each Company

Subsidiary, and of the Company Stockholders, and all consents to material actions taken thereby, are reflected accurately in all material

respects in the minutes and records contained in the corporate minute books of the Company and each Company Subsidiary and made available

to Parent.

IV.7 Subsidiaries. Schedule 4.7 sets

forth a true and complete list of each Company Subsidiary, its jurisdiction of organization and the Company’s direct or indirect

ownership interest therein. Except as set forth on Schedule 4.7, neither the Company nor any Company Subsidiary owns, directly or indirectly,

any equity interest in any other Person.

IV.8 Consents. Schedule 4.8 sets forth

all Material Contracts requiring the consent of, or notice to, any Person in connection with the execution, delivery or performance of

this Agreement or the consummation of the Transactions (collectively, the “Company Consents”). Except as set forth

on Schedule 4.8, no such consent or notice is required.

IV.9 Financial Statements.

(a) The

Company has made available to Parent, including through its SEC Documents, true and complete copies of its audited financial statements

for the fiscal year ended December 31, 2025 and its unaudited interim financial statements for the quarter ended March 31, 2026 (collectively,

the “Company Financial Statements”). The Company Financial Statements have been prepared, in all material respects,

in accordance with U.S. GAAP consistently applied throughout the periods presented (except, in the case of unaudited interim financial

statements, for normal year-end adjustments and the absence of footnote disclosures permitted by applicable SEC rules) and fairly present,

in all material respects, the financial position of the Company as of the respective dates thereof and the results of operations and cash

flows for the respective periods then ended.

(b) Since

March 31, 2026 (the “Balance Sheet Date”), except as disclosed in the Company SEC Documents filed after such date and

prior to the date of this Agreement, the Company has not incurred any liabilities or obligations required by U.S. GAAP, to

be reflected on a balance sheet, other than (i) liabilities incurred in the ordinary course of business consistent with past practice,

(ii) obligations arising under this Agreement or the Transactions, and (iii) liabilities that would not reasonably be expected to have,

individually or in the aggregate, a Material Adverse Effect.

Company has timely filed all forms, reports, schedules, statements and other documents required to be filed by it with the SEC under the

Exchange Act since becoming subject thereto (the “Company SEC Documents”). As of their respective filing dates (or,

if amended, as of the date of the last such amendment), the Company SEC Documents complied in all material respects with the applicable

requirements of the Securities Act and the Exchange Act, as applicable, and did not contain any untrue statement of a material fact or

omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances

under which they were made, not misleading.

(d) The

Company maintains a system of internal accounting controls and disclosure controls and procedures reasonably designed to provide reasonable

assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP. To

the Knowledge of the Company, since the Balance Sheet Date, there has not been any material weakness in internal control over financial

reporting or any material fraud involving management or other employees having a significant role in the Company’s internal controls

or financial reporting, except as disclosed in the Company SEC Documents

IV.10 Internal

Accounting Controls. The Company and the Company Subsidiaries have established and maintain a system of internal accounting

controls sufficient to provide reasonable assurance that: (a) transactions are executed in accordance with management’s

general or specific authorizations; (b) transactions are recorded as necessary to permit preparation of financial statements in

conformity with the historical practices of the Company and the Company Subsidiaries and to maintain asset accountability; (c)

access to assets is permitted only in accordance with management’s general or specific authorization; and (d) the recorded

accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect

to any differences. The Company and the Company Subsidiaries have not identified and have not received notice from any independent

auditor of (x) any significant deficiency or material weakness in the system of internal controls utilized by the Company or any

Company Subsidiary, (y) any material fraud that involves the management of the Company or any Company Subsidiary, or other employees

of the Company or any Company Subsidiary who have a significant role in the preparation of financial statements or the internal

controls over financial reporting utilized by the Company or any Company Subsidiary or (z) any claim or allegation regarding any of

the foregoing.

IV.11 Absence of Certain Changes.

(a) From

the Balance Sheet Date until the date of this Agreement, (a) the Company and each Company Subsidiary has conducted in all material

respects the Business in the ordinary course and in a manner consistent with past practice; (b) there has not been any Material

Adverse Effect; and (c) the Company and the Company Subsidiaries have not taken any action, or committed or agreed to take any

action, that, if taken after the date of this Agreement and prior to the consummation of the Transactions, would require the consent

of Parent pursuant to Section 6.1.

(b) No

measures have been taken for the dissolution and liquidation or declaration of bankruptcy of the Company or any Company Subsidiary and

no events have occurred which would justify any such measures to be taken, in particular (i) no order has been made, petition presented,

resolution passed or meeting convened for the winding up, dissolution or liquidation of the Company or any Company Subsidiary and there

are no proceedings under applicable insolvency, bankruptcy, composition, moratorium, reorganization or similar laws and no events have

occurred which would require the initiation of any such proceedings; and (ii) no receiver, liquidator, administrator, commissioner or

similar official has been appointed in respect of the Company or any Company Subsidiary and no step has been taken for or with a view

to the appointment of such a person. The Company and the Company Subsidiaries are neither over-indebted nor insolvent nor unable to pay

their debts as they fall due pursuant to applicable Law.

IV.12

Properties; Title to the Company’s Assets. The Company and each Company Subsidiary have good and valid title to, or valid

leasehold or license interests in, all material assets used in the conduct of the Business, free and clear of all Liens other than Permitted

Liens. Such assets are sufficient in all material respects to conduct the Business immediately following the Closing in substantially

the same manner as conducted immediately prior to the Closing.

IV.13 Litigation. There is no Action

pending or, to the Knowledge of the Company, threatened against or affecting the Company or any Company Subsidiary, any of the officers

or directors of the Company or any Company Subsidiary (in their capacities as such), the Business, any of the assets or properties of

the Company or any Company Subsidiary or any Contract before any Authority that any manner challenges or seeks to prevent, enjoin, alter

or delay the Transactions. There are no outstanding judgments against the Company or any Company Subsidiary. The Company and the Company

Subsidiaries are not, and have not been, subject to any Action, Order, settlement agreement or other similar written agreement by or

with, or to the Knowledge of the Company, investigation by, any Authority.

IV.14 Material Contracts.

(a) Company

Schedule 4.14 sets forth all Material Contracts of the Company and each Company Subsidiary. The Company has made available to Parent

true and complete copies of all Material Contracts, including all material amendments thereto.

(b) Each

Material Contract is (i) a legal, valid and binding obligation of the Company or any Company Subsidiary and, to the Knowledge of the

Company, the other parties thereto, (ii) in full force and effect and (iii) enforceable by and against the Company or any Company

Subsidiary and each counterparty that is party thereto, subject, in the case of this clause (iii), to the Enforceability

Exceptions. Neither the Company, any Company Subsidiary, nor, to the Company’s Knowledge, any other party to a Material

Contract, is in material breach, violation or default (whether with or without the passage of time or the giving of notice or both)

under the terms of any such Material Contract nor has any Material Contract been cancelled by the other party. Neither the Company

nor any Company Subsidiary has assigned, delegated or otherwise transferred any of its rights or obligations under any Material

Contract or granted any power of attorney with respect thereto. Neither the Company nor any Company Subsidiary has received any

claim of default under any such Material Contract, except for any such conflicts, violations, breaches, defaults or other

occurrences which would not adversely affect the Company or any Company Subsidiary in any material respect. Except as would not

adversely affect the Company or any Company Subsidiary in any material respect, no party to a Material Contract has given notice of

or, to the Knowledge of the Company, threatened (A) any potential exercise of termination rights with respect to any Material

Contract or (B) any non-renewal or modification of any Material Contract.

as set forth on Company Schedule 4.14, none of the execution, delivery or performance by the Company of this Agreement or any

Additional Agreement to which the Company or any Company Subsidiary is or will be a party or the consummation by the Company or any Company

Subsidiary of the Transactions constitutes or will constitute a default under or gives rise or will give rise to any right of termination,

cancellation or acceleration of any obligation of the Company or any Company Subsidiary or any right of termination or cancellation of

any obligation of the counterparty thereto or to a loss of any material benefit to which the Company or any Company Subsidiary is entitled

under any provision of any Material Contract.

“Material Contract”

means any Contract: (i) required to be filed as an exhibit pursuant to Item 601 of Regulation S-K; (ii) involving aggregate payments or

obligations in excess of $250,000;(iii) relating to indebtedness; (iv) relating to the acquisition or disposition of material assets;

(v) containing material non-competition, exclusivity or change-of-control provisions; or (vi) otherwise material to the Business.

IV.15 Permits. The Company and

each Company Subsidiary hold all material permits, licenses, approvals, registrations, certifications and other governmental authorizations

(collectively, the “Permits”) necessary to own, lease and operate their respective assets and to conduct the Business

as currently conducted. The Permits are valid and in full force and effect, and neither the Company nor any Company Subsidiary is in

material violation of, or default under, any Permit, except where such violation or default would not reasonably be expected to have

a Material Adverse Effect. To the Knowledge of the Company, no Action is pending or threatened by any Governmental Authority seeking

to revoke, suspend or materially limit any material Permit.

IV.16 Compliance

with Laws. Except as set forth on Schedule 4.16, the Company and each Company Subsidiary are, and since their respective

dates of formation have been, in compliance in all material respects with all applicable Laws and Orders governing the conduct of

the Business, except where any non-compliance would not reasonably be expected to have a Material Adverse Effect. Neither the

Company nor any Company Subsidiary has received written notice from any Governmental Authority alleging any material violation of

applicable Law that remains unresolved, and, to the Knowledge of the Company, there is no pending or threatened investigation or

Action by any Governmental Authority alleging any such material violation.

Without limiting

the foregoing, the Company and each Company Subsidiary are, in all material respects, in compliance with all applicable Anti-Corruption

Laws, applicable economic sanctions Laws and applicable Data Protection Laws, except where any non-compliance would not reasonably be

expected to have a Material Adverse Effect.

IV.17

Intellectual Property. Except as set forth on Schedule 4.17, the Company and each Company Subsidiary own, or possess valid licenses

or other rights to use, all material Intellectual Property necessary to conduct the Business as currently conducted. Schedule 4.17 sets

forth all material registered Intellectual Property owned by the Company and each Company Subsidiary. To the Knowledge of the Company:

(a) the

operation of the Business does not materially infringe, misappropriate or otherwise violate the Intellectual Property Rights of any Person;

(b) no

Person is materially infringing, misappropriating or otherwise violating any material Intellectual Property owned by the Company or any

Company Subsidiary; and

is no pending or threatened Action challenging the ownership, validity or enforceability of any material Intellectual Property owned by

the Company or any Company Subsidiary or alleging that the operation of the Business infringes, misappropriates or otherwise violates

the Intellectual Property Rights of any Person.

Except as set forth

on Schedule 4.17, the consummation of the Transactions will not, by itself, result in the loss or impairment of any material rights

of the Company or any Company Subsidiary to own or use any material Intellectual Property necessary to conduct the Business as currently

conducted.

IV.18 Accounts Payable; Affiliate Loans.

Except as set forth on Schedule 4.18, all accounts payable reflected on the Company Financial Statements, and all accounts payable

incurred since the Balance Sheet Date, arose in the ordinary course of business consistent with past practice. Schedule 4.18 sets forth

all material indebtedness or other obligations between the Company or any Company Subsidiary, on the one hand, and any Affiliate, on

the other hand

IV.19 Employees; Employment Matters.

(a) Company

Schedule 4.19(a) sets forth a true, correct and complete list of each employee of the Company and each Company Subsidiary as of the

date hereof, setting forth the name, title, current salary or compensation rate for each such person and total compensation (including

bonuses and commissions) paid to each such person for the fiscal year ended December 31, 2025.

(b) Except

as set forth on Company Schedule 4.19(b), neither the Company nor any Company Subsidiary are a party to or subject to any

collective bargaining agreement, or any similar agreement, and there has been no activity or proceeding by a labor union or

representative thereof to organize any employees of the Company or any Company Subsidiary. There is no labor strike, material

slowdown or material work stoppage or lockout pending or, to the Knowledge of the Company, threatened against or affecting the

Company or any Company Subsidiary, and neither the Company nor any Company Subsidiary have experienced any strike, material slowdown

or material work stoppage, lockout or other collective labor action by or with respect to its employees.

Company and each Company Subsidiary are, and have been, in compliance in all material respects with all applicable Laws relating to employment,

including those relating to wages and hours, discrimination, workplace safety, employee classification, immigration and the withholding

and payment of employment Taxes, except where any non-compliance would not reasonably be expected to have a Material Adverse Effect.

(d) Except

as set forth on Schedule 4.19(d), neither the Company nor any Company Subsidiary has agreed to pay any bonus, retention payment, severance

or similar compensation that becomes payable solely as a result of the consummation of the Transactions.

(e) To

the Knowledge of the Company, no employee of the Company or any Company Subsidiary, in the ordinary course of his or her duties, has breached

or will imminently or potentially breach any obligation to a former employer in respect of any covenant against competition or soliciting

clients or employees or servicing clients or any confidentiality or proprietary right of any former employer.

IV.20 Real Property. Schedule 4.20

identifies all real property leased, subleased or otherwise occupied by the Company and each Company Subsidiary (the “Leased

Real Property”). The Company has made available to Parent true and complete copies of all material leases relating to the Leased

Real Property.

The Company and

each Company Subsidiary have valid leasehold interests in the Leased Real Property, free and clear of all Liens other than Permitted Liens.

Each material lease relating to the Leased Real Property is in full force and effect and, to the Knowledge of the Company, no material

default exists thereunder by the Company, any Company Subsidiary or the other party thereto.

Except as set forth

on Schedule 4.20, neither the Company nor any Company Subsidiary owns any real property

IV.21 Tax Matters. Except as set forth

on Schedule 4.21:

(a) The

Company and each Company Subsidiary have timely filed all material Tax Returns required to be filed and have timely paid all material

Taxes due and payable.

(b) The

Company and each Company Subsidiary have complied in all material respects with all applicable Laws relating to the withholding, collection

and payment of Taxes.

are no pending or, to the Knowledge of the Company, threatened audits, examinations or other proceedings relating to any material Taxes

or Tax Returns of the Company or any Company Subsidiary.

(d) There

are no Liens for Taxes upon any assets of the Company or any Company Subsidiary other than Permitted Liens.

(e) Neither

the Company nor any Company Subsidiary is party to any Tax allocation, Tax sharing or Tax indemnification agreement (other than customary

provisions contained in commercial agreements not primarily related to Taxes).

(f) Neither

the Company nor any Company Subsidiary has participated in a transaction described in Section 355 of the Code or a reportable transaction

within the meaning of Treasury Regulation Section 1.6011-4.

(g) Neither

the Company nor any Company Subsidiary has taken or agreed to take any action, or is aware of any fact or circumstance, that would reasonably

be expected to prevent the Transactions from qualifying for the Intended Tax Treatment.

IV.22 Environmental Laws. Except as would

not reasonably be expected to have a Material Adverse Effect, (a) the Company and each Company Subsidiary are, and since their respective

dates of formation have been, in compliance with all applicable Environmental Laws, (b) neither the Company nor any Company Subsidiary

has received any written notice of any pending or threatened Action alleging liability under any Environmental Law that remains unresolved,

and (c) neither the Company nor any Company Subsidiary has assumed or undertaken any material liability of any other Person under any

Environmental Law

IV.23 Licenses

and Regulatory Approvals. The Company and each Company Subsidiary hold, and are in compliance in all material respects with, all licenses,

permits, registrations, certifications, approvals, exemptions, authorizations, and other governmental or professional approvals required

by each Regulatory Authority to own and operate their respective businesses as currently conducted, including the Point Med Acquisition.

Each such license, permit, registration, certification, approval, exemption, authorization, and other governmental or professional approval

is valid and in full force and effect, and neither the Company nor any Company Subsidiary has received written notice of any pending or

threatened suspension, revocation, cancellation, non-renewal, limitation, or adverse modification thereof, except as would not reasonably

be expected to be material to the Company and the Company Subsidiaries, taken as a whole.

IV.24 Finders’ Fees. Except as

set forth on Company Schedule 4.23, there is no investment banker, broker, finder or other intermediary which has been retained

by or is authorized to act on behalf of the Company or any Company Subsidiary or any of their Affiliates who might be entitled to any

fee or commission from the Company, any Company Subsidiary, Merger Sub, Parent or any of their Affiliates upon consummation of the Transactions.

IV.25 Powers of Attorney and Suretyships.

Neither the Company nor any Company Subsidiary has any general or special powers of attorney outstanding (whether as grantor or grantee

thereof) or any obligation or liability (whether actual, accrued, accruing, contingent or otherwise) as guarantor, surety, co-signer,

endorser, co-maker, indemnitor or otherwise in respect of the obligation of any Person.

IV.26 Directors and Officers. Company

Schedule 4.25 sets forth a true, correct and complete list of all directors and officers of the Company and each Company Subsidiary.

IV.27 Anti-Corruption

Laws, Anti-Money Laundering Laws and Sanctions. Except as would not reasonably be expected to have a Material Adverse Effect,

the Company and each Company Subsidiary are, and since their respective dates of formation have been, in compliance in all material

respects with applicable Anti-Corruption Laws, Anti-Money Laundering Laws, applicable economic sanctions Laws and other applicable

international trade Laws. Neither the Company nor any Company Subsidiary has received written notice of any pending investigation by

any Governmental Authority alleging a material violation of any such Laws.

IV.28 Insurance. Schedule 4.27 sets forth

all material insurance policies maintained by the Company and each Company Subsidiary. Such policies are in full force and effect, all

premiums due thereunder have been paid, and, to the Knowledge of the Company, no written notice of cancellation or termination has been

received with respect to any such policy.

IV.29 Related Party Transactions. Except

as disclosed in the Company SEC Documents filed prior to the date of this Agreement or on Schedule 4.28, there are no transactions

required to be disclosed pursuant to Item 404 of Regulation S-K involving the Company or any Company Subsidiary.

IV.30 Top Customers, Vendors, and Suppliers.

Schedule 4.29 identifies the Company’s material suppliers. To the Knowledge of the Company, no Material Supplier has provided

written notice that it intends to terminate or materially reduce its business relationship with the Company

IV.31 No Undisclosed Liabilities. Except

as reflected in the Company Financial Statements, disclosed in the Company SEC Documents filed prior to the date of this Agreement or

incurred in the ordinary course of business since the Balance Sheet Date, neither the Company nor any Company Subsidiary has any liabilities

that would reasonably be expected to have a Material Adverse Effect.

ARTICLE

REPRESENTATIONS

AND WARRANTIES OF PARENT AND MERGER SUB

Except as set forth

in the Parent Schedules or as disclosed in the Parent SEC Documents filed with or furnished to the SEC prior to the date of this Agreement

(other than any risk factor disclosures or other similar cautionary or predictive statements therein), Parent and Merger Sub (the “Parent

Parties”) hereby represent and warrant to the Company as of the date of this Agreement and as of the Closing Date (except for

representations and warranties that are made as of a specific date, which are made only as of such date).

V.1 Corporate Existence and Power. Parent

is a Cayman Islands exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands. Merger

Sub is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware. Parent has all

power and authority, corporate and otherwise, and all governmental Permits, required to own, lease or otherwise hold, and operate, all

of its properties and assets and to carry on its business as presently conducted. Merger Sub has been formed solely for the purpose of

engaging in the Transactions contemplated hereby and, except for activities incidental to its organization and the Transactions, has

not held any material assets or incurred any material liabilities or conducted any business.

V.2

Authorization.

(a) The

Parent Parties have all requisite power and authority to execute, deliver and perform this Agreement and the Additional Agreements to

which they are or will be parties and to consummate the Transactions, in the case of Parent, subject to receipt of the Parent Shareholder

Approval. The execution, delivery and performance by the Parent Parties of this Agreement and the Additional Agreements to which they

are or will be a party, and the consummation by the Parent Parties of the Transactions have been duly authorized by all necessary action

on the part of the Parent Parties, in the case of Parent, subject to receipt of the Parent Shareholder Approval. This Agreement constitutes,

and, upon the execution and delivery thereof, each Additional Agreement to which the Parent Parties are or will be a party will constitute,

a valid and legally binding agreement of Parent Parties, enforceable against Parent Parties in accordance with its terms, except as may

be limited by the Enforceability Exceptions.

(b) As

of the date of this Agreement, the Parent Board has duly (i) determined that this Agreement, the Additional Agreements and the Transactions

are advisable and in the best interests of Parent and its shareholders, (ii) approved this Agreement, the Additional Agreements and the

Transactions, including the Domestication and the Merger, and (iii) resolved to recommend that Parent’s shareholders approve the

Parent Proposals (the “Parent Board Recommendation”).

Parent Shareholder Approval is the only vote of the holders of Parent Ordinary Shares necessary to approve this Agreement, the Domestication,

the Merger and the other Transactions.

V.3 Governmental Authorization. Assuming

the accuracy of the representations and warranties set forth in Section 4.3, none of the execution, delivery or performance by

the Parent Parties of this Agreement or any Additional Agreement to which the Parent Parties are or will be a party, or the consummation

of the Transactions, requires any consent, approval, license, Order, or other action by or in respect of, or registration, declaration

or filing with, any Authority, except for (a) any SEC or Nasdaq filings and approval required to consummate the Transactions, (b) filing

with the Secretary of State of the State of Nevada a Articles of Conversion with respect to the Domestication, (c) filings required to

be made with the Cayman Registrar in connection with the Domestication, and (d) the filings of the Certificate of Merger with the Secretary

of State of the State of Delaware pursuant to the DGCL, the filing of articles of merger with the Secretary of State of the State of

Nevada pursuant to the NRS, and the filing of the PubCo COI with the Secretary of State of the State of Nevada pursuant to the NRS.

V.4 Non-Contravention. Subject to the

receipt of the Parent Shareholder Approval, none of the execution, delivery or performance by the Parent Parties of this Agreement or

any Additional Agreement to which the Parent Parties are or will be a party does or will (a) conflict with or violate the Organizational

Documents of Parent or Merger Sub; (b) violate any applicable Law or Order applicable to Parent or Merger Sub; or (c) result in any material

breach of, constitute a material default under, or give rise to any right of termination or acceleration under any Material Contract

of Parent or Merger Sub, except, in the case of clauses (b) and (c), where such conflict, violation, breach, default, termination or

acceleration would not reasonably be expected to materially delay or prevent the consummation of the Transactions

V.5 Finders’

Fees. Except for the Persons identified on Parent Schedule 5.5, there is no investment banker, broker, finder or other

intermediary which has been retained by or is authorized to act on behalf of the Parent Parties or their Affiliates who might be

entitled to any fee or commission from the Company, any Company Subsidiary or any of their Affiliates upon consummation of the

Transactions.

V.6

Capitalization.

(a) The authorized share capital of Parent

consists of: US$50,000 divided into (i) 450,000,000 ordinary shares of a par value of US$0.0001 each, of which 6,042,500 ] shares

are issued and outstanding (of which 5,750,000 shares are subject to possible redemption) and (ii) 50,000,000 Class B Ordinary

Shares of a par value of US$0.0001 each, 2,012,500 of which are issued and outstanding. Except as contemplated by this Agreement or

any of the Additional Agreements, no other share capital or other voting securities of Parent are issued, reserved for issuance or

outstanding. All issued and outstanding Parent Ordinary Shares are duly authorized, validly issued, fully paid and nonassessable and

are not subject to, and were not issued in violation of, any purchase option, right of first refusal, preemptive right, subscription

right or any similar right under any provision of the Cayman Companies Act, Parent Articles or any contract to which Parent is a

party or by which Parent is bound. Except as set forth in the Parent Articles, there are no outstanding contractual obligations of

Parent to repurchase, redeem or otherwise acquire any Parent Ordinary Shares or any capital equity of Parent. There are no

outstanding contractual obligations of Parent to provide funds to, or make any investment (in the form of a loan, capital

contribution or otherwise) in, any other Person.

(b) The

Merger Sub is authorized to issue 1,000 shares, par value $0.0001 per share (“Merger Sub Common Stock”), of which 1,000

shares of Merger Sub Common Stock are issued and outstanding as of the date hereof. No other shares or other voting securities of Merger

Sub are issued, reserved for issuance or outstanding. All issued and outstanding shares of Merger Sub Common Stock are duly authorized,

validly issued, fully paid and nonassessable and are not subject to, and were not issued in violation of, any purchase option, right of

first refusal, preemptive right, subscription right or any similar right under any provision of the NRS, the Merger Sub’s organizational

documents or any contract to which Merger Sub is a party or by which Merger Sub is bound. There are no outstanding contractual obligations

of Merger Sub to repurchase, redeem or otherwise acquire any shares of Merger Sub Common Stock or any equity capital of Merger Sub. There

are no outstanding contractual obligations of Merger Sub to provide funds to, or make any investment (in the form of a loan, capital contribution

or otherwise) in, any other Person.

V.7 Information Supplied. None of the

information supplied or to be supplied by the Parent Parties expressly for inclusion or incorporation by reference in the filings with

the SEC and mailings to the Parent Shareholders with respect to the solicitation of proxies to approve the transactions contemplated

by this Agreement and the Additional Agreements, if applicable, will, at the date of filing or mailing, at the time of the Parent Shareholder

Meeting, the Domestication Effective Time, or at the Merger Effective Time, as the case may be, contain any untrue statement of a material

fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light

of the circumstances under which they are made, not misleading (subject to the qualifications and limitations set forth in the materials

provided by Parent or included in the Parent SEC Documents, the Additional Parent SEC Documents, the Registration Statement or any Other

Filing).

V.8 Trust

Account. As of the last quarterly report, dated March 31, 2026, Parent has at least $58,360,098 in the trust account established

by Parent for the benefit of its public shareholders (the “Trust Account”) maintained by Odyssey Trust Company

(the “Trustee”) and such monies are invested in “government securities” (as such term is defined in

the Investment Company Act of 1940) and held in trust by the Trustee pursuant to the Investment Management Trust Agreement dated as

of November 3, 2025, between Parent and the Trustee (the “Trust Agreement”). The Trust Agreement is valid and in

full force and effect and enforceable in accordance with its terms, except as may be limited by the Enforceability Exceptions, and

has not been amended or modified. There are no separate agreements, side letters or other agreements or understandings (whether

written or unwritten, express or implied) that would cause the description of the Trust Agreement in the Parent SEC Documents to be

inaccurate in any material respect or that would entitle any Person (other than Parent Shareholders who have validly elected to

submit their Parent Ordinary Shares in the Redemption pursuant to the Parent Articles) to any portion of the proceeds in the Trust

Account. Prior to the Closing, none of the funds held in the Trust Account may be released except in accordance with the Trust

Agreement and the Parent Articles. The Parent has performed all material obligations required to be performed by it to date under,

and is not in material default or delinquent in performance or any other respect (claimed or actual) in connection with, the Trust

Agreement, and, to the Knowledge of Parent, no event has occurred which, with due notice or lapse of time or both, would constitute

such a material default thereunder. There are no claims or proceedings pending with respect to the Trust Account.

V.9 Parent SEC Documents and Financial Statements.

(a) Parent

has, since becoming subject to the reporting requirements of the Exchange Act, filed all forms, reports, schedules, statements and other

documents required to be filed or furnished by Parent with the SEC under the Securities Act and/or the Exchange Act, together with any

amendments, restatements or supplements thereto (all of the foregoing filed prior to the date of this Agreement, the “Parent

SEC Documents”) and will have filed all such forms, reports, schedules, statements and other documents (except for the Registration

Statement, the Proxy Statement/Prospectus, and any other forms reports, schedules, statements and other documents filed or furnished with

respect to the Transactions) required to be filed on or subsequent to the date of this Agreement through the Closing Date (the “Additional

Parent SEC Documents”). All of the Parent SEC Documents, Additional Parent SEC Documents, any correspondence from or to the

SEC or Nasdaq (other than such correspondence in connection with the IPO of Parent) and all certifications and statements required by:

(i) Rule 13a-14 or 15d-14 under the Exchange Act; or (ii) 18 U.S.C. § 1350 (Section 906) of the Sarbanes-Oxley Act with respect to

any of the foregoing (collectively, the “Public Certifications”) are available on the SEC’s Electronic Data-Gathering,

Analysis and Retrieval system (EDGAR) in full without redaction.

(b) The

financial statements included in the Parent SEC Documents have been prepared, in all material respects, in accordance with U.S. GAAP consistently

applied throughout the periods presented (except, in the case of unaudited interim financial statements, for normal year-end adjustments

and the absence of footnote disclosures permitted by applicable SEC rules) and fairly present, in all material respects, the financial

position of Parent as of the respective dates thereof and the results of operations and cash flows for the respective periods then ended.

maintains disclosure controls and procedures and internal accounting controls reasonably designed to comply with applicable securities

laws and to provide reasonable assurance regarding the reliability of financial reporting.

V.10 Affiliate

Transactions. Except as disclosed in the Parent SEC Documents filed prior to the date of this Agreement or on Parent Schedule

5.10, there are no transactions, agreements, arrangements or relationships involving Parent, Merger Sub or any Related Party of

Parent that are required to be disclosed pursuant to Item 404 of Regulation S-K. Except as disclosed in the Parent SEC Documents or

on Parent Schedule 5.13, no Parent Related Party is indebted to Parent or Merger Sub, and neither Parent nor Merger Sub is indebted

to any Parent Related Party, other than reimbursement obligations incurred in the ordinary course of business.

V.11

Litigation. There is no (a) Action pending, or, to the Knowledge of Parent, threatened against either Parent Party or that affects

its or their assets or properties, or (b) Order outstanding against either Parent Party or that affects its or their assets or properties.

Neither either Parent Party is party to a settlement or similar agreement regarding any of the matters set forth in the preceding sentence

that contains any ongoing obligations, restrictions or liabilities (of any nature) that are material to either Parent Party.

V.12

Expenses, Indebtedness and Other Liabilities. Except as set forth in the Parent SEC Documents, neither Parent Party has any Indebtedness

or other liabilities, except as incurred in the ordinary course of business, as disclosed in the Parent SEC Documents, or as a result

of its activities in connection with the Domestication, Merger, and the other Transactions.

V.13

Tax Matters.

(a)

Parent and Merger Sub have timely filed all material Tax Returns required to be filed and have timely paid all material Taxes due

and payable.

(b) Parent

and Merger Sub have complied in all material respects with all applicable Laws relating to the withholding, collection and payment of

Taxes.

(c)

There are no pending or, to the Knowledge of Parent, threatened audits, examinations or other proceedings relating to any material

Taxes or Tax Returns of Parent or Merger Sub.

(d) There

are no Liens for Taxes upon any assets of Parent or Merger Sub, other than Permitted Liens.

(e)

Neither Parent nor Merger Sub is party to any Tax allocation, Tax sharing or Tax indemnification agreement (other than customary

Tax provisions contained in commercial agreements not primarily related to Taxes).

(f)

Neither Parent nor Merger Sub has participated in a transaction described in Section 355 of the Code or a reportable transaction

within the meaning of Treasury Regulation Section 1.6011-4.

(g)

Parent and Merger Sub have not taken or agreed to take any action, and are not aware of any fact or circumstance, that would reasonably

be expected to prevent the Transactions from qualifying for the Intended Tax Treatment.

V.14

Parent Benefit Arrangements. Parent and Merger Sub have never, and do not currently, maintain, sponsor or contribute to, or have

any liability pursuant to any plan, program or arrangement that would fall under the definition of “Plan” determined as if

such definition referenced Parent and Merger Sub, as applicable, instead of the Company or the Company Subsidiaries. Other than any officers

as described in the Parent SEC Documents, Parent and Merger Sub have never employed any employees. Other than repayment of working capital

loans or cash advances made by, or reimbursement of any out-of-pocket expenses incurred by, Parent’s officers and directors in

connection with activities on Parent’s behalf, neither Parent nor Merger Sub has any unsatisfied material liability with respect

to any officer or director.

V.15

Business Activities; Contracts and Liabilities. Since its incorporation, Parent has not conducted any business other than activities

incident to its organization, its initial public offering, maintaining its status as a publicly traded special purpose acquisition company,

identifying, evaluating and pursuing a business combination, and activities related or incidental to the Transactions. Except as disclosed

in the Parent SEC Documents or on Parent Schedule 5.15, Parent is not party to any Material Contract that would reasonably be expected

to materially impair or delay the consummation of the Transactions, and neither Parent nor Merger Sub has any material Indebtedness other

than as disclosed in the Parent SEC Documents or incurred in connection with the Transactions

V.16

No Undisclosed Liabilities. Except as reflected in the Parent Financial Statements included in the Parent SEC Documents, disclosed

in the Parent SEC Documents filed prior to the date of this Agreement, incurred in the ordinary course of business consistent with past

practice since the date of the most recent balance sheet included therein, or incurred in connection with this Agreement and the Transactions,

neither Parent nor Merger Sub has any liabilities that would reasonably be expected to have a Material Adverse Effect on Parent or materially

impair the consummation of the Transactions.

V.17

PIPE Investment. Prior to the Closing, the Company will have entered into agreements with PIPE investors for the purchase

of Series D preferred Stock in the purchase amount of $10,000,000.

ARTICLE VI

COVENANTS OF

THE PARTIES

VI.1

Conduct of Business. Each of the Company and Parent covenants and agrees that:

(a)

From the date until the earlier of the Closing or the termination of this Agreement in accordance with Article X (the “Interim

Period”), except (i) as expressly contemplated by this Agreement or any Additional Agreement, (ii) as set forth on the applicable

Disclosure Schedules, (iii) as required by applicable Law, or (iv) with the prior written consent of the other Party (which consent shall

not be unreasonably withheld, conditioned or delayed), each of Parent and the Company shall, and the Company shall cause each Company

Subsidiary to, conduct its business in the ordinary course consistent with past practice and use commercially reasonable efforts to preserve

its business organization, material assets, goodwill and material business relationships.

(b)

Without limiting Section 6.1(a), during the Interim Period, neither Parent nor the Company (or, in the case of the Company, any

Company Subsidiary) shall, except as otherwise permitted by this Agreement, disclosed on the applicable Disclosure Schedules, required

by Law or with the prior written consent of the other Party:

(i)

amend, amend its organizational documents in any material respect;

(ii)

issue, redeem, repurchase, split, combine or reclassify any equity securities, other than as expressly contemplated by this Agreement

;

(iii)

enter into, amend or terminate any Material Contract outside the ordinary course of business if such action would reasonably be

expected to have a Material Adverse Effect or materially impair or delay the consummation of the Transactions;

(iv) ncur

any material indebtedness, make any material loan or capital contribution, or create any material Lien (other than Permitted Liens),

except in the ordinary course of business or as expressly contemplated by this Agreement;

(v)

acquire or dispose of any material assets or any business outside the ordinary course of business;

(vi)

declare or pay any dividend or other distribution on its equity securities, other than as expressly contemplated by this Agreement;

(vii)

settle any material Action involving payments in excess of $500,000 or imposing material non-monetary obligations;

(viii)

make any material change in its accounting principles or methods, except as required by U.S. GAAP or applicable Law;

(ix)

make, revoke or change any material Tax election or settle any material Tax proceeding, except as required by applicable Law; or

(x)

authorize or agree to take any of the foregoing actions.

VI.2

Exclusivity.

(a)

During the Interim Period, neither Parent nor the Company shall, and each shall cause its Representatives (and, in the case of

the Company, each Company Subsidiary and its Representatives) not to, directly or indirectly:

(i)

solicit, initiate, knowingly encourage or facilitate any inquiry, proposal or offer relating to an Alternative Transaction;

(ii)

engage in discussions or negotiations regarding, or furnish non-public information in connection with, any Alternative Transaction;

(iii)

approve, recommend, enter into or publicly announce any Alternative Transaction or any agreement relating thereto.

(b)

Each Party shall promptly terminate any existing discussions or negotiations relating to any Alternative Transaction (other than

the Transactions contemplated by this Agreement) and shall promptly, and in any event within one (1) Business Day, notify the other Party

of any bona fide written Alternative Proposal received during the Interim Period, including the identity of the proposing party and the

material terms thereof.

(c)

For purposes of this Agreement, “Alternative Transaction” means any merger, consolidation, business combination,

recapitalization, share exchange, sale of all or substantially all assets, or acquisition of a majority of the equity securities of Parent

or the Company (as applicable), other than the Transactions contemplated by this Agreement.

(d)

Notwithstanding the foregoing, the Company may complete the Permitted Company Financing in accordance with the terms of this Agreement.

VI.3

Access to Information. During the Interim Period, the Company and Parent shall each (and in the case of the Company, shall cause

each Company Subsidiary to), to the best of its ability, (a) continue to give such other party and such other party’s legal counsel

and other Representatives full access to the offices, properties, employees, and Books and Records of the Company and the Company Subsidiaries,

on the one hand, and Parent, on the other hand, as applicable, (b) furnish to the other party, its legal counsel and its other Representatives

such financial and operating data and other information relating to the Business and the Company and the Company Subsidiaries, on the

one hand, and Parent, on the other hand, as applicable, as such Persons may request and (c) cause its employees, legal counsel, accountants

and other Representatives to cooperate with such other party and its Representatives in such other party’s investigation of the

Company, the Company Subsidiaries or the Business (in the case of the Company and the Company Subsidiaries) or the Parent or the business

of Parent (in the case of Parent); provided, that any access granted pursuant to this Section 6.3 shall utilize commercially

reasonable security measures, and be during normal business hours and upon reasonable prior written notice and in such manner as not

to interfere unreasonably with the conduct of the Business (in the case of the Company and the Company Subsidiaries) or the business

of Parent (in the case of Parent). Notwithstanding anything to the contrary expressed or implied in this Agreement, neither party hereto

shall be required to provide the access described above or disclose any information to the other party if doing so is, in such party’s

reasonable judgement, reasonably likely to (i) result in a waiver of attorney-client privilege, work product doctrine or similar privilege,

(ii) violate any applicable Law to which it is subject, or (iii) violate any legally-binding obligation of the Company or any Company

Subsidiary with respect to confidentiality, non-disclosure or privacy; provided, that, the Company and Parent shall use (and in

the case of the Company, shall cause each Company Subsidiary to use) their reasonable best efforts to cause such information to be provided

in a manner that would not result in such waiver or violation.

VI.4

Notices of Certain Events. During the Interim Period, each of Parent and the Company shall promptly notify such other party of:

(a)

any notice or other communication from any Person alleging or raising the possibility that the consent of such Person is or may

be required in connection with the Transactions or that the Transactions might give rise to any Action or other rights by or on behalf

of such Person or result in the loss of any rights or privileges of the Company or any Company Subsidiary (or PubCo, post-Closing) to

any such Person or create any Lien on any of the Company’s, any Company Subsidiary’s or PubCo’s assets;

(b)

any notice or other communication from any Authority in connection with the Transactions;

(c)

the occurrence of any fact or circumstance which constitutes or results in, or would reasonably be expected to constitute or result

in, a Material Adverse Effect; and

(d)

any inaccuracy of any representation or warranty of such party contained in this Agreement at any time during the term hereof,

or any failure of such party to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it hereunder,

that would reasonably be expected to cause any of the conditions set forth in ARTICLE IX not to be satisfied.

No notice pursuant to this Section

6.4 shall affect any representation or warranty in this Agreement of any party hereto, or any condition to the obligations of any

party hereto.

VI.5

Cooperation with Registration Statement, Proxy Statement/Prospectus; Other Filings.

(a)

As promptly as reasonably practicable following the date of this Agreement, Parent shall prepare and file with the SEC a Current

Report on Form 8-K announcing the execution of this Agreement and shall issue a mutually agreed press release regarding the Transactions.

Parent shall provide the Company with a reasonable opportunity to review and comment on such filing and press release prior to their release

or filing.

(b)

As promptly as reasonably practicable, Parent shall prepare and file with the SEC a Registration Statement on Form S-4, which shall

include the Proxy Statement/Prospectus relating to the Parent Shareholder Meeting. The Company shall promptly furnish Parent with such

information concerning the Company and the Company Subsidiaries as is reasonably requested for inclusion in the Registration Statement.

Parent shall keep the Company reasonably informed regarding SEC comments and shall provide the Company with a reasonable opportunity to

review and comment on material responses to the SEC.

(c)

Following the effectiveness of the Registration Statement, Parent shall promptly distribute the Proxy Statement/Prospectus to its

shareholders, duly call and hold the Parent Shareholder Meeting, and use reasonable best efforts to obtain the Parent Shareholder Approval.

Unless otherwise permitted by this Agreement, the Parent Board shall recommend that Parent’s shareholders approve the Parent Proposals.

(d)

Parent and the Company shall each promptly notify the other if it becomes aware of any information that would require an amendment

or supplement to the Registration Statement or Proxy Statement/Prospectus and shall cooperate in preparing and filing any such amendment

or supplement required by applicable Law.

(e)

Promptly following the Closing, PubCo shall issue a mutually agreed press release announcing the Closing and shall file a Current

Report on Form 8-K with the SEC within the time required by the Exchange Act.

VI.6

Company Financial Statements and Financial Information.

(a)

Promptly following the date of this Agreement, the Company shall provide Parent with audited financial statements, including balance

sheets, statements of operations, statements of cash flows, and statements of stockholders equity, of the Company as of and for each of

the year ended December 31, 2025, in each case, prepared in accordance with U.S. GAAP and Regulation S-X and audited in accordance with

the standards of the PCAOB and containing an unqualified report of the Company’s auditors (the “Company PCAOB Audited Financial

Statements”).

(b)

Promptly following the end of each calendar quarter during the Interim Period, and in any event no later than forty (40) calendar

days following the end of each such quarter, the Company shall provide Parent with the unaudited financial statements, including balance

sheets, statements of operations, statements of cash flows and statements of stockholders equity, of the Company (and the Company Subsidiaries

on a consolidated basis) as of and for each interim period required to be presented in the Registration Statement, in each case, prepared

in accordance with U.S. GAAP and Regulation S-X and reviewed in accordance with SAS 100 review procedures (the “Company Unaudited

Interim Financial Statements”).

(c)

Promptly following the date of this Agreement, and in any event no later than July 31, 2026, the Company shall provide Parent with

audited financial statements, including balance sheets, statements of operations, statements of cash flows, and statements of stockholders

equity, of each business of the Company or any Company Subsidiary which represents a significant probable or completed acquisition, as

such concepts are defined and understood in accordance with Regulation S-X Rule 3-05 or Rule 8-04, as applicable (the “Company

Acquisition Financial Statements”). The Company Acquisition Financial Statements shall be prepared in accordance with U.S. GAAP

and Regulation S-X, and audited in accordance with the standards of the PCAOB and containing an unqualified audit report.

(d)

The Company shall promptly provide Parent with additional Company and Company Subsidiary financial information reasonably requested

by Parent for inclusion in the Registration Statement, the Proxy Statement/Prospectus and any other filings to be made by Parent with

the SEC. Notwithstanding the generality of the foregoing, the Company shall reasonably cooperate, and shall cause each Company Subsidiary

to cooperate, with Parent in connection with the preparation for inclusion in the Offer Documents of pro forma financial statements that

comply with the requirements of Regulation S-X under the rules and regulations of the SEC (as interpreted by the staff of the SEC) to

the extent such pro forma financial statements are required by Form S-4.

VI.7

Reasonable Best Efforts; Further Assurances; Governmental Consents.

(a) Except

with respect to the matters set forth in Section 6.5, which shall be governed by the terms and condition of Section

6.5, or otherwise as subject to the terms and conditions of this Agreement, each party hereto shall use its reasonable best

efforts, and shall cooperate fully with the other parties hereto, to take, or cause to be taken, all actions and to do, or cause to

be done, all things necessary or desirable under applicable Laws, or as reasonably requested by the other parties, to consummate and

implement expeditiously each of the Transactions, including using its reasonable best efforts to (i) obtain all necessary actions,

nonactions, waivers, consents, approvals and other authorizations from all applicable Authorities or other third Persons prior to

the Merger Effective Time, (ii) avoid an Action by any Authority, and (iii) execute and deliver any additional instruments necessary

to consummate the Transactions. The parties hereto shall execute and deliver such other documents, certificates, agreements and

other writings and take such other actions as may be necessary or desirable in order to consummate or implement expeditiously each

of the Transactions.

(b) In

furtherance and not in limitation of Section 6.7(a), to the extent required under the HSR Act or any Laws that are designed

to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of

competition through merger or acquisition (“Antitrust Laws”), each party hereto agrees to make any required

filing or application under Antitrust Laws, as applicable, at such party’s sole cost and expense (except that any fees or

other amounts charged by any Authorities relating to such filings or applications will be split equally between the Parent, on the

one hand, and the Company, on the other hand), with respect to the transactions contemplated hereby as promptly as practicable and

in any event as soon a practicably possible after the date of this Agreement, to supply as promptly as reasonably practicable any

additional information and documentary material that may be reasonably requested pursuant to Antitrust Laws and to take all other

actions reasonably necessary, proper or advisable to cause the expiration or termination of the applicable waiting periods under

Antitrust Laws as soon as practicable, including by requesting early termination of the waiting period provided for under the

Antitrust Laws. Each party shall, in connection with its efforts to obtain all requisite approvals and authorizations for the

transactions contemplated by this Agreement under any Antitrust Law, use its commercially reasonable efforts to: (i) cooperate in

all respects with each other party or its Affiliates in connection with any filing or submission and in connection with any

investigation or other inquiry, including any proceeding initiated by a private Person; (ii) keep the other Parties reasonably

informed of any communication received by such party or its Representatives from, or given by such party or its Representatives to,

any Authority and of any communication received or given in connection with any proceeding by a private Person, in each case

regarding any of the transactions contemplated by this Agreement; (iii) permit a Representative of the other Parties and their

respective outside counsel to review any communication given by it to, and consult with each other in advance of any meeting or

conference with, any Authority or, in connection with any proceeding by a private Person, with any other Person, and to the extent

permitted by such Authority or other Person, give a Representative or Representatives of the other Parties the opportunity to attend

and participate in such meetings and conferences; (iv) in the event a party’s Representative is prohibited from participating

in or attending any meetings or conferences, the other Parties shall keep such party promptly and reasonably apprised with respect

thereto; and (v) use reasonable best efforts to cooperate in the filing of any memoranda, white papers, filings, correspondence or

other written communications explaining or defending the transactions contemplated hereby, articulating any regulatory or

competitive argument, and/or responding to requests or objections made by any Authority.

with respect to the matter set forth in Section 6.5, which shall be governed by the terms and condition of Section

6.5, or otherwise as subject to applicable Law, each of the Company and Parent agrees to (i) cooperate and consult with the

other regarding obtaining and making all notifications and filings with Authorities, (ii) furnish to the other such information and

assistance as the other may reasonably request in connection with its preparation of any notifications or filings, (iii) keep the

other apprised of the status of matters relating to the completion of the Transactions, including promptly furnishing the other with

copies of notices or other communications received by such party from, or given by such party to, any third party or any Authority

with respect to such transactions, (iv) permit the other party to review and incorporate the other party’s reasonable comments

in any communication to be given by it to any Authority with respect to any filings required to be made with, or action or

nonactions, waivers, expirations or terminations of waiting periods, clearances, consents or orders required to be obtained from,

such Authority in connection with execution and delivery of this Agreement and the consummation of the Transactions and (v) to the

extent reasonably practicable, consult with the other in advance of and not participate in any meeting or discussion relating to the

Transactions, either in person or by telephone, with any Authority in connection with the Transactions unless it gives the other

party the opportunity to attend and observe; provided, however, that, in each of clauses (ii), (iii) and (iv)

above, that materials may be redacted (A) to remove references concerning the valuation of such party and its Affiliates, (B) as

necessary to comply with contractual arrangements or applicable Laws, and (C) as necessary to address reasonable attorney-client or

other privilege or confidentiality concerns.

(d)

In case, at any time after the Closing, any further action is necessary or desirable to carry out the purposes of this Agreement,

the proper officers and directors of each party hereto shall use their reasonable best efforts to take all such action.

VI.8

Confidentiality.

(a) Each

party hereto acknowledges and understands that, in connection with the Transactions, it will receive certain Confidential

Information of the other parties hereto (the recipient of such Confidential Information, the “Recipient” and the

party hereto disclosing such Confidential Information, the “Disclosing Party”). During the Interim Period, and,

in the event that this Agreement is terminated pursuant to ARTICLE X, for a period of two years after such termination, the

Recipient shall, and shall instruct its Representatives to, use Confidential Information solely for the purpose of consummating the

Transactions, and, in furtherance and not in limitation of the foregoing, shall (i) undertake commercially reasonable precautions to

safeguard and protect the confidentiality of the Confidential Information; (ii) not disclose or cause to be disclosed in any manner

whatsoever, directly or indirectly, in whole or in part, Confidential Information, except as is expressly permitted under this

Agreement; and (iii) except as permitted by Section 6.8(c) below, disclose the Confidential Information only to its

Representatives who have been advised by the Recipient of the existence of this Section 6.8 and have been instructed to

comply with the provisions of this Section 6.8, or are otherwise subject to a confidentiality agreement with the Disclosing

Party.

(b) The

term “Confidential Information” means all documents, information (whether oral, written, or electronic),

interpretations, and other materials about the Disclosing Party or the Disclosing Party’s business furnished by the Disclosing

Party to the Recipient or its Representatives in connection with this Agreement or the Transactions, in each case, that are

non-public, confidential, or proprietary, including without limitation, non-public, confidential, or proprietary information related

to accounting, financial matters, tax, legal and operational information, proprietary oral, written, or electronic communications,

confidential memoranda, presentations, notes, reports, analyses, compilations, forecasts, data, studies, or other documents or

materials prepared by the Disclosing Party or its Representatives, or prepared by the Recipient or its Representatives to the extent

based on the information or materials referenced in this first sentence of Section 6.8(b). The term “Confidential

Information” does not include information that: (i) is, was, or becomes available to the public other than as a result of

a disclosure by the Recipient or any of its Representatives in violation of this Section 6.8; (ii) is, was, or becomes

available to the Recipient or any of its Representatives from a source other than the Disclosing Party or its Representatives if

such source is not known by the Recipient at the time of the disclosure to be bound by a confidentiality agreement with, or other

known contractual or legal obligation of confidentiality to, the Disclosing Party with respect to such information; (iii) was or is

independently developed by the Recipient or its Representatives without using Confidential Information; (iv) is obtained by the

Recipient or its Representatives through subpoena, formal legal proceedings or discovery, or other process; (v) is determined by a

court of competent jurisdiction not to be Confidential Information pursuant to a final order not subject to appeal; (vi) is already

within the Recipient’s possession prior to it being furnished to the Recipient or its Representatives by or on behalf of the

Disclosing Party and not covered by some other confidentiality obligation between the Recipient and the Disclosing Party; or (vii)

is agreed by the Disclosing Party in writing (including by email) not to be Confidential Information.

anything to the contrary in this Section 6.8, the Recipient may disclose any Confidential Information in the event that the

Recipient or its Representatives are requested or required (as determined in good faith by the Recipient or such Representative upon

the advice of counsel) to disclose all or any portion of the Confidential Information by any applicable Law or applicable stock

exchange rules or by request of any Authority (whether by oral questions, interrogatories, requests for information or documents in

legal or regulatory proceedings, subpoena, civil investigative demand or other similar process). Notwithstanding the foregoing, with

respect to any such request made under applicable Law, to the extent reasonably practicable and permitted by applicable Law, the

Recipient agrees to promptly notify the Disclosing Party of such request so that the Disclosing Party may intervene (at the

Disclosing Party’s sole cost and expense) to take legally available steps to resist or narrow such request, including the

Disclosing Party’s efforts to seek a protective order or other appropriate remedy (at the Disclosing Party’s sole cost

and expense). In addition, to the extent permitted by applicable Law, the Recipient will not oppose and, to the extent requested by

the Disclosing Party, will use commercially reasonable efforts to cooperate with the Disclosing Party (at the Disclosing

Party’s sole cost and expense) with regard to, any action by the Disclosing Party to obtain an appropriate protective order or

other reliable assurance that confidential treatment will be accorded to the Confidential Information, or to resist or narrow the

request or requirement for information. Provided the Recipient and its Representatives comply with the notice and other provisions

of this Section 6.8(c), if the Recipient, or any of its Representatives, is requested by any Authority or is required by

applicable Law to disclose Confidential Information, the Recipient or its Representatives may disclose that portion of the

Confidential Information that the Recipient, or any of its Representatives, reasonably believes is requested or required by

applicable Law without any liability for such disclosure. Notwithstanding anything in this Agreement to the contrary, the Recipient

and its Representatives may disclose Confidential Information without notice or other obligation to the Disclosing Party or taking

any other action hereunder in connection with routine supervisory examinations, inspections, investigations or inquiries by an

auditor, banking or other regulatory or self-regulatory authorities having jurisdiction or any other ordinary course regulatory

audits of the Recipient’s or any of its Representatives’ respective businesses, provided that such examinations,

inspections, investigations or inquiries are not specifically directed at the Disclosing Party, the Transaction, or any Confidential

Information (as determined by the Recipient or such Representative upon the advice of counsel).

(d) Upon

the Disclosing Party’s written request (email being sufficient), the Recipient shall (within five (5) Business Days following

the receipt of such written request), and shall promptly direct its Representatives to, deliver to the Disclosing Party or, at the

option of the Recipient, destroy (to the extent technically and reasonably practicable) all written Confidential Information without

retaining, in whole or in part, any copies, extracts, or other reproductions (whatever the form or storage medium) of such

Confidential Information, and, if applicable, upon written request, shall confirm the destruction of such Confidential Information

in writing (which may be by email) to the Disclosing Party. Notwithstanding the foregoing sentence, the Recipient and its

Representatives may retain: (i) that portion of the Confidential Information that consists of copies, electronic copies, notes,

analyses, compilations, studies, interpretations, or other documents prepared by the Recipient or any Representative of the

Recipient; (ii) such documents, records, and copies as it reasonably believes may be required in order to satisfy any internal

compliance, record keeping, retention policies and/or procedures or Law to which the Recipient or such Representative is subject;

(iii) any portion of the Confidential Information that is no longer in their sole custody and control pursuant to a prior disclosure

under Law; (iv) Confidential Information contained in backup tapes or other media made in the ordinary course of business pursuant

to automated archival processes; and (v) any portions of the Confidential Information that have been disclosed to the public

pursuant to the terms of this Agreement.

(e) The

Company acknowledges and agrees that it and each Company Subsidiary is aware, and their respective Affiliates and Representatives

are aware (or upon receipt of any material nonpublic information of Parent, will be advised), of the restrictions imposed by the

United States federal securities Laws and other applicable foreign and domestic Laws on Persons possessing material nonpublic

information about a public company. The Company hereby agrees, except in connection with or support of the Transactions and as

contemplated by this Agreement, while any of them are in possession of such material nonpublic information, during the Interim

Period, none of such Persons shall, directly or indirectly (through its Affiliates or otherwise), acquire, offer or propose to

acquire, agree to acquire, sell or transfer or offer or propose to sell or transfer any securities of Parent, communicate such

information to any other Person or cause or encourage any Person to do any of the foregoing.

VI.9

Directors’ and Officers’ Indemnification and Liability Insurance.

(a) The

parties hereto agree that for a period of six (6) years from the Closing Date, the parties hereto shall, and shall cause PubCo and

the Surviving Corporation to, maintain in effect, in favor of any individual who, at or prior to the Closing, was a director,

officer, employee or agent of Parent, Merger Sub, the Company or any Company Subsidiaries, as the case may be, or who, at the

request of Parent, Merger Sub, the Company or any Company Subsidiary, as the case may be, served as a director, officer, member,

manager, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or

enterprise (collectively, with such individual’s heirs, executors or administrators, (each, together with such Person’s

heirs, executors or administrators, a “D&O Indemnified Party”)), the exculpation, indemnification and

advancement of expenses provisions of Parent’s, Merger Sub’s, the Company’s and the Company Subsidiaries’

respective organizational documents as in effect immediately prior to the Closing Date or in any indemnification agreements of

Parent, Merger Sub, the Company or the Company Subsidiaries, on the one hand, with any D&O Indemnified Party, on the other hand,

as in effect immediately prior to the Closing Date, (which, for the avoidance of doubt, shall provide for the advancement of

reasonable attorneys’ fees and expenses of any such Person as incurred to the fullest extent permitted under applicable Law

(including in connection with any Action brought by any such Person to enforce his or her rights under this Section 6.9)) and

the parties hereto shall, and shall cause PubCo and the Surviving Corporation to, not amend, repeal or otherwise modify any such

provisions in any manner that would adversely affect the rights thereunder of any D&O Indemnified Party; provided, however,

that all rights to indemnification or advancement of expenses in respect of any Actions pending or asserted or any claim made within

such period shall continue until the disposition of such Action or resolution of such claim. From and after the Closing Date, PubCo

shall cause the Surviving Corporation to honor, in accordance with their respective terms, each of the covenants contained in this Section

6.9 without limit as to time.

(b)

At or prior to the Closing, each of Parent and the Company shall purchase a “tail” directors’ and officers’

liability insurance policy (the “D&O Tail”) in respect of acts or omissions occurring prior to the Closing covering

each such Person that is currently covered by a directors’ and officers’ liability insurance policy of Parent and the Company

(including the Company Subsidiaries), respectively, on terms with respect to coverage, deductibles and amounts no less favorable than

those of such applicable policy in effect on the date of this Agreement for the six (6) year period following the Closing; provided,

that in no event shall Parent and the Company (including the Company Subsidiaries), respectively, be required to expend on the premium

thereof in excess of 350% of the aggregate annual premiums currently payable by Parent and the Company (including the Company Subsidiaries),

respectively, with respect to such current policies (the “Premium Cap”); provided, further, that if such

minimum coverage under any such D&O Tail is or becomes not available at the Premium Cap, then any such D&O Tail shall contain

the maximum coverage available at the Premium Cap. From and after the Merger Effective Time, Parent shall maintain the D&O Tail in

full force and effect for its full term and cause all obligations thereunder to be honored by PubCo and the Surviving Corporation, as

applicable, and no other party shall have any further obligation to purchase or pay for such insurance pursuant to this Section 6.9(b).

No claims made under or in respect of the D&O Tail related to any fiduciary or employee of the Company or any Company Subsidiary shall

be settled without the prior written consent of Parent, such consent not to be unreasonably withheld, delayed or conditioned.

(c)

The rights of each D&O Indemnified Party hereunder shall be in addition to, and not in limitation of, any other rights such

Person may have under the organizational documents of Parent, Merger Sub, the Company or any Company Subsidiary, any other indemnification

arrangement, any Law or otherwise. The obligations of Parent and the Company under this Section 6.9(c) shall not be terminated

or modified after the Closing in such a manner as to materially and adversely affect any D&O Indemnified Party without the consent

of such D&O Indemnified Party. The provisions of this Section 6.9 shall survive the Closing and expressly are intended to benefit,

and are enforceable by, each of the D&O Indemnified Parties, each of whom is an intended third-party beneficiary of this Section

6.9.

(d)

If Parent or, after the Closing, PubCo or the Surviving Corporation, or any of their respective successors or assigns: (i) consolidates

with or merges into any other Person and shall not be the continuing or surviving entity of such consolidation or merger; or (ii) transfers

or conveys all or substantially all of its properties and assets to any Person, then, in each such case, proper provision shall be made

so that the successors and assigns of PubCo or the Surviving Corporation, as applicable, assume the obligations set forth in this Section

6.9.

VI.10

Certain Tax Matters.

(a) For

U.S. federal (and applicable state and local) income Tax purposes, each of the parties hereto intends that (a) the Domestication

qualifies for the Domestication Intended Tax Treatment and (b) the Merger qualifies for the Merger Intended Tax Treatment. The

parties hereto hereby (i) adopt this Agreement as a “plan of reorganization” within the meaning of Section 368 of the

Code and the Treasury Regulations promulgated thereunder, (ii) agree to file and retain such information as shall be required under

Treasury Regulations Section 1.368-3, and (iii) agree to file all Tax Returns on a basis consistent with the Intended Tax Treatment

and not otherwise to take any position or action inconsistent with the Intended Tax Treatment, in each case, unless otherwise

required by an Authority as a result of a “determination” that is final within the meaning of Section 1313(a) of the

Code (or any similar provision of applicable state, local or non-U.S. Tax Law) or a change in applicable Law. Each party hereto

agrees to use reasonable best efforts to promptly notify all other parties hereto of any challenge to the qualification of the

relevant portion of the transactions contemplated by this Agreement for its Intended Tax Treatment by any Authority. None of the

parties hereto shall (and none of the parties hereto shall permit or cause any of their respective Affiliates, Subsidiaries or

Representatives to) take or fail to take any action, or become obligated to take or fail to take any action, which action or failure

could reasonably be expected to prevent or impede the transactions contemplated by this Agreement from qualifying for the Intended

Tax Treatment, and each of the parties hereto shall use its reasonable best efforts to cause the Domestication to qualify for the

Domestication Intended Tax Treatment and the Merger to qualify for the Merger Intended Tax Treatment. Each of the parties

acknowledges and agrees that each has had the opportunity to obtain independent legal and Tax advice with respect to the

transactions contemplated by this Agreement.

(b)

Parent and the Company shall promptly notify the other party in writing if, before the Closing Date, either such party knows

or has reason to believe that the Domestication may not qualify for the Domestication Intended Tax Treatment or that the Merger may not

qualify for the Merger Intended Tax Treatment (and whether the terms of this Agreement could be reasonably amended in order to facilitate

such qualification, which amendments shall be made if the Company and Parent reasonably determine on the advice of their respective counsel

that such amendments would be reasonably expected to result in the Domestication Intended Tax Treatment or the Merger Intended Tax Treatment

and would not be commercially impracticable).

the event the SEC requires that an opinion of external counsel relating to the Tax consequences of, or related to, the transactions

contemplated by this Agreement be issued in connection with the Registration Statement, the Proxy Statement/Prospectus or Other

Filings, each of the parties hereto shall reasonably cooperate in good faith with one another in connection with the issuance of

such a Tax opinion. In connection with the foregoing, each of the parties hereto shall (and shall cause their respective Affiliates,

Subsidiaries or Representatives to) execute and deliver customary Tax representation letters to the applicable counsel, upon

reasonable request therefore, dated as of the necessary date and signed by an officer of the applicable party and in form and

substance reasonably satisfactory to such counsel (including containing customary representations, warranties and covenants) and

reasonably necessary or appropriate to enable such counsel to render any such Tax opinion. Notwithstanding anything to the contrary

in this Agreement, Sichenzia Ross Ference Carmel LLP (“Sichenzia”) or other advisors of the Company shall not be

required to provide any opinion to any party regarding the Domestication Intended Tax Treatment or with respect to any Tax matters

affecting Parent or any of its equity holders, and Celine and Partners, PLLC or other advisors of Parent shall not be required to

provide any opinion to any party regarding the Merger Intended Tax Treatment or with respect to any Tax matters affecting the

Company or any of its equity holders. Notwithstanding anything to the contrary in this Agreement, neither counsel nor advisors to

Parent or the Company shall be required, or be deemed to be required, to provide any Tax opinion as an express condition precedent

to the transactions contemplated by this Agreement.

(d)

The parties hereto shall reasonably cooperate in connection with Tax compliance matters, including any requests from equity

holders of the Parent in connection with matters relating to Parent’s U.S. federal tax classification as a “passive foreign

investment company” or “controlled foreign corporation.”

(a)

All Transfer Taxes shall be paid by the Surviving Corporation. After the Closing Date, the Surviving Corporation will prepare and

file all necessary Tax Returns and other documentation with respect to all such Transfer Taxes that are required to be filed after the

Closing Date, and, if required by applicable Law, the parties hereto will, and will cause their respective Affiliates to, cooperate and

join in the execution of any such Tax Returns and other documentation, as applicable. Each party hereto shall (and shall cause its Affiliates

to) provide certificates or forms, and timely execute any Tax Return, that are necessary or appropriate to establish an exemption for

(or reduction in) any Transfer Tax.

VI.11

Litigation. During the Interim Period, Parent, on the one hand, and the Company, on the other hand, shall each notify the other

in writing promptly after learning of any shareholder demands or other shareholder Actions (including derivative claims) relating to

this Agreement, any Additional Agreement or any matters relating thereto (collectively, the “Transaction Litigation”)

commenced (or to such party’s knowledge threatened) against, in the case of Parent, any of Parent or any of its Representatives

(in their capacity as a representative of Parent) or, in the case of the Company, the Company, any Company Subsidiary or any of their

respective Representatives (in their capacity as a representative of the Company or any Company Subsidiary). Parent and the Company shall

each (i) keep the other reasonably informed regarding any Transaction Litigation, (ii) give the other the opportunity to, at its own

cost and expense, participate in (subject to a customary joint defense agreement), but not control, the defense, settlement and compromise

of any such Transaction Litigation and reasonably cooperate with the other in connection with the defense, settlement and compromise

of any such Transaction Litigation, (iii) consider in good faith the other’s advice with respect to any such Transaction Litigation

and (iv) reasonably cooperate with each other. In no event shall (A) any of Parent or any of its Representatives settle or compromise

any Transaction Litigation without the Company’s prior written consent (such consent not to be unreasonably withheld, conditioned

or delayed) or (B) the Company, any Company Subsidiary or any of their respective Representatives settle or compromise any Transaction

Litigation without Parent’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed).

VI.12

Regulatory Authority Communications. From the date of this Agreement until the earlier of the Closing or the termination of this

Agreement in accordance with ARTICLE X, the Company shall keep Parent reasonably apprised of the status of matters relating to

any Regulatory Authority’s review of the Company’s or any Company Subsidiaries’ activities by: (a) furnishing Parent

with copies of all written communications received by the Company or the Company Subsidiaries from any Regulatory Authority and all material

written communications provided by the Company or any Company Subsidiaries to the U.S Drug Enforcement Agency (the “DEA”),

in each case promptly following receipt or delivery thereof; and (b) providing Parent with a written summary of any material oral communications

between the Company or any Company Subsidiary and each Regulatory Authority, upon reasonable request by Parent. Any disclosures or provisions

of information by the Company or the Company Subsidiaries pursuant to this Section 6.13 may be redacted or withheld to the extent

required to protect information that is protected by the attorney-client privilege or the attorney work product doctrine; provided,

that the Company shall notify Parent of any such redaction or withholding and shall use commercially reasonable efforts to provide such

information in a manner that would not result in the loss of such privilege or protection.

ARTICLE VII

COVENANTS OF

THE COMPANY

VII.1

Commercially Reasonable Efforts to Obtain Consents. The Company shall use (and shall cause each Company Subsidiary to use) its

commercially reasonable efforts to obtain each Company Consent set forth on Company Schedule 7.1.

VII.2

Company Stockholder Approval. The Company shall ensure that, within twenty-four (24) hours after the execution and delivery of

this Agreement (the “Company Stockholder Written Consent Deadline”), a stockholder written consent in substantially

the form attached hereto as Exhibit H (the “Company Stockholder Written Consent”), duly executed and delivered

by such Company Stockholders as is required to fully and irrevocably obtain the Company Stockholder Approval, shall be delivered to Parent.

The Company shall ensure that the Company Stockholder Written Consents executed and delivered in accordance with the foregoing sentence

shall have been obtained and executed in compliance with, and are valid and effective under, the applicable provisions of the DGCL and

any other applicable Laws and the Company’s organizational documents. Concurrently with the delivery of the Company Stockholder

Written Consent to Parent pursuant to this Section 7.2, the Company shall deliver to Parent a Company Support Agreement in substantially

the form attached hereto as Exhibit E, duly executed by each Company Stockholder that executes and delivers the Company Stockholder

Written Consent pursuant to this Section 7.2. Promptly following the receipt of the Company Stockholder Approval via the executed

Company Stockholder Written Consents, the Company will prepare (subject to the reasonable approval of Parent) and deliver, to the holders

of Company Capital Stock who have not executed and delivered the Company Stockholder Written Consent, the notice required by Section

228(e) of the DGCL, which shall include a description of the appraisal and dissenter rights of such holders available under Section 262

of the DGCL, along with such other information as is required thereunder and pursuant to other applicable Law. Neither the Company’s

Board of Directors, nor any committee thereof, shall withhold, withdraw, amend, modify, change, qualify or propose or resolve to withhold,

withdraw, amend, modify or change, in each case in a manner adverse to Parent, the Company Board Recommendation.

VII.3

No Parent Securities Transactions

(a) From and after the date of this Agreement until the Merger Effective Time, except as otherwise contemplated by this Agreement, the

Company shall not engage (and shall cause the Company Subsidiaries not to engage) in any transactions involving the securities of

Parent without the prior consent of Parent if the Company or any Company Subsidiary possesses material nonpublic information of

Parent.

VII.4

Stock Exchange Listing. The Company shall use its reasonable best efforts to cause (a) PubCo’s initial listing application

with the Stock Exchange in connection with the Transactions to have been approved; (b) all applicable initial listing requirements of

the Stock Exchange to be satisfied; and (c) the PubCo Common Stock, including the PubCo Common Stock to be issued as Aggregate Merger

Consideration, to be approved for listing on the Stock Exchange, subject to official notice of issuance, in each case, as promptly as

reasonably practicable after the date of this Agreement and in any event prior to the Merger Effective Time.

ARTICLE VIII

COVENANTS OF

PARENT

VIII.1

PubCo Equity Incentive Plan and PubCo ESPP. Prior to the S-4 Effective Date, Parent shall adopt a new equity incentive plan in

substantially the form attached hereto as Exhibit I, with such changes or modifications thereto as the Company and Parent may

mutually agree (such agreement not to be unreasonably withheld, conditioned or delayed by either the Company or Parent, as applicable)

(the “PubCo Equity Incentive Plan”). The PubCo Equity Incentive Plan shall have such number of shares available for

issuance not to exceed fifteen percent (15%) of the PubCo Common Stock on a fully-diluted basis (calculated after giving effect to the

transactions hereunder but excluding any Company Converted Options) and shall include an “evergreen” provision that is mutually

agreeable to the Company and Parent that will provide for an automatic increase on the first day of each fiscal year in the number of

shares available for issuance under the PubCo Equity Incentive Plan not to exceed five percent (5%) of the PubCo Common Stock on a fully-diluted

basis, as determined by PubCo’s Board of Directors. In addition, prior to the S-4 Effective Date, Parent shall adopt an employee

stock purchase plan in substantially the form attached hereto as Exhibit J, with such changes or modifications thereto as the

Company and Parent may mutually agree (such agreement not to be unreasonably withheld, conditioned or delayed by either the Company or

Parent, as applicable) (the “PubCo ESPP”). The PubCo ESPP shall have such number of shares available for issuance

not to exceed one and one-half percent (1.5%) of the PubCo Common Stock on a fully diluted basis (calculated after giving effect to the

transactions hereunder) and shall include an “evergreen” provision that is mutually agreeable to the Company and Parent that

will provide for an automatic increase on the first day of each fiscal year in the number of shares available for issuance under the

PubCo ESPP of one percent (1%) of the PubCo Common Stock outstanding as of the day prior to such increase. Within ten (10) Business Days

following the expiration of the sixty (60) day period following the date PubCo has filed current Form 10 information with the SEC reflecting

its status as an entity that is not a shell company, PubCo shall file an effective registration statement on Form S-8 (or other applicable

form, including Form S-3) with respect to the shares of PubCo Common Stock issuable under the PubCo Equity Incentive Plan and the PubCo

ESPP. The initial number of shares of PubCo Common Stock to be made available under the PubCo Equity Incentive Plan and the PubCo ESPP

(within the applicable caps set forth above) shall be agreed upon by Parent and the Company prior to the Closing, based on customary

market benchmarking and taking into account unvested incentive equity of the Company outstanding as of the Closing Date.

VIII.2

Trust Account. Parent shall cause the funds in the Trust Account to be disbursed in accordance with the Trust Agreement, including

for the payment of (a) all amounts payable to public shareholders of Parent in connection with the Redemption (the “Parent Redemption

Amount”), (b) deferred underwriting compensation and the other Transaction Expenses to the third parties to which they are

owed, and (c) the remaining monies in the Trust Account to PubCo after the Closing.

VIII.3 PIPE

Investment. Parent has delivered to the Company copies of the Subscription Agreements entered into by Parent and the PIPE

Investors as of the date of this Agreement. From and after the date of this Agreement none of Parent, Merger Sub or Sponsor shall

enter into any Contract with any Person relating to any Equity Interests, including any Subscription Agreement without the

Company’s prior written consent in the Company’s reasonable discretion (not to be unreasonably withheld, conditioned, or

delayed). Parent shall not amend, modify or waive, or consent to any amendment, modification or waiver of, any term of any

Subscription Agreement, in each case, without the prior written consent of the Company in the Company’s reasonable discretion; provided

that any modification or waiver that is ministerial in nature and does not affect any economic or any other material term of a

Subscription Agreement shall not require the prior written consent of the Company. Subject to the immediately preceding sentence,

Parent shall use its reasonable best efforts, and the Company shall use its reasonable best efforts to cooperate with it, (a) to

take, or to cause to be taken, all actions required, necessary or that it otherwise deems to be proper or advisable to consummate

the transactions contemplated by the Subscription Agreements on or prior to the Closing on the terms described therein, and (b) to

satisfy on a timely basis all conditions and covenants applicable to Parent in the Subscription Agreements and otherwise comply with

its obligations thereunder and to enforce the rights of Parent under the Subscription Agreements to cause the PIPE Investors to pay

to (or as directed by) Parent the applicable purchase price under each PIPE Investor’s applicable Subscription Agreement in

accordance with its terms. As promptly as practicable after Parent acquires knowledge thereof, Parent shall give the Company written

notice: (i) of any breach or default (or any event or circumstance that, with or without notice, lapse of time or both, could give

rise to any breach or default) by any party to any Subscription Agreement known to Parent; (ii) of the receipt of any written notice

or other written communication from any party to any Subscription Agreement with respect to any actual, potential or claimed

expiration, lapse, withdrawal, breach, default, termination or repudiation by any party to any Subscription Agreement or any

provisions of any Subscription Agreement; or (iii) if Parent does not expect to receive all or any portion of the PIPE Investment on

the terms, in the manner or from the sources contemplated by the Subscription Agreements.

VIII.4

Adoption of Registration Statement. Within one Business Day of the Closing Date, PubCo, as the successor to the pre-Domestication

Parent, shall file a post-effective amendment to the Registration Statement pursuant to Rule 414(d) of the Securities Act.

VIII.5

Section 16 Matters. Prior to the Domestication Effective Time, each of the Company and Parent shall take all such steps as may

be required (to the extent permitted under applicable Law) to cause any dispositions of Parent Ordinary Shares or acquisitions of PubCo

Common Stock (including, in each case, securities deliverable upon exercise, vesting or settlement of any derivative securities) resulting

from the transactions contemplated hereby by each individual who may be or become subject to the reporting requirements of Section 16

of the Exchange Act to be an exempt disposition or exempt acquisition pursuant to Rule 16b-3 promulgated under the Exchange Act.

VIII.6

Obligations of Merger Sub. Parent shall take all action necessary to cause Merger Sub to perform its obligations under this Agreement

and to consummate the transactions contemplated by this Agreement, upon the terms and subject to the conditions set forth in this Agreement.

ARTICLE IX

CONDITIONS TO

CLOSING

IX.1

Condition to the Obligations of the Parties. The obligations of each of the parties hereto to consummate the Transactions are

subject to the satisfaction of all of the following conditions at or prior to the Domestication Effective Time (or, with respect to the

conditions in Section 9.1(a), at or prior to the Merger Effective Time), any one or more of which may be waived (where permissible)

in writing by both Parent (on behalf of itself and Merger Sub) and the Company (on behalf of itself and the Company Subsidiaries):

(a)

No Prohibition. No Authority having competent jurisdiction over the parties hereto with respect to the Transactions shall

have (i) enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment, decree, executive order or award that

is in effect or (ii) brought an Action or issued or granted any Order (whether temporary, preliminary, or permanent) that is in effect

and is final and non-appealable, and, in each case, which has the effect of making the Transactions illegal or otherwise restraining,

enjoining, or prohibiting consummation of the Transactions.

(b)

Registration Statement. The Registration Statement shall have become effective under the Securities Act and no stop order

suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been

initiated or threatened by the SEC and not withdrawn.

(c)

Stock Exchange Listing. PubCo’s initial listing application with the Stock Exchange in connection with the Transactions

shall have been approved and the PubCo Common Stock to be issued in connection with this Agreement, including the Aggregate Merger Consideration,

shall have been approved for listing on the Stock Exchange, subject to official notice of issuance.

IX.2

Conditions to Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate the Transactions are

subject to the satisfaction of all the following further conditions any one or more of which may be waived (where permissible) in writing

by Parent (in its sole and absolute discretion):

(a)

Agreements and Covenants. The Company shall have duly performed or complied with, in all material respects, all of its obligations

hereunder required to be performed or complied with (without giving effect to any materiality or similar qualifiers contained therein)

at or prior to the Closing; provided, that for purposes of this Section 9.2(a), an obligation of Company shall only be deemed to

have not been performed or complied with the Company has materially breached such obligation and failed to cure within five (5) days after

written notice of such breach has been delivered to Company (or if earlier, the Outside Closing Date).

(b)

Representations and Warranties. (i) The Company Fundamental Representations shall be true and correct (without giving effect

to any limitation as to “materiality” or “Material Adverse Effect” or any similar limitation set forth herein)

in all material respects as of the date of this Agreement and as of the Domestication Effective Time, as if made as of such date and time

(except to the extent that any such representation and warranty is expressly made as of an earlier date or time, in which case such representation

and warranty shall be true and correct in all material respects as of such earlier date or time, as applicable), and (ii) the representations

and warranties of the Company set forth in ARTICLE IV (other than the Company Fundamental Representations) shall be true and correct

(without giving effect to any limitation as to “materiality” or “Material Adverse Effect” or any similar limitation

set forth herein) in all respects as of the date of this Agreement and as of the Domestication Effective Time, as if made as of such date

and time (except to the extent that any such representation and warranty is made expressly as of an earlier date or time, in which case

such representation and warranty shall be true and correct in all respects as of such earlier date or time, as applicable), except, in

each case of this subclause (ii), where the failure of such representations and warranties to be true and correct (without giving

effect to any limitation as to “materiality” or “Material Adverse Effect” or any similar limitation set forth

herein), individually or in the aggregate, does not cause a Material Adverse Effect.

(c)

No Material Adverse Effect. There shall not have occurred a Material Adverse Effect since the date hereof that is continuing.

(d)

Officer’s Certificate. Parent shall have received a certificate signed by the Chief Executive Officer or the Chief

Financial Officer of the Company certifying the accuracy of the foregoing clauses (a), (b) and (c) of this Section

9.2.

(e) FIRPTA

Certificate. The Company shall have delivered to Parent a duly executed certificate conforming to the requirements of Treasury

Regulations Sections 1.897-2(h)(1)(i) and 1.1445-2(c)(3)(i), and a notice to be delivered to the United States Internal Revenue

Service as required under Treasury Regulations Section 1.897-2(h)(2), each dated no more than thirty (30) days prior to the Closing

Date and in substantially the form attached hereto as Exhibit K, certifying that no interest in the Company is, or has been

during the relevant period specified in Section 897(c)(1)(A)(ii) of the Code, a “U.S. real property interest” within the

meaning of Section 897(c) of the Code.

(f)

Termination of Certain Contracts. The Company shall have delivered to Parent evidence, in form and substance reasonably

acceptable to Parent, that each of the Terminating Contracts shall be terminated effective as of immediately prior to the Merger Effective

Time without any further obligations of the Company, the Company Subsidiaries or PubCo.

(g)

Company Stockholder Approval. The Company Stockholder Approval shall have been obtained.

(h)

Required Company Consents. The Company and the Company Subsidiaries, as applicable, shall have obtained each Required Company

Consent and delivered to Parent evidence thereof, in form and substance reasonably acceptable to Parent.

(i)

No Adverse Regulatory Authority Communication

(j) .

Parent shall not have received any formal or informal written communication from the DEA or other Regulatory Authority that would,

or would reasonably be expected to, (i) materially and adversely affect the ability of the Company or any Company Subsidiary to

conduct their business as currently conducted or as proposed to be conducted following the Closing, or (ii) prevent the Company or

any Company Subsidiary from continuing their regulatory engagement with the DEA or other Regulatory Authority, in each case which

communication has not been resolved to the reasonable satisfaction of Parent and the Company prior to the Closing.

(a)

Lock-Up Agreement. Each of the Lock-Up Stockholders shall have executed and delivered to Parent a copy of the Lock-Up Agreement.

(b)

Outstanding Tax Returns. The Company shall have timely filed all material Tax Returns identified on Schedule 4.21(i) as outstanding

as of the date of this Agreement and shall have delivered to Parent copies of such filed Tax Returns or other evidence reasonably satisfactory

to Parent demonstrating such filings.

(c)

Point Med Acquisitions. The consummation of the acquisition of all of the capital stock of the Point Med Entities pursuant

to the applicable Point Med Acquisition Agreements shall occur substantially simultaneously with the Closing, using funds released at

the Closing pursuant to the Closing Cash Distribution.

IX.3

Conditions to Obligations of the Company.

IX.4

The obligation of the Company to consummate the Transactions is subject to the satisfaction of all of the following further conditions

any one or more of which may be waived (where permissible) in writing by the Company (in its sole and absolute discretion):

(a) Agreements

and Covenants. Parent and Merger Sub shall each have duly performed or complied with, in all material respects, all of its

obligations hereunder required to be performed or complied with at or prior to the Closing; provided, that for purposes of

this Section 9.3(a), an obligation of Parent or Merger Sub, as applicable, shall only be deemed to have not been performed or

complied with if Parent or Merger Sub, respectively, has materially breached such obligation and failed to cure within five (5) days

after written notice of such breach has been delivered to Parent (or if earlier, the Outside Closing Date).

(b)

Representations and Warranties. (i) the Parent Fundamental Representations shall be true and correct in all material respects

as of the date of this Agreement and as of the Domestication Effective Time, as if made as of such date and time (except to the extent

that any such representation and warranty is made expressly as of an earlier date or time, in which case such representation and warranty

shall be true and correct in all material respects as of such earlier date or time, as applicable), (ii) the representations and warranties

of Parent (other than the Parent Fundamental Representations) contained in ARTICLE V of this Agreement shall be true and correct

(without giving effect to any limitation as to “materiality” or “Parent Material Adverse Effect” or any similar

limitation set forth herein) in all respects as of the date of this Agreement and as of the Domestication Effective Time, as if made as

of such date and time (except to the extent that any such representation and warranty is made expressly as of an earlier date or time,

in which case such representation and warranty shall be true and correct as of such earlier date or time, as applicable), except where

the failure of such representations and warranties to be true and correct (without giving effect to any limitation as to “materiality”

or “Parent Material Adverse Effect” or any similar limitation set forth herein), individually or in the aggregate, does not

cause a Parent Material Adverse Effect.

(c)

Officer’s Certificate. The Company shall have received a certificate signed by an authorized officer of Parent certifying

the accuracy of the foregoing clauses (a) and (b) of this Section 9.3.

(d)

PubCo AOI. The PubCo AOI shall have been filed with, and declared effective by, the Nevada Secretary of State.

(e)

Registration Rights Agreement. Sponsor shall have executed and delivered to the Company a copy of the Registration Rights

Agreement.

(f)

Lock-Up Agreement. Parent and the Lock-Up Stockholders shall have executed and delivered to the Company a copy of the Lock-Up

Agreement.

(g)

Parent Support Agreement. The Parent Supporting Shareholders shall have complied in all material respects with the respective

covenants required to be performed or complied with by them pursuant to the Parent Support Agreement and the Parent Support Agreement

shall not have been terminated.

(h)

Parent Shareholder Approval. The Parent Shareholder Approval shall have been obtained.

(i)

No Parent Material Adverse Effect. There shall not have occurred a Parent Material Adverse Effect since the date hereof

that is continuing.

IX.5

Frustration of Conditions. Notwithstanding anything contained herein to the contrary, no party hereto may rely on the failure of any

condition set forth in this ARTICLE IX to be satisfied if such failure was caused by the failure of such party or its Affiliates failure

to comply with or perform any of its covenants or obligations set forth in this Agreement.

IX.6

Waiver of Conditions. Upon the occurrence of the Closing, any condition set forth in this ARTICLE IX that was not satisfied

as of the Closing shall be deemed to have been waived as of and from the Closing.

ARTICLE X

TERMINATION

X.1

Termination Without Default.

(a)

In the event that the Closing has not occurred by March 31, 2027 (the “Outside Closing Date”) (provided,

that, if the SEC has not declared the Registration Statement effective on or prior to February 28, 2027, the Outside Closing Date shall

be automatically extended to April 30, 2027 then each of Parent and the Company shall have the right, at its sole option, to terminate

this Agreement without liability to the other party. Such right may be exercised by Parent or the Company, as the case may be, giving

written notice to the other at any time after the Outside Closing Date. Notwithstanding the foregoing, the right to terminate this Agreement

under this Section 10.1(a) shall not be available if the failure by the party seeking to terminate this Agreement to fulfill any

obligation under this Agreement has been the proximate cause of the failure of the Closing to occur on or before the Outside Closing Date.

(b)

In the event an Authority shall have issued an Order or enacted a Law, having the effect of making the Transactions illegal or

permanently restraining, enjoining or otherwise prohibiting the Transactions, which Order or Law is final and non-appealable, Parent or

the Company shall have the right, at its sole option, at any time prior to the Closing to terminate this Agreement without liability to

the other party by giving written notice to such other party; provided, however, that the right to terminate this Agreement

under this Section 10.1(b) shall not be available to Parent or the Company if the failure of such Person to fulfill any obligation

under this Agreement has been the proximate cause of such Law or Order.

(c)

This Agreement may be terminated at any time prior to the Closing by the written consent of the Company and Parent.

(d)

This Agreement may be terminated at any time prior to the Domestication by the Company or the Parent by written notice to the other

if the Parent Shareholder Approval is not obtained at the Parent Shareholder Meeting (subject to any adjournment or postponement thereof).

X.2

Termination Upon Default.

(a)

Parent may terminate this Agreement by giving written notice to the Company at any time prior to the Domestication, without prejudice

to any rights or obligations Parent or Merger Sub may have: (i) (x) if the Company shall have breached any representation, warranty, agreement

or covenant contained herein which has rendered or would reasonably be expected to render the satisfaction of any of the conditions set

forth in Section 9.2(a) or Section 9.2(b) impossible and (y) such breach cannot be cured or is not cured by the earlier

of the Outside Closing Date and thirty (30) days following receipt by the Company of a written notice from Parent describing in reasonable

detail the nature of such breach; or (ii) if the Company Stockholder Written Consent is not obtained or is not delivered to Parent by

the Company Stockholder Written Consent Deadline in accordance with Section 7.2; provided, however, that Parent shall

not have the right to terminate pursuant to this clause (ii) unless Parent provides written notice of its intention to terminate

on or prior to five (5) Business Days following the Company Stockholder Written Consent Deadline.

(b) The

Company may terminate this Agreement by giving written notice to Parent at any time prior to the Domestication, without prejudice to

any rights or obligations the Company may have, if: (i) Parent shall have breached any of its covenants, agreements,

representations, and warranties contained herein, which has rendered or would reasonably be expected to render the satisfaction of

any of the conditions set forth in Section 9.3(a) or Section 9.3(b) impossible; and (ii) such breach cannot be cured

or is not cured by the earlier of the Outside Closing Date and thirty (30) days following receipt by Parent of a written notice from

the Company describing in reasonable detail the nature of such breach.

X.3

Effect of Termination. If this Agreement is terminated pursuant to this ARTICLE X, this Agreement shall become void and

be of no further force or effect, without any liability on the part of any party hereto (or any shareholder, director, officer, employee,

Affiliate, agent, consultant or Representative of such party) to any other party hereto or any other Person; provided, that, no

such termination shall relieve any party from liability arising out of or incurred as a result of the willful breach by such party of

this Agreement or such party’s fraud. The provisions of Section 6.8, Section 6.9, ARTICLE X, and ARTICLE

XI, and any other Section or Article of this Agreement which is required to survive in order to give appropriate effect to Section

6.8, Section 6.9, ARTICLE X, and ARTICLE XI, shall survive any termination hereof pursuant to this ARTICLE

ARTICLE XI

MISCELLANEOUS

XI.1

Notices. Any notice hereunder shall be sent in writing, addressed as specified below, and shall be deemed given: (a) if by hand

or recognized courier service, by 5:00 PM on a Business Day, addressee’s day and time, on the date of delivery, and otherwise on

the first Business Day after such delivery; (b) if by fax, on the date that transmission is confirmed electronically, if by 5:00 PM on

a Business Day, addressee’s day and time, and otherwise on the first Business Day after the date of such confirmation; (c) if by

email, on the date of transmission; or (d) five (5) days after mailing by certified or registered mail, return receipt requested. Notices

shall be addressed to the respective parties as follows (excluding telephone numbers, which are for convenience only), or to such other

address as a party shall specify to the others in accordance with these notice provisions:

if to the

Company or the Company Subsidiaries (or, following the Closing, the Surviving Corporation or PubCo), to:

First Choice Healthcare Solutions, Inc.

95 Bulldog Blvd, Suite 202, Melbourne,

Florida 32901

Attn: Lance Friedman,

Chief Executive Officer

E-mail: LFriedman@myfcmg.com

with a copy (which shall not constitute

notice) to:

Sichenzia Ross Ference Carmel LLP

1185 Avenue of the Americas, 26th Floor

New York, NY 10036

Attention: Arthur Marcus, Esq.

E-mail: amarcus@srfc.law

if to

Parent or Merger Sub:

Westin Acquisition Corp.

Suite 1165-L 3 Coleman Street #03-24

Singapore 179804

Telephone: +65 9488 4425

E-mail: stanney@westinacquisitioncorp.com

with a copy (which shall not constitute

notice) to:

Celine & Partners PLLC

1345 Avenue of the Americas, 2nd

New York, NY 10105

Attention: Hui Chen

E-mail: hchen@celinelaw.com

XI.2

Amendments; No Waivers; Remedies.

(a)

This Agreement cannot be amended, except by a writing signed by each party hereto, and cannot be terminated orally or by course

of conduct. No provision hereof can be waived, except by a writing signed by the party against whom such waiver is to be enforced, and

any such waiver shall apply only in the particular instance in which such waiver shall have been given.

(b)

Neither any failure or delay in exercising any right or remedy hereunder or in requiring satisfaction of any condition herein nor

any course of dealing shall constitute a waiver of or prevent any party hereto from enforcing any right or remedy or from requiring satisfaction

of any condition. No notice to or demand on a party hereto waives or otherwise affects any obligation of that party or impairs any right

of the party giving such notice or making such demand, including any right to take any action without notice or demand not otherwise required

by this Agreement. No exercise of any right or remedy with respect to a breach of this Agreement shall preclude exercise of any other

right or remedy, as appropriate to make the aggrieved party whole with respect to such breach, or subsequent exercise of any right or

remedy with respect to any other breach.

(c)

Except as otherwise expressly provided herein, any and all remedies provided herein will be deemed cumulative with and not exclusive

of any other remedy conferred hereby, or by law or equity upon any party hereto, and the exercise by a party hereto of any one remedy

will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage for which monetary damages, even

if available, would not be an adequate remedy, would occur in the event that the parties hereto do not perform their respective obligations

under the provisions of this Agreement (including failing to take such actions as are required of them hereunder to consummate the Transactions)

in accordance with their specific terms or otherwise breach such provisions. It is accordingly agreed that the parties hereto shall be

entitled to seek to obtain an injunction or injunctions, specific performance and other equitable relief to prevent breaches of this Agreement

and to enforce specifically the terms and provisions of this Agreement, in each case, without posting a bond or undertaking and without

proof of damages and this being in addition to any other remedy to which they are entitled at law or in equity. Each of the parties hereto

agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief when expressly available

pursuant to the terms of this Agreement on the basis that the other parties hereto have an adequate remedy at law or an award of specific

performance is not an appropriate remedy for any reason at law or equity.

(d)

Notwithstanding anything to the contrary contained herein, no party hereto shall seek, nor shall any party hereto be liable for,

punitive or exemplary damages under any tort, contract, equity or other legal theory with respect to any breach (or alleged breach) of

this Agreement or any provision hereof or any matter otherwise relating hereto or arising in connection herewith.

XI.3

Arm’s Length Bargaining; No Presumption Against Drafter. This Agreement has been negotiated at arm’s-length by parties

of equal bargaining strength, each represented by counsel and having participated in the drafting of this Agreement. This Agreement creates

no fiduciary or other special relationship between the parties, and no such relationship otherwise exists. No presumption in favor of

or against any party hereto in the construction or interpretation of this Agreement or any provision hereof shall be made based upon

which Person might have drafted this Agreement or such provision.

XI.4

Publicity. Except as set forth in this Agreement, required by applicable Law or applicable stock exchange rules and except with

respect to the Additional Parent SEC Documents, the parties hereto agree that neither they nor their respective Representatives shall

issue any press release or make any other public disclosure concerning the Transactions without the prior approval of the other parties

hereto. If a party hereto is required to make such a disclosure as required by applicable Law or applicable stock exchange rules, the

party making such determination will, if practicable in the circumstances, use reasonable commercial efforts to allow the other parties

hereto reasonable time to comment on such disclosure in advance of its issuance.

XI.5

Expenses. Except as otherwise set forth herein, the payment of any filing fees with the SEC relating to the Offer Documents shall

be borne equally by the Company and Parent; provided, however, that all filing fees payable under the Hart Scott Rodino Act shall be

borne solely by the Company. If the Closing does not take place, each party hereto shall be responsible for its own expenses. Upon the

Closing, all Transaction Expenses shall be paid by wire transfer of immediately available funds, from Aggregate Parent Closing Cash,

and to the extent such funds are exhausted, will be paid by the PubCo.

XI.6

No Assignment or Delegation. No party hereto may assign any right or delegate any obligation hereunder, including by merger, consolidation,

operation of law or otherwise, without the written consent of the other party. Any purported assignment or delegation without such consent

shall be void, in addition to constituting a material breach of this Agreement.

XI.7

Governing Law. This Agreement shall be construed in accordance with and governed by the laws of the State of New York applicable

to agreements made and to be performed entirely within such State, without giving effect to the conflict of laws principles thereof to

the extent that the application of the laws of another jurisdiction would be required thereby (except that the NRS shall also apply to

the Domestication and the Merger to the extent required in respect of Parent, PubCo and Merger Sub, the DGCL shall also apply to the

Merger to the extent required in respect of the Company and the Surviving Corporation, and the Cayman Companies Act shall also apply

to the Domestication).

XI.8

Waiver of Jury Trial.

THE PARTIES HERETO EACH HEREBY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY

OF ANY PROCEEDING (I) ARISING UNDER THIS AGREEMENT OR UNDER ANY ADDITIONAL AGREEMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED OR

INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY ADDITIONAL AGREEMENT OR ANY OF THE TRANSACTIONS

RELATED HERETO OR THERETO OR ANY FINANCING IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREBY OR ANY OF THE TRANSACTIONS CONTEMPLATED

THEREBY, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. THE PARTIES HERETO EACH HEREBY

AGREES AND CONSENTS THAT ANY SUCH PROCEEDING SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES HERETO MAY FILE AN ORIGINAL

COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR

RIGHT TO TRIAL BY JURY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY

HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER,

(B) EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY

AND (D) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN

THIS SECTION 11.8.

XI.9

Submission to Jurisdiction. Each of the parties hereto irrevocably and unconditionally submits to the exclusive jurisdiction of

the courts of the State of New York and of the United States of America, in each case located in the Borough of Manhattan, City and State

of New York (or any appellate courts thereof), for the purposes of any Action (a) arising under this Agreement or under any Additional

Agreement or (b) in any way connected with or related or incidental to the dealings of the parties hereto in respect of this Agreement

or any Additional Agreement or any of the transactions contemplated hereby or thereby, and irrevocably and unconditionally waives any

objection to the laying of venue of any such Action in any such court, and further irrevocably and unconditionally waives and agrees

not to plead or claim in any such court that any such Action has been brought in an inconvenient forum. Each party hereto hereby irrevocably

and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action (i)

arising under this Agreement or under any Additional Agreement or (ii) in any way connected with or related or incidental to the dealings

of the parties hereto in respect of this Agreement or any Additional Agreement or any of the transactions contemplated hereby or thereby,(A)

any claim that it is not personally subject to the jurisdiction of the courts as described in this Section 11.9 for any reason,

(B) that it or its property is exempt or immune from the jurisdiction of any such court or from any Action commenced in such courts (whether

through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise)

and(C) that (x) the Action in any such court is brought in an inconvenient forum, (y) the venue of such Action is improper or (z) this

Agreement, or the subject matter hereof, may not be enforced in or by such courts. Each party hereto agrees that service of any process,

summons, notice or document by registered mail to such party’s respective address set forth in Section 11.1 shall be effective

service of process for any such Action.

XI.10

Counterparts; Facsimile Signatures. This Agreement may be executed in counterparts, each of which shall constitute an original,

but all of which shall constitute one agreement. This Agreement shall become effective upon delivery to each party hereto of an executed

counterpart or the earlier delivery to each party hereto of original, photocopied, or electronically transmitted (including scanned .pdf

image) signature pages that together (but need not individually) bear the signatures of all other parties hereto.

XI.11 Entire

Agreement. This Agreement, together with the Additional Agreements, sets forth the entire agreement of the parties hereto with

respect to the subject matter hereof and thereof and supersedes all prior and contemporaneous understandings and agreements related

thereto (whether written or oral), all of which are merged herein. No provision of this Agreement or any Additional Agreement may be

explained or qualified by any agreement, negotiations, understanding, discussion, conduct or course of conduct or by any trade

usage. Except as otherwise expressly stated herein or in any Additional Agreement, there is no condition precedent to the

effectiveness of any provision hereof or thereof.

XI.12

Severability. Whenever possible, each provision of this Agreement will be interpreted in such a manner as to be effective and

valid under applicable Law, but if any term or other provision of this Agreement is held to be invalid, illegal or unenforceable under

applicable Law, all other provisions of this Agreement shall remain in full force and effect so long as the economic or legal substance

of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto. The parties hereto shall

cooperate in good faith to substitute (or cause such court or other legal authority to substitute) for any provision so held to be invalid

a valid provision, so as to effect the original intent of the parties hereto as closely as possible in an acceptable manner in order

that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible.

XI.13

Further Assurances. Each party hereto shall execute and deliver such documents and take such action, as may reasonably be considered

within the scope of such party’s obligations hereunder, necessary to effectuate the Transactions.

XI.14

Third Party Beneficiaries. Except as provided in Sections 6.8, 6.9, 6.10, ARTICLE X and Section

11.16, neither this Agreement nor any provision hereof confers any benefit or right upon or may be enforced by any Person not a signatory

hereto.

XI.15

Waiver. Reference is made to the final prospectus of Parent, dated April 29, 2025 (the “IPO Prospectus”). The

Company has read the IPO Prospectus and understands that Parent has established the Trust Account for the benefit of the public shareholders

of Parent and the underwriters of the IPO pursuant to the Trust Agreement and that Parent may disburse monies from the Trust Account

only for the purposes set forth in the Trust Agreement. For and in consideration of Parent agreeing to enter into this Agreement, the

Company, for itself and on behalf of the Company Subsidiaries and their respective Affiliates and Representatives, hereby (a) agrees

that it does not now and shall not at any time hereafter have any right, title, interest or claim of any kind in or to any monies in

the Trust Account as a result of, or arising out of, any negotiations, contracts or agreements with Parent regardless of whether such

claim arises based on contract, tort, equity or any other theory of legal liability (any and all such claims are collectively referred

to hereafter as the “Released Claims”), (b) irrevocably waives any Released Claims that it may have against the monies

in the Trust Account now or in the future as a result of, or arising out of, this Agreement, and (c) agrees that it will not seek recourse

against the monies in the Trust Account for any reason provided, however, that the foregoing waiver will not limit or prohibit

the Company or any Company Subsidiary from pursuing a claim against Parent, Merger Sub or any other Person for legal relief against monies

outside the Trust Account or other assets of Parent or Merger Sub held outside of the Trust Account or for specific performance or other

equitable relief in connection with the Transactions, including a claim against Parent and Merger Sub to specifically perform its obligations

under this Agreement in accordance with the terms of this Agreement.

XI.16

Non-Recourse. This Agreement may be enforced only against, and any dispute, claim or controversy based upon, arising out of or

related to this Agreement or the Transactions may be brought only against, the entities that are expressly named as parties hereto and

then only with respect to the specific obligations set forth in this Agreement with respect to such party. No past, present or future

director, officer, employee, incorporator, member, partner, shareholder, agent, attorney, advisor, lender or Representative or Affiliate

of any named party to this Agreement (which Persons are intended third party beneficiaries of this Section 11.16) shall have any

liability (whether in contract or tort, at law or in equity or otherwise, or based upon any theory that seeks to impose liability of

an entity party against its owners or Affiliates) for any one or more of the representations, warranties, covenants, agreements or other

obligations or liabilities of such named party or for any dispute, claim or controversy based on, arising out of, or related to this

Agreement or the Transactions.

XI.17

Non-Survival of Representations and Warranties. Except as otherwise set forth in Section 10.3 or in the case of claims

against a Person in respect of such Person’s common law fraud, none of the representations, warranties, covenants, obligations

or other agreements in this Agreement or in any certificate, statement or instrument delivered pursuant to this Agreement, including

any rights arising out of any breach of such representations, warranties, covenants, obligations, agreements and other provisions, shall

survive the Closing (and there shall be no liability after the Closing in respect thereof), except for (a) those covenants and agreements

contained herein that by their terms expressly apply in whole or in part at or after the Closing, and then only with respect to any breaches

occurring at or after the Closing and (b) this ARTICLE XI.

XI.18

No Other Representations; No Reliance.

(a) NEITHER

THE COMPANY, THE COMPANY SUBSIDIARIES, ANY COMPANY SECURITYHOLDER NOR ANY OF THEIR RESPECTIVE REPRESENTATIVES HAS MADE ANY

REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, OF ANY NATURE WHATSOEVER RELATING TO THE COMPANY, THE COMPANY SUBSIDIARIES OR THE

BUSINESS OR OTHERWISE IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY ADDITIONAL AGREEMENT, OTHER THAN

THOSE REPRESENTATIONS AND WARRANTIES EXPRESSLY SET FORTH IN ARTICLE IV, IN EACH CASE, AS MODIFIED BY THE COMPANY SCHEDULES.

Without limiting the generality of the foregoing, neither the Company, the Company Subsidiaries, any Company Securityholder nor any

of their respective Representatives has made, and shall not be deemed to have made, any representations or warranties in the

materials relating to the Company or any Company Subsidiary made available to Parent and its Representatives, including due

diligence materials, or in any presentation of the Business of the Company or any Company Subsidiary by management of the Company,

any Company Subsidiary or others in connection with the Transactions, and no statement contained in any of such materials or made in

any such presentation shall be deemed a representation or warranty hereunder or otherwise or deemed to be relied upon by Parent or

Merger Sub in executing, delivering and performing this Agreement, the Additional Agreements or the Transactions, in each case

except for the representations and warranties set forth in ARTICLE IV as modified by the Company Schedules. It is understood

that any cost estimates, projections or other predictions, any data, any financial information or any memoranda or offering

materials or presentations, including any offering memorandum or similar materials made available by the Company, any Company

Subsidiary, any Company Securityholder or their respective Representatives are not and shall not be deemed to be or to include

representations or warranties of the Company, any Company Subsidiary or any Company Securityholder, and are not and shall not be

deemed to be relied upon by Parent or Merger Sub in executing, delivering and performing this Agreement, the Additional Agreement

and the Transactions, in each case except for the representations and warranties set forth in ARTICLE IV, in each case, as

modified by the Company Schedules. Except for the specific representations and warranties expressly made by the Company in ARTICLE

IV, in each case as modified by the Company Schedules: (i) each of Parent and Merger Sub acknowledges and agrees that: (A)

neither the Company, the Company Subsidiaries, the Company Securityholders nor any of their respective Representatives is making or

has made any representation or warranty, express or implied, at law or in equity, in respect of the Company, the Company

Subsidiaries, the Business, assets, liabilities, operations, prospects or condition (financial or otherwise) of the Company or any

Company Subsidiary, the nature or extent of any liabilities of the Company or any Company Subsidiary, the effectiveness or the

success of any operations of the Company or the Company Subsidiaries or the accuracy or completeness of any confidential information

memoranda, projections, forecasts or estimates of earnings, or other information (financial or otherwise) regarding the Company or

the Company Subsidiaries furnished to Parent, Merger Sub or their respective Representatives or made available to Parent and its

Representatives in any “data rooms,” “virtual data rooms,” management presentations or any other form in

expectation of, or in connection with, the Transactions, or in respect of any other matter or thing whatsoever; and (B) no

Representative of any Company Securityholder or the Company (including the Company Subsidiaries) has any authority, express or

implied, to make any representations, warranties or agreements not specifically set forth in ARTICLE IV and subject to the

limited remedies herein provided; (ii) Parent specifically disclaims that it is relying upon or has relied upon any such other

representations or warranties that may have been made by any Person, and acknowledges and agrees that the Company Securityholders

and the Company (including the Company Subsidiaries) have specifically disclaimed and do hereby specifically disclaim any such other

representation or warranty made by any Person; and (iii) none of the Company, the Company Subsidiaries, the Company Securityholders

or any other Person shall have any liability to Parent or any other Person with respect to any such other representations or

warranties, including projections, forecasts, estimates, plans or budgets of future revenue, expenses or expenditures, future

results of operations, future cash flows or the future financial condition of the Company or any Company Subsidiary or the future

business, operations or affairs of the Company or any Company Subsidiary.

(b) NONE

OF PARENT, MERGER SUB, SPONSOR OR ANY OTHER HOLDERS OF EQUITY INTERESTS OF PARENT OR MERGER SUB, NOR ANY OF THEIR RESPECTIVE

REPRESENTATIVES HAS MADE ANY REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, OF ANY NATURE WHATSOEVER RELATING TO PARENT OR

MERGER SUB OR THEIR RESPECTIVE BUSINESSES OR OTHERWISE IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY

ADDITIONAL AGREEMENT, OTHER THAN THOSE REPRESENTATIONS AND WARRANTIES EXPRESSLY SET FORTH IN ARTICLE V, IN EACH CASE, AS

MODIFIED BY THE PARENT SCHEDULES. Without limiting the generality of the foregoing, none of Parent, Merger Sub, Sponsor or any other

holders of Equity Interests of Parent or Merger Sub nor any of their respective Representatives has made, and shall not be deemed to

have made, any representations or warranties in the materials relating to Parent or Merger Sub made available to the Company and its

Representatives, including due diligence materials, or in any presentation of the business of Parent or Merger Sub made by

management of Parent or Merger Sub or others in connection with the Transactions, and no statement contained in any of such

materials or made in any such presentation shall be deemed a representation or warranty hereunder or otherwise or deemed to be

relied upon by the Company in executing, delivering and performing this Agreement, the Additional Agreements or the Transactions, in

each case except for the representations and warranties set forth in ARTICLE V as modified by the Parent Schedules. It is

understood that any cost estimates, projections or other predictions, any data, any financial information or any memoranda or

offering materials or presentations, including any offering memorandum or similar materials made available by Parent, Merger Sub,

Sponsor or any other holders of Equity Interests of Parent or Merger Sub or their respective Representatives are not and shall not

be deemed to be or to include representations or warranties of Parent, Merger Sub, Sponsor or any other holders of Equity Interests

of Parent or Merger Sub, and are not and shall not be deemed to be relied upon by the Company in executing, delivering and

performing this Agreement, the Additional Agreement and the Transactions, in each case except for the representations and warranties

set forth in ARTICLE V, in each case, as modified by the Parent Schedules. Except for the specific representations and

warranties expressly made by Parent and Merger Sub in ARTICLE V, in each case as modified by the Parent Schedules: (i) the

Company acknowledges and agrees that: (A) none of Parent, Merger Sub, Sponsor nor any other holders of Equity Interests of Parent or

Merger Sub or any of their respective Representatives is making or has made any representation or warranty, express or implied, at

law or in equity, in respect of Parent or Merger Sub or the business, assets, liabilities, operations, prospects or condition

(financial or otherwise) of Parent or Merger Sub, the nature or extent of any liabilities of Parent or Merger Sub, the effectiveness

or the success of any operations of Parent or Merger Sub or the accuracy or completeness of any confidential information memoranda,

projections, forecasts or estimates of earnings, or other information (financial or otherwise) regarding Parent or Merger Sub

furnished to the Company or its Representatives or made available to the Company and its Representatives in any “data

rooms,” “virtual data rooms,” management presentations or any other form in expectation of, or in connection with,

the Transactions (including with respect to the Company Subsidiaries), or in respect of any other matter or thing whatsoever; and

(B) no Representative of Parent, Merger Sub, Sponsor or any other holders of Equity Interests of Parent or Merger Sub has any

authority, express or implied, to make any representations, warranties or agreements not specifically set forth in ARTICLE V

and subject to the limited remedies herein provided; (ii) the Company specifically disclaims that it is relying upon or has relied

upon any such other representations or warranties that may have been made by any Person, and acknowledges and agrees that Parent,

Merger Sub, Sponsor and the other holders of Equity Interests of Parent and Merger Sub have specifically disclaimed and do hereby

specifically disclaim any such other representation or warranty made by any Person; and (iii) none of Parent, Merger Sub, Sponsor or

any other holders of Equity Interests of Parent or Merger Sub nor any other Person shall have any liability to the Company or any

other Person with respect to any such other representations or warranties, including projections, forecasts, estimates, plans or

budgets of future revenue, expenses or expenditures, future results of operations, future cash flows or the future financial

condition of Parent or Merger Sub or the future business, operations or affairs of Parent or Merger Sub.

XI.19

Conflicts and Privilege.

(a)

Each of the parties hereto, on its own behalf and on behalf of its Affiliates from time to time, hereby agree that, in the event

that a dispute with respect to this Agreement or the Transactions arises after the Closing between or among (x) the Sponsor, the shareholders

or holders of other Equity Interests of Parent or the Sponsor and/or any of their respective directors, members, partners, officers, employees

or Affiliates (collectively, the “Parent Group”), on the one hand, and (y) the Company or PubCo, on the other hand,

any legal counsel, including Celine and Partners, PLLC (“Celine & Partners”), that represented Parent and/or the

Sponsor prior to the Closing may represent the Sponsor and/or any other member of the Parent Group in such dispute even though the interests

of such Persons may be directly adverse to the Company or PubCo, and even though such counsel may have represented the Parent Group and/or

PubCo in a matter substantially related to such dispute, or may be handling ongoing matters for PubCo, the Company and/or the Sponsor.

The parties hereto, on behalf of their respective successors and assigns (including, after the Closing, PubCo), further agree that, as

to all legally privileged communications prior to the Closing (made in connection with the negotiation, preparation, execution, delivery

and performance under, or any dispute or Action arising out of or relating to, this Agreement, any Additional Agreements or the transactions

contemplated hereby or thereby) between or among Parent, the Sponsor and/or any other member of the Parent Group, on the one hand, and

White & Case, on the other hand, the attorney-client privilege and the expectation of client confidence shall survive the Transactions

and belong to the Parent Group after the Closing, and shall not pass to or be claimed or controlled by PubCo or the Company. Notwithstanding

the foregoing, any privileged communications or information shared by the Company prior to the Closing with Parent or the Sponsor under

a common interest agreement shall remain the privileged communications or information of the Company.

(b)

The parties hereto, on behalf of their respective successors and assigns (including, after the Closing, PubCo), hereby agree that,

in the event a dispute with respect to this Agreement or the transactions contemplated hereby arises after the Closing between or among

(x) the stockholders or holders of other Equity Interests of the Company, the Company Subsidiaries and/or any of their respective directors,

members, partners, officers, employees or Affiliates (collectively, the “Company Group”), on the one hand, and (y)

any member of the Parent Group, on the other hand, any legal counsel, including Sichenzia that represented the Company or any Company

Subsidiary prior to the Closing may represent any member of the Company Group in such dispute even though the interests of such Persons

may be directly adverse to the Parent Group, and even though such counsel may have represented Parent and/or the Company or any Company

Subsidiary in a matter substantially related to such dispute, or may be handling ongoing matters for the Company or any Company Subsidiary,

and further agree that, as to all legally privileged communications prior to the Closing (made in connection with the negotiation, preparation,

execution, delivery and performance under, or any dispute or Action arising out of or relating to, this Agreement, any Additional Agreements

or the transactions contemplated hereby or thereby) between or among any member of the Company Group, on the one hand, and Sichenzia,

on the other hand, the attorney-client privilege and the expectation of client confidence shall survive the Transactions and belong to

the Company Group after the Closing, and shall not pass to or be claimed or controlled by the PubCo. Notwithstanding the foregoing, any

privileged communications or information shared by Parent prior to the Closing with the Company (including the Company Subsidiaries) under

a common interest agreement shall remain the privileged communications or information of Parent.

[The remainder of this page intentionally

left blank; signature pages to follow]

IN WITNESS

WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

Parent:

WESTIN ACQUISITION CORP.

By:

/s/ Stanney Majawit

Name:

Stanney Majawit

Title:

Chief

Financial Officer

Merger Sub:

FIRST

CHOICE ACQUISITION INC.

By:

/s/ Kok Peng Na

Name:

Kok Peng Na

Title:

Director

Company:

FIRST

CHOICE HEALTHCARE SOLUTIONS INC.

By:

/s/ Lance Friedman

Name:

Lance Friedman

Title:

Chief Executive office

EX-10.1 — PARENT SUPPORT AGREEMENT, DATED AS OF JULY 22, 2026, BY AND AMONG WESTIN ACQUISITION CORP., FIRST CHOICE HEALTHCARE SOLUTIONS, INC. AND THE OTHER PARENT SUPPORTING SHAREHOLDERS THERETO

EX-10.1

Filename: ea029926201ex10-1.htm · Sequence: 3

Exhibit 10.1

PARENT SUPPORT AGREEMENT

This PARENT SUPPORT AGREEMENT (this “Agreement”),

dated as of July 22, 2026, is made by and among Westin Acquisition Corp., a Cayman Islands exempted company (“Parent”), First

Choice Healthcare Solutions, Inc., a Delaware corporation (the “Company”), and each of the Persons identified on Schedule

A hereto (each, a “Parent Supporting Shareholder” and, collectively, the “Parent Supporting Shareholders”). Parent,

the Company and the Parent Supporting Shareholders are referred to herein collectively as the “Parties.” Capitalized terms

used but not otherwise defined herein shall have the meanings ascribed to such terms in the Business Combination Agreement (as defined

below).

WHEREAS, Parent, the Company and First Choice Acquisition

Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), have entered into that certain Business

Combination Agreement, dated as of July 22, 2026 (as it may be amended, supplemented or otherwise modified from time to time in accordance

with its terms, the “Business Combination Agreement”);

WHEREAS, as of the date hereof, each Parent Supporting

Shareholder is the record or beneficial owner of the Parent Ordinary Shares, Parent Units and/or Parent Rights set forth opposite such

Parent Supporting Shareholder’s name on Schedule A (together with any other equity securities of Parent acquired by such Parent

Supporting Shareholder after the date hereof, the “Subject Securities”);

WHEREAS, pursuant to the Business Combination Agreement,

Parent will domesticate as a Nevada corporation and change its name to “Wellgevity 360, Inc.” (“PubCo”) one Business

Day prior to the Closing, following which Merger Sub will merge with and into the Company, with the Company surviving the Merger as a

wholly owned subsidiary of PubCo; and

WHEREAS, as a condition and inducement to the willingness

of Parent and the Company to enter into the Business Combination Agreement, the Parent Supporting Shareholders are entering into this

Agreement.

NOW, THEREFORE, in consideration of the foregoing

and the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of

which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows:

1. Agreement to Vote.

(a) From the date hereof until the Expiration Time

(as defined in Section 11), at each meeting of the Parent Shareholders (and at each adjournment or postponement thereof), and in connection

with each written consent of the Parent Shareholders, each Parent Supporting Shareholder shall cause all Parent Ordinary Shares included

in its Subject Securities and entitled to vote thereon (the “Subject Shares”) to be present for purposes of establishing a

quorum and shall vote (or cause to be voted) the Subject Shares: (i) in favor of the Parent Proposals, including the approval and adoption

of the Business Combination Agreement and the Transactions, the Domestication and the Merger; (ii) in favor of any proposal to adjourn

or postpone such meeting to a later date if there are not sufficient votes to approve the Parent Proposals; and (iii) against any Alternative

Transaction and against any other action, agreement or proposal that would reasonably be expected to impede, interfere with, delay, postpone,

discourage or adversely affect the consummation of the Transactions or result in a breach of any representation, warranty, covenant or

agreement of Parent under the Business Combination Agreement.

(b) Each Parent Supporting Shareholder hereby revokes

any proxy, voting agreement or similar arrangement previously granted with respect to the Subject Shares that is inconsistent with this

Agreement and agrees not to grant any proxy or enter into any voting agreement or similar arrangement that is inconsistent with this Agreement.

2. Waiver of Redemption

Rights. Each Parent Supporting Shareholder hereby irrevocably and unconditionally agrees not to elect to redeem, tender or submit

for redemption, or otherwise exercise any right to redeem, any Subject Shares in connection with the Transactions, including any vote

to approve the Parent Proposals or any amendment to the Parent Articles made in connection with the Transactions. If any redemption election

has been made with respect to any Subject Shares, such Parent Supporting Shareholder shall promptly withdraw, or cause to be withdrawn,

such redemption election.

3. Waiver of Anti-Dilution

and Similar Protections. Each Parent Supporting Shareholder hereby irrevocably and unconditionally waives, and agrees not to exercise,

assert or perfect, any adjustment to the conversion ratio or any anti-dilution, preemptive, conversion, redemption or similar protection

with respect to any Parent Class B Ordinary Shares or other Subject Securities that may arise under the Parent Articles or any other agreement

in connection with the Transactions or the issuance of PubCo Common Stock or any other securities contemplated by the Business Combination

Agreement or any Additional Agreement. Without limiting the foregoing, each Parent Supporting Shareholder agrees that its Parent Class

B Ordinary Shares shall convert in connection with the Domestication on a one-for-one basis into shares of PubCo Common Stock, subject

only to adjustments expressly contemplated by the Business Combination Agreement.

4. Transfer Restrictions.

(a) From the date hereof until the Expiration Time,

no Parent Supporting Shareholder shall, directly or indirectly: (i) sell, assign, transfer (including by operation of law), tender, pledge,

hypothecate, encumber, gift or otherwise dispose of any Subject Securities or any interest therein (each, a “Transfer”); (ii)

deposit any Subject Securities into a voting trust or enter into a voting agreement, proxy or other arrangement with respect to the voting

of any Subject Shares that is inconsistent with this Agreement; (iii) enter into any contract, option, derivative, hedging or other arrangement

with respect to the Transfer or economic consequences of ownership of any Subject Securities; or (iv) take any action that would reasonably

be expected to prevent or materially delay the performance of its obligations under this Agreement.

(b) Notwithstanding Section 4(a), a Parent Supporting

Shareholder may Transfer Subject Securities: (i) to an Affiliate; (ii) in the case of an individual, by gift to an immediate family member,

a trust for the benefit of an immediate family member or a charitable organization, by will or intestacy, or pursuant to a qualified domestic

relations order; or (iii) with the prior written consent of the Parent and the Company; provided that, in each case, the transferee executes

and delivers to Parent and the Company, before such Transfer, a joinder to this Agreement in form and substance reasonably satisfactory

to Parent and the Company. Any Transfer in violation of this Section 4 shall be null and void.

5. Additional Securities.

If, after the date hereof, a Parent Supporting Shareholder acquires record or beneficial ownership of any additional Parent Ordinary Shares,

Parent Units, Parent Rights or other equity or voting securities of Parent (including by stock dividend, stock split, recapitalization,

purchase, conversion, exchange or otherwise), such securities shall automatically become Subject Securities and be subject to this Agreement.

Each Parent Supporting Shareholder shall promptly notify Parent and the Company in writing of any such acquisition and of any change in

the information set forth opposite its name on Schedule A.

6. Further Assurances;

No Inconsistent Agreement. Each Parent Supporting Shareholder shall execute and deliver such additional documents and take such further

actions as may be reasonably requested by Parent or the Company to carry out this Agreement and consummate the Transactions. Each Parent

Supporting Shareholder represents and covenants that it has not entered into, and shall not enter into, any agreement or arrangement that

would restrict, limit, interfere with or be inconsistent with the performance of its obligations under this Agreement.

7. Consent to Disclosure.

Each Parent Supporting Shareholder consents to the publication and disclosure in the Registration Statement and any other filing, document

or communication required by applicable securities Laws, the SEC, Nasdaq or any other Authority of: (a) such Parent Supporting Shareholder’s

identity; (b) its beneficial ownership of the Subject Securities; and (c) the nature of its commitments, arrangements and understandings

under this Agreement. Each Parent Supporting Shareholder shall promptly provide information reasonably requested by Parent or the Company

for any filing or approval sought in connection with the Transactions.

- 2 -

8. Representations and Warranties of the Parent

Supporting Shareholders. Each Parent Supporting Shareholder, severally and not jointly, represents and warrants to Parent and the

Company as follows:

(a) Ownership. Such Parent Supporting Shareholder

is the record or beneficial owner of the Subject Securities set forth opposite its name on Schedule A, free and clear of all Liens other

than transfer restrictions under applicable securities Laws, the Parent Articles and this Agreement. Such Parent Supporting Shareholder

has sole voting power (or the power to direct the voting) with respect to the Subject Shares, and the Subject Securities set forth on

Schedule A constitute all equity and voting securities of Parent owned of record or beneficially by such Parent Supporting Shareholder

as of the date hereof.

(b) Organization; Authority. If such Parent Supporting

Shareholder is an entity, it is duly organized, validly existing and in good standing (where applicable) under the Laws of its jurisdiction

of organization, and the execution, delivery and performance of this Agreement have been duly authorized by all necessary organizational

action. If such Parent Supporting Shareholder is an individual, such individual has full legal capacity, right and authority to execute

and deliver this Agreement and perform his or her obligations hereunder.

duly executed and delivered by such Parent Supporting Shareholder and, assuming due authorization, execution and delivery by the other

Parties, constitutes a valid and binding obligation of such Parent Supporting Shareholder, enforceable against it in accordance with its

terms, subject to the Enforceability Exceptions.

(d) No Conflict. The execution and delivery of

this Agreement and the performance of such Parent Supporting Shareholder’s obligations hereunder do not and will not: (i) violate

any applicable Law; (ii) if such Parent Supporting Shareholder is an entity, violate its Organizational Documents; (iii) conflict with

or result in a breach of any Contract binding upon it or the Subject Securities; or (iv) require any consent or approval that has not

been obtained, except, in the case of clauses (i), (iii) and (iv), as would not reasonably be expected to prevent or materially delay

such Parent Supporting Shareholder’s performance of its obligations hereunder.

(e) Proceedings. There is no Action pending or,

to such Parent Supporting Shareholder’s knowledge, threatened against it that would reasonably be expected to prevent or materially

delay the performance of its obligations under this Agreement.

(f) Reliance. Such Parent Supporting Shareholder

has reviewed the Business Combination Agreement and this Agreement, has had an opportunity to consult with its legal, tax and financial

advisors, and is entering into this Agreement voluntarily and without reliance on any representation or warranty other than those expressly

set forth in this Agreement or the Business Combination Agreement.

9. Capacity. Each

Parent Supporting Shareholder enters into this Agreement solely in its capacity as a record or beneficial owner of the Subject Securities.

Nothing in this Agreement shall limit or affect any action or inaction by any individual serving as a director, officer or fiduciary of

Parent when acting in such capacity; provided that this Section 9 shall not relieve any Parent Supporting Shareholder of its obligations

under this Agreement.

10. No Ownership Interest.

Nothing in this Agreement shall be deemed to vest in Parent, the Company or any of their respective Affiliates any direct or indirect

ownership of the Subject Securities. Except for the restrictions and obligations expressly set forth herein, all rights, ownership and

economic benefits relating to the Subject Securities shall remain vested in the applicable Parent Supporting Shareholder.

- 3 -

11. Termination. This

Agreement shall terminate and be of no further force or effect upon the earliest of: (a) the Merger Effective Time; (b) the valid termination

of the Business Combination Agreement in accordance with Article X thereof; and (c) the written agreement of Parent and the Company (the

“Expiration Time”). Upon termination, no Party shall have any further obligation or liability under this Agreement; provided

that such termination shall not relieve any Party from liability for any Willful Breach or Fraud occurring prior to termination. Sections

11 through 16 shall survive any termination of this Agreement to the extent applicable.

12. Specific Performance.

The Parties acknowledge that irreparable damage would occur if any provision of this Agreement were not performed in accordance with its

specific terms or were otherwise breached and that money damages would not be an adequate remedy. Accordingly, each Party shall be entitled

to seek an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and enforce its terms, without

proof of actual damages or the posting of any bond, in addition to any other remedy available at law or in equity.

13. Several Obligations.

The representations, warranties, covenants and agreements of the Parent Supporting Shareholders under this Agreement are several and not

joint or joint and several. No Parent Supporting Shareholder shall be responsible for the breach of this Agreement by any other Parent

Supporting Shareholder.

14. Notices. All notices,

requests, claims, demands and other communications under this Agreement shall be made in accordance with Section 11.4 of the Business

Combination Agreement. Any notice to a Parent Supporting Shareholder shall be delivered to the address or email address set forth opposite

such Parent Supporting Shareholder’s name on Schedule A.

15. Incorporation by Reference.

Sections 1.3 (Construction), 11.2 (Amendments; No Waivers; Remedies), 11.6 (No Assignment or Delegation), 11.7 (Governing Law), 11.8 (Waiver

of Jury Trial), 11.9 (Submission to Jurisdiction), 11.10 (Counterparts; Electronic Signatures), 11.11 (Entire Agreement) and 11.12 (Severability)

of the Business Combination Agreement are incorporated herein by reference and shall apply to this Agreement mutatis mutandis.

16. Amendment of Schedule

A. Schedule A may be amended by Parent and the Company from time to time to add a Person that executes a joinder to this Agreement

and to reflect changes in ownership of Subject Securities permitted by this Agreement, without the consent of any other Parent Supporting

Shareholder.

[Signature Pages Follow]

- 4 -

IN WITNESS WHEREOF, the Parties have caused this Parent Support Agreement

to be duly executed as of the date first written above.

WESTIN ACQUISITION CORP.

By:

Name:

Stanney Majawit

Title:

Chief Financial Officer

FIRST CHOICE HEALTHCARE SOLUTIONS, INC.

By:

Name:

Lance Friedman

Title:

Chief Executive Officer

- 5 -

PARENT SUPPORTING SHAREHOLDER:

[NAME OF PARENT SUPPORTING SHAREHOLDER]

By:

Name:

Title:

- 6 -

SCHEDULE A

PARENT SUPPORTING SHAREHOLDERS AND SUBJECT SECURITIES

Parent Supporting Shareholder

Parent Class A Ordinary Shares

Parent Class B Ordinary Shares

Parent Units

Parent Rights

Notice Address

Westin Investment Co. Ltd

[●]

- 7 -

EX-10.2 — COMPANY SUPPORT AGREEMENT DATED AS OF JULY 22, 2026, BY AND AMONG WESTIN ACQUISITION CORP., FIRST CHOICE HEALTHCARE SOLUTIONS, INC. AND THE OTHER COMPANY SUPPORTING SHAREHOLDERS THERETO

EX-10.2

Filename: ea029926201ex10-2.htm · Sequence: 4

Exhibit 10.2

COMPANY SUPPORT AGREEMENT

This COMPANY SUPPORT AGREEMENT

(this “Agreement”), dated as of July 22, 2026, is made by and among Westin Acquisition Corp., a Cayman Islands exempted

company (which shall domesticate as a Delaware corporation one Business Day prior to the Closing) (“Parent”), First

Choice Healthcare Solutions, Inc., a Delaware corporation (the “Company”) and the undersigned stockholder of the Company

(the “Stockholder”). Parent, Company and Stockholder shall be referred to herein from time to time collectively as

the “Parties.” Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms

in the Business Combination Agreement (as defined below).

WHEREAS, this Agreement is

being entered into in connection with the Business Combination Agreement, in the form executed on July 22, 2026, (the “Business

Combination Agreement”), by and among Parent, the Company, and First Choice Acquisition Corp., a Delaware corporation (“Merger

Sub”);

WHEREAS, upon and subject

to the occurrence of the consummation of the Merger, on the terms and subject to the conditions set forth herein, each of the agreements

listed on Schedule I hereto (collectively, the “Investor Agreements” and each, an “Investor Agreement”)

will terminate pursuant to the requisite consent of the Company and the parties thereto ; and

WHEREAS, the Business Combination

Agreement contemplates that the Parties will enter into this Agreement concurrently with the entry into the Business Combination Agreement

by the parties thereto, pursuant to which, among other things, the Company and Stockholder, as applicable, will, subject to the terms

and conditions set forth herein, consent to the entry by the Company into the Business Combination Agreement and the consummation by the

Company of the transactions contemplated thereby on the terms and subject to the conditions set

forth herein.

NOW, THEREFORE, in order to

induce the Company to enter into the Business Combination Agreement and in consideration of the premises and the mutual promises contained

herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, each

intending to be legally bound, hereby agree as follows:

1. Binding

Effects of the Business Combination Agreement; Acknowledgement of Consultation with Advisors. Stockholder hereby acknowledges that

it has read the Business Combination Agreement and this Agreement and has had the opportunity to discuss their content with its tax and

legal advisors to understand their tax and legal implications. The Stockholder shall be bound by, be subject to and comply with Sections

6.2 (Exclusivity) and 6.8 (Confidentiality), of the Business Combination Agreement (and any relevant definitions contained

in any such Sections) as if the Stockholder was an original signatory to the Business Combination Agreement with respect to such provisions.

2. Transfer

Restrictions on Shares. Except as expressly contemplated by the Business Combination Agreement, with the prior written consent of

the Company, or with respect to a Transfer (as defined below) of the type set forth in clause (i) through clause (vi)

below, from and after the date hereof until the Expiration Time, Stockholder hereby agrees that he, she or it shall not (a) sell, assign,

transfer (including by operation of law), place a lien on, pledge, dispose of or otherwise encumber any of his, her or its shares of

Company Capital Stock (or any instruments convertible into Company Capital Stock) held of record or beneficially by Stockholder as of

such time (the “Subject Company Equity Securities”) or otherwise agree to do any of the foregoing (each, a “Transfer”),

(b) deposit any of his, her or its Subject Company Equity Securities into a voting trust or enter into a voting agreement or arrangement

or grant any proxy or power of attorney with respect to any of his, her or its Subject Company Equity Securities that conflicts with

any of the covenants or agreements set forth in this Agreement, (c) enter into any contract, option or other arrangement or undertaking

with respect to the direct or indirect acquisition or sale, assignment, transfer (including by operation of law) or other disposition

of any of his, her or its Subject Company Equity Securities, (d) engage in any hedging or other transaction which is designed to,

or which would (either alone or in connection with one or more developments or events (including the satisfaction or waiver of any conditions

precedent)), lead to or result in a sale or disposition of his, her or its Subject Company Equity Securities or (e) take any action

that would have the effect of preventing or materially delaying the performance of his, her or its obligations hereunder; provided,

however, that the foregoing shall not apply to any Transfer (i) to any affiliates or family member of any of the Company’s

officers or directors, or any employees of such affiliates; (ii) in the case of an individual, by gift to a member of one of the

individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an

affiliate of such person or to a charitable organization; (iii) in the case of an individual, by virtue of laws of descent and distribution

upon death of the individual; (iv) in the case of an individual, pursuant to a qualified domestic relations order; (v) in the

case of an entity, Transfers between Stockholder and any Affiliate of Stockholder; or (vi) by virtue of Company Certificate of Incorporation

and Company Bylaws upon liquidation or dissolution of the Company; provided, that any transferee of any Transfer of the type set

forth in clause (i) through clause (vi) must enter into a written agreement in form and substance reasonably

satisfactory to the Company agreeing to be bound by this Agreement prior to the occurrence of such Transfer. Any Transfer in violation

of this Section 2 shall be null and void.

3. New

Securities. In the event that (a) any shares of Company Capital Stock or other equity securities of the Company are issued to Stockholder

after the date of this Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification, combination, exchange,

or otherwise, (b) Stockholder purchases or otherwise acquires beneficial ownership of any shares of Company Capital Stock after the date

of this Agreement, or (c) Stockholder acquires the right to vote or share in the voting of any shares of Company Capital Stock or other

equity securities of the Company after the date of this Agreement (such shares or other equity securities, collectively, the “New

Securities”), then such New Securities acquired or purchased by Stockholder shall automatically be subject to the terms of this

Agreement (including the transfer restrictions under Section 2) to the same extent as if they constituted the Subject Company Equity

Securities owned by Stockholder as of the date hereof, and shall be included in the definition of “Subject Company Equity Securities”

for all purposes hereof without further action by any Party.

4. Closing

Date Deliverables. On the Closing Date, Stockholder shall deliver (or cause to be delivered) to Parent and the Company:

(a) a

properly completed and duly executed IRS Form W-9 (or applicable IRS Form W-8) from Stockholder;

(b) a

duly executed counterpart signature page to the Lock-Up Agreement;

duly executed counterpart signature page to any other Additional Agreement to which Stockholder is required to be a party pursuant to

the Business Combination Agreement; and

(d) such

other documents, instruments and certificates as are required to be delivered by Stockholder pursuant to the Business Combination Agreement

or any other Additional Agreement, including any documents required by any Governmental Entity in connection with the Transactions.

5. No

Challenges. Stockholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary

to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, the Company or any of

their respective successors, directors, officers, employees or agents: (a) challenging the validity of, or seeking to enjoin the operation

of, any provision of this Agreement, the Business Combination Agreement, or the Transactions; or (b) alleging a breach of any fiduciary

duty of any Person in connection with the evaluation, negotiation, entry into, or consummation of this Agreement, the Business Combination

Agreement, or the Transactions. Notwithstanding anything herein to the contrary, nothing in this Agreement shall limit or restrict the

ability of Stockholder to enforce its rights under the Business Combination Agreement, this Agreement or any other Additional Agreement

to which Stockholder is a party or has third-party beneficiary rights with respect to, or to seek any other remedies with respect to any

breach of the Business Combination Agreement, this Agreement or such other Additional Agreement by any other party hereto or thereto,

including by commencing any Action in connection therewith.

6. Further

Assurances. Stockholder shall take, or cause to be taken, all actions and do, or cause to be done, all things reasonably necessary

under applicable Law, or as reasonably requested by Parent or the Company, to effect the actions set forth in this Agreement and to consummate

the Transactions on the terms and subject to the conditions set forth in the Business Combination Agreement.

7. No

Inconsistent Agreement. Stockholder hereby represents and covenants that Stockholder has not entered into, and shall not enter into,

any agreement that would restrict, limit, or interfere with the performance of Stockholder’s obligations under this Agreement, including

any voting agreement, proxy, power of attorney, or other instrument with respect to any Subject Company Equity Securities that conflicts

in any respect with the obligations of Stockholder set forth herein. Stockholder agrees to reasonably promptly notify Parent and the Company

in writing of (a) any updates to the number or type of Subject Company Equity Securities held by Stockholder, (b) any new equity securities

of the Company acquired by Stockholder, in each case after the date hereof and prior to the Closing, and (c) any encumbrance, lien, pledge,

option, charge, security interest or other restriction imposed on any Subject Company Equity Securities after the date hereof and prior

to the Closing.

8. Termination

of Investor Agreements. Stockholder hereby agrees that, notwithstanding anything to the contrary contained in any Investor Agreement,

(a) each of the Investor Agreements shall be automatically terminated and of no further force and effect (including any provision of any

such agreement that, by its terms, survives such termination) effective as of, and subject to and conditioned upon the occurrence of,

the Closing, (b) upon such termination neither the Company nor any of its Affiliates shall have any further obligations or liabilities

under each such Investor Agreement and (c) from and after such termination, Stockholder shall not have any claims, rights or remedies

against the Company or any of its Affiliates arising under any Investor Agreement (whether arising before, on or after the Closing Date).

9. Other

Covenants. From the date hereof until the Expiration Time, Stockholder shall not, and shall instruct its representatives not to, (a)

make any proposal or offer that constitutes an Alternative Transaction, (b) initiate any discussions or negotiations with any Person with

respect to an Alternative Transaction or (c) enter into any acquisition agreement, business combination, merger agreement or similar definitive

agreement, or any letter of intent, memorandum of understanding or agreement in principle, or any other agreement relating to an Alternative

Transaction, in each case, other than to or with the Company and its respective representatives. From and after the date hereof until

the Expiration Time, Stockholder shall, and shall instruct its officers and directors (if applicable) and its representatives to, immediately

cease and terminate all discussions and negotiations with any Persons that may be ongoing with respect to an Alternative Proposal or any

negotiations which may lead to an Alternative Proposal (other than the Company and its representatives).

10. Appraisal Rights.

Stockholder hereby waives and agrees not to exercise any rights of appraisal or rights to dissent from the Transactions that it may have

under applicable Law with respect to the Subject Company Equity Securities held by the Stockholder.

11. Waiver of Preemptive

Rights. To the extent Stockholder holds any rights of first offer, preemptive rights, anti-dilution rights, or similar rights under

any Investor Agreement, the Company Certificate of Incorporation, the Company Bylaws, or any other agreement with or among the Company

or its stockholders (collectively, “Preemptive Rights”), Stockholder hereby irrevocably and unconditionally waives

any and all such Preemptive Rights with respect to (a) any issuance of equity securities of the Company contemplated by the Business

Combination Agreement or any Additional Agreement (including any recapitalization step or PIPE Investment), (b) any issuance of PubCo

Common Stock or other securities of Parent (as PubCo) in connection with the Transactions, and (c) any other equity issuance expressly

permitted by the Business Combination Agreement. [To the extent any Investor Agreement requires the consent or waiver of a specified

percentage or group of holders to effect a waiver of Preemptive Rights on behalf of all holders, each Stockholder that qualifies as a

member of such group hereby further acknowledges that such requisite consent or waiver has been obtained (or is hereby given) in accordance

with the terms of such Investor Agreement, and that this waiver shall apply to all holders of Preemptive Rights under such Investor Agreement

in the same fashion.]

12. Waiver

of Certain Rights.

(a) Stockholder,

severally and not jointly, hereby irrevocably and unconditionally waives, effective as of the date hereof, any and all rights of first

refusal, co-sale rights, tag-along rights, participation rights, or similar rights that Stockholder may have under any Investor Agreement,

the Company Certificate of Incorporation, the Company Bylaws, or any other agreement with or among the Company or its stockholders, in

each case solely to the extent such rights would be applicable to or triggered by (i) the Transactions (including any recapitalization

step, merger, equity issuance, or other transfer of Company equity interests contemplated by or effected in connection with the Business

Combination Agreement or any Additional Agreement), (ii) any PIPE Investment or other equity financing contemplated by the Business Combination

Agreement, or (iii) any sale, transfer, assignment, distribution, or other disposition of Company equity interests expressly permitted

by the Business Combination Agreement.

(b) Stockholder,

severally and not jointly, hereby irrevocably and unconditionally waives, effective as of the date hereof, any and all transfer restrictions,

consent rights, notice requirements, board approval rights, or similar restrictions applicable to the transfer of Company Capital Stock

under the Company Certificate of Incorporation, the Company Bylaws, or any Investor Agreement, in each case solely to the extent such

restrictions would be applicable to or triggered by any of the events described in clauses (i) through (iii) of Section

12(a).

acknowledges and agrees that the waivers set forth in this Section 12 are a material inducement to each of Parent’s and the

Company’s willingness to enter into the Business Combination Agreement and shall be effective during the period commencing on the

date hereof and ending at the Expiration Time and, solely with respect to the Transactions, shall survive the Expiration Time to the extent

necessary to consummate the Transactions. For the avoidance of doubt, the waivers set forth in this Section 12 are in addition

to, and not in limitation of, the termination of the Investor Agreements at Closing pursuant to Section 8 of this Agreement and

any waiver of preemptive rights set forth in Section 11 of this Agreement.

13. Consent

to Disclosure. Stockholder hereby consents to the publication and disclosure in the Registration Statement (and, as and to the extent

otherwise required by applicable securities Laws or the SEC or any other securities authorities, any documents or communications provided

by the Parent or the Company to any Authority and to Parent Shareholders) of the Stockholder’s identity and beneficial ownership

of the Subject Company Equity Securities and the nature of the Stockholder’s commitments, arrangements and understandings under

and relating to this Agreement and, if deemed appropriate by the Parent and the Company, a copy of this Agreement. Stockholder will promptly

provide any information reasonably requested by Parent or the Company that is reasonably necessary for any regulatory application or filing

made or approval sought in connection with the Transactions (including filings with the SEC).

14. Stockholder

Representations and Warranties. Stockholder hereby represents and warrants to the Company as follows, solely with respect to such

Stockholder:

(a) Ownership.

To the extent any Stockholder owns any Subject Company Equity Securities, Stockholder owns free and clear of all Liens (other than transfer

restrictions under applicable securities Laws) the number of Subject Company Equity Securities set forth opposite Stockholder’s

name on the signature page to this Agreement. Stockholder has, and will have at all times during the term of this Agreement, the sole

voting power with respect to his, her or its Subject Company Equity Securities. Such Subject Company Equity Securities are the only equity

securities in the Company owned of record or beneficially by Stockholder on the date of this Agreement, and none of such Subject Company

Equity Securities are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such Subject

Company Equity Securities, except as provided hereunder. Other than as set forth on the signature page hereto, Stockholder does not hold

or own any rights to acquire (directly or indirectly) any equity interests in the Company or any equity securities convertible into, or

that can be exchanged for, equity securities of the Company.

(b) Organization.

If Stockholder is not an individual, it is duly organized, validly existing and in good standing (where applicable) under the Laws of

the jurisdiction in which it is incorporated, organized or constituted, and the execution, delivery and performance of this Agreement

and the consummation of the transactions contemplated hereby are within Stockholder’s corporate or organizational powers and have

been duly authorized by all necessary corporate or organizational action on the part of Stockholder. If Stockholder is an individual,

Stockholder has full legal capacity, right and authority to execute and deliver this Agreement and to perform Stockholder’s obligations

hereunder.

This Agreement has been duly executed and delivered by Stockholder and, assuming the due authorization, execution and delivery hereof

by the other Parties hereto, this Agreement constitutes a legally valid and binding obligation of Stockholder, enforceable against Stockholder

in accordance with the terms hereof (subject to applicable bankruptcy, insolvency, reorganization, moratorium or other Laws affecting

generally the enforcement of creditors’ rights and subject to general principles of equity). If this Agreement is being executed

in a representative or fiduciary capacity, the Person signing this Agreement has full power and authority to enter into this Agreement

on behalf of Stockholder.

(d) Non-Contravention.

The execution and delivery of this Agreement by Stockholder does not, and the performance by Stockholder of its obligations hereunder

will not, (i) result in a violation of applicable Law, except for such violations which would not reasonably be expected, individually

or in the aggregate, to have a material adverse effect upon Stockholder’s ability to perform its obligations under this Agreement

or to consummate the transactions contemplated by this Agreement, (ii) if Stockholder is not an individual, conflict with or result in

a violation of the governing documents of Stockholder, or (iii) require any consent or approval that has not been given or other action

that has not been taken by any Person (including under any Contract binding upon Stockholder or Stockholder’s Subject Company Equity

Securities).

(e) Legal

Proceedings. As of the date of this Agreement, there is no Action pending against, or to the knowledge of Stockholder, threatened

against Stockholder or any of its Affiliates, by or before (or that would be by or before) any Authority that, if determined or resolved

adversely in accordance with the plaintiff’s demands, would reasonably be expected, individually or in the aggregate, to have a

material adverse effect upon the ability of Stockholder to perform its obligations under this Agreement or to consummate the transactions

contemplated by this Agreement. None of Stockholder or any of its Affiliates is subject to any Order that would reasonably be expected,

individually or in the aggregate, to have a material adverse effect upon the ability of Stockholder to perform its obligations under this

Agreement or to consummate the transactions contemplated by this Agreement or the Business Combination Agreement.

(f) Brokers.

No broker, finder, financial advisor, investment banker or other agent is entitled to any brokerage, finder’s, financial advisor’s,

investment banking or other similar fee or commission payable by the Company or any of its Subsidiaries in connection with the transactions

contemplated hereby based upon arrangements made by or, to the knowledge of Stockholder, on behalf of Stockholder.

(g) Adequate

Information.

(i) Stockholder

has been furnished or given access to adequate information concerning the business, financial condition, operations, and prospects of

Parent and the Company to make an informed decision regarding this Agreement and the Transactions. Stockholder has independently and without

reliance upon Parent or the Company (or any of their respective officers, directors, employees, agents, or advisors), and based on such

information as Stockholder has deemed appropriate, made its own analysis, evaluation, and decision to enter into this Agreement.

(ii) Stockholder

acknowledges that neither Parent nor the Company has made, and does not make, any representation or warranty, whether express or implied,

of any kind or character except as expressly set forth in this Agreement or the Business Combination Agreement.

(h) Acknowledgment.

Stockholder acknowledges and agrees that (A) the agreements and obligations contained in this Agreement, including transfer restrictions

under Section 2, are irrevocable (subject only to termination upon the occurrence of the Expiration Time), (B) such obligations

result in, among other things, the waiver set forth in Section 10 (Appraisal Rights) of any right of Stockholder to demand

appraisal in connection with the Business Combination under Section 262 of the General Corporation Law of the State of Delaware and any

other applicable Law, and (C) each of Parent and the Company is entering into the Business Combination Agreement in reliance upon Stockholder’s

execution, delivery, and performance of this Agreement.

15. Termination.

This Agreement and all of its provisions shall terminate and be

of no further force or effect upon the earliest of (the “Expiration

Time”) (a) the Merger Effective Time, (b) such date as the Business Combination Agreement shall be validly terminated in accordance

with Article X thereof; and (c) the effective date of a written agreement of the parties hereto terminating this Agreement. Upon termination

of this Agreement, all obligations of the parties under this Agreement will terminate, without

any obligations or liabilities on the part of any party hereto to any Person in respect hereof or the transactions contemplated

hereby, and no party hereto shall have any claim against another (and no person shall have any rights against such party), whether under

contract, tort or otherwise, with respect to the subject matter hereof; provided, however, that the termination of this Agreement shall

not relieve any party hereto from liability arising in respect of (x) any breach of this Agreement prior to such termination, (y) Fraud

or (z) any obligations that by their terms expressly survive termination.

This Section 15 along with Sections 16, 17, 19, 20, and 22

shall survive the termination of this Agreement.

16. Specific

Performance. The parties hereto agree that irreparable damage may occur in the event that any of the provisions of this Agreement

were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto

shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and

provisions of this Agreement in the chancery court or any other state or federal court within the State of Delaware, this being in addition

to any other remedy to which such party is entitled at law or in equity. In the event that any action shall be brought in equity to enforce

the provisions of this Agreement, no party shall allege, and each party hereby waives the defense, that there is an adequate remedy at

law, and each party agrees to waive any requirement for the securing or posting of any bond in connection therewith.

17. No

Recourse. This Agreement may be enforced only against, and any claim or cause of action based upon, arising out of, or related to

this Agreement may be made only against, the Parties. Except to the extent a Party hereto (and then only to the extent of the specific

obligations undertaken by such Party herein), (i) no past, present or future director, manager, officer, employee, incorporator, member,

partner, direct or indirect equityholder, Affiliate, agent, attorney, advisor or representative or Affiliate of a Party, (ii) no past,

present or future director, officer, employee, incorporator, member, partner, direct or indirect equityholder, stockholder, Affiliate,

agent, attorney, advisor or representative or Affiliate of a Party and (iii) no successor, heir or representative of a Party shall have

any liability (whether in Contract, tort, equity or otherwise) for any one or more of the representations, warranties, covenants, agreements

or other obligations or liabilities of any one or more of the Parties under this Agreement for any claim based on, arising out of, or

related to this Agreement.

18. Fiduciary

Duties. Notwithstanding anything in this Agreement to the contrary, (a) Stockholder does not make any agreement or understanding herein

in any capacity other than in Stockholder’s capacity as a record holder and beneficial owner of the Subject Company Equity Securities,

and not, as applicable, in Stockholder’s capacity as a director, officer or employee of the Company and (b) nothing herein will

be construed to limit or affect any action or inaction by Stockholder or any other Person serving as a member of the board of directors

(or other similar governing body) of the Company or any of its Subsidiaries or as an officer, employee or fiduciary of the Company or

any of its Subsidiaries, in each case, acting in such Person’s capacity as a director, officer, employee or fiduciary of the Company

or any of its Subsidiaries; provided, that, for the avoidance of doubt, this Section 18 shall not relieve Stockholder of its obligations

under this Agreement, including, without limitation, the transfer restrictions set forth in Section 2 and the covenants set forth

in Sections 5, 9 and 10.

19. No

Third-Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties and their respective successors and permitted

assigns and is not intended, nor shall be construed, to give any Person, other than the Parties and their respective successors and assigns,

any legal or equitable right, benefit or remedy of any nature whatsoever by reason of this Agreement. Nothing in this Agreement, expressed

or implied, is intended to or shall constitute the Parties, partners or participants in a joint venture.

20. Fees

and Expenses. Except as otherwise expressly set forth in the Business Combination Agreement, all fees and expenses incurred in connection

with this Agreement and the transactions contemplated hereby, including the fees and disbursements of counsel, financial advisors and

accountants, shall be paid by the Party incurring such fees or expenses.

21. No

Ownership Interest. Nothing contained in this Agreement will be deemed to vest in the Company or any of its Affiliates or Parent or

any of its Affiliates any direct or indirect ownership or incidents of ownership of or with respect to Subject Company Equity Securities.

All rights, ownership and economic benefits of and relating to the applicable Subject Company Equity Securities shall remain vested in

and belong to Stockholder, and the Company and Parent (and each of their respective Affiliates) shall have no authority to exercise any

power or authority to direct Stockholder in the voting of any Subject Company Equity Securities owned by him, her or it (if any). Stockholder

shall not be restricted from voting in favor of, against or abstaining with respect to any other matters presented to the stockholders

of the Company.

22. Several

and Not Joint. The representations, warranties, covenants and agreements set forth herein shall be several (and not joint or joint

and several) representations, warranties, covenants and agreements of Stockholder.

23. Notices.

Any notice, requests, claims, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given

(a) when delivered in person, (b) when delivered after posting in the United States mail having been sent registered or certified mail,

return receipt requested, postage prepaid, (c) when delivered by FedEx or another nationally recognized overnight delivery service or

(d) when delivered by email (unless an “undeliverable” or similar message is received with respect to each email address provided

in or pursuant to this Section 23 for the applicable Party) (provided, that, any such notice or other communication delivered in

the manner described in any of the preceding clauses (a), (b) and (c) shall also be delivered by email no later than

24 hours after being dispatched in the manner described in the preceding clause (a), (b) or (c), as applicable),

in each case, addressed as follows:

If to Stockholder, to:

[●]

Attention: [●]

Email: [●]

with a copy (which shall not constitute notice) to:

[●]

Attention: [●]

Email: [●]

If to the Company:

First Choice Healthcare Solutions, Inc.

95 Bulldog Blvd, Suite 202, Melbourne, Florida 32901Attn: Lance

Friedman, Chief Executive Officer

E-mail: LFriedman@myfcmg.com

with a copy (which shall not constitute notice) to

Sichenzia Ross Ference Carmel LLP

1185 Avenue of the Americas 26th Floor

New York, NY 10036

Attention: Arthur Marcua

Email: amarcus@srfc.law

If to Parent, to:

Westin Acquisition Corp.

Suite 1165-L 3 Coleman Street #03-24

Singapore 179804

Telephone: +65 9488 4425

E-mail: stanney@westinacquisitioncorp.com

with a copy (which shall not constitute notice) to:

Celine & Partners PLLC

1345 Avenue of the Americas, 2nd FL New York, NY 10105

Attention: Hui Chen

24. E-mail: hchen@celinelaw.com

Incorporation by Reference. Sections 1.3 (Construction); 11.2 (Amendments; No Waivers; Remedies), 11.6 (No Assignment

or Delegation), 11.7 (Governing Law), 11.8 (Waiver of Jury Trial), 11.9 (Submission to Jurisdiction), 11.10

(Counterparts; Electronic Signatures), 11.11 (Entire Agreement), and 11.12 (Severability) of the Business

Combination Agreement are incorporated herein and shall apply to this Agreement mutatis mutandis.

[Signature Pages Follow]

IN WITNESS WHEREOF, each

of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

FIRST CHOICE HEALTHCARE SOLUTIONS, INC.

By:

Name:

Lance Friedman

Title:

Chief Executive Officer

[Signature Page to Company Support Agreement]

IN WITNESS WHEREOF, each

of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

WESTIN ACQUISITION CORP.

By:

Name:

Stanney Majawit

Title:

Chief Financial Officer

[Signature Page to Company

Support Agreement]

STOCKHOLDER

[_]

[Signature Page to Company

Support Agreement]

SCHEDULE I

Investor Agreements

[●]1

NTD: Subject to Parent’s due diligence.

EX-10.3 — FORM OF LOCK-UP AGREEMENT

EX-10.3

Filename: ea029926201ex10-3.htm · Sequence: 5

Exhibit 10.3

FORM OF LOCK-UP AGREEMENT

_____________, 2026

Re: Business Combination Agreement, dated as of July 22, 2026 (the

“BCA”), by and among First Choice Healthcare Solutions, Inc., a Delaware corporation (the “Company”),

Westin Acquisition Corp., a Cayman Islands exempted company (“Parent,” and after deregistration from the Register of Companies

in the Cayman Islands and subsequent domestication into the State of Delaware, “PubCo”), and First Choice Acquisition,

Inc., a Delaware corporation (“Merger Sub”).

Ladies and Gentlemen:

Capitalized terms

used herein and not otherwise defined in this letter agreement (the “Letter Agreement”) shall have the meanings set

forth in the BCA.1

In connection with,

and as a material inducement to the parties to the Business Combination Agreement to enter into and consummate the transaction contemplated

thereby (the “Transactions”), the undersigned irrevocably agrees with PubCo that, during the Restriction Period, the undersigned

will not offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to,

or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to

cash settlement or otherwise) by the undersigned or any Affiliate of the undersigned or any person in privity with the undersigned or

any Affiliate of the undersigned), directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease

a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange

Act”), with respect to, Restricted Shares (as defined below). Beneficial ownership shall be calculated in accordance with Section

13(d) of the Exchange Act. For the purposes of this Letter Agreement, “Restricted Shares” means all shares of PubCo

Common Stock issued to the undersigned in the Transactions and including, in the case of the Founder in the event of a conversion of any

shares of PubCo Class B Ordinary Shares into shares of PubCo Class A Common Stock, Founder’s Ordinary Class A shares of PubCo Class

A Common Stock; provided, however, that Restricted Shares shall not include: any shares of PubCo Class A Common Stock issued

in exchange for shares initially issued as part of the units sold in Parent’s initial public offering (the “Public Shares”)

For purposes of

this Letter Agreement, “Restriction Period” means the period beginning on the Closing Date and ending on the earliest

of (x) the date that is six (6) months after the Closing; (y) the date on which the last reported closing sale price of the PubCo Class

A Common Stock has equaled or exceeded $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,

recapitalizations and the like) for thirty (30) consecutive trading days beginning twelve (12) months after the Closing; and (z) the date

on which PubCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all

of PubCo’s stockholders having the right to exchange their shares of PubCo Class A Common Stock for cash, securities or other property.

Notwithstanding

the foregoing, and subject to the conditions below, the undersigned may transfer Restricted Shares, provided that (1) PubCo

receives a signed lock-up letter agreement (in the form of this Letter Agreement) for the balance of the Restriction Period from each

donee, trustee, distributee, or transferee, as the case may be, prior to such transfer, (2) any such transfer shall not involve a

disposition for value, (3) such transfer is not required to be reported with the Securities and Exchange Commission in accordance

with the Exchange Act and no report of such transfer shall be made voluntarily, and (4) neither the undersigned nor any donee, trustee,

distributee or transferee, as the case may be, otherwise voluntarily effects any public filing or report regarding such transfers, with

respect to transfer:

(a) as a bona fide gift or gifts;

(b) to any immediate family member or to any trust for the direct or indirect benefit of the undersigned or

the immediate family of the undersigned (for purposes of this Letter Agreement, “immediate family” shall mean any relationship

by blood, marriage or adoption, not more remote than first cousin);

holders of which consist of the undersigned and/or immediate family of the undersigned;

(d) if the undersigned if a corporation, partnership, limited liability company, trust or other business entity

(i) to another corporation, partnership, limited liability company, trust or other business entity that is an Affiliate of the undersigned

or (ii) in the form of a distribution to limited partners, limited liability company members or stockholders of the undersigned;

(e) if the undersigned is a trust, to the beneficiary of such trust;

(f) by will, other testamentary document or intestate succession to the legal representative, heir, beneficiary

or a member of the immediate family of the undersigned;

(g) of securities purchased in open market transactions after the Closing Date;

(h) of securities to a charity or educational institution;

(i) the transfer of securities that occurs by operation of law, such as pursuant to a qualified domestic order

or in connection with a divorce settlement, provided that the transferee agrees to sign and deliver a lock-up agreement substantially

in the form of this lock-up agreement for the balance of the Restriction Period, and provided further that any filing under Section 13

of the Exchange Act that is required to be made during the Restriction Period as a result of such transfer shall include a statement that

such transfer has occurred by operation of law; and provided further that competent legal counsel for PubCo shall have first advised that

such transfer is a mandatory and not voluntary transfer; or

(j) the transfer of securities pursuant to a bona fide third party tender offer, merger, consolidation, or

other similar transaction made to all holders of the securities involving a Change of Control (as defined below) of PubCo after the Closing

and approved by PubCo’s board of directors; provided that in the event that the tender offer, merger, consolidation or other such

transaction is not completed, the securities owned by the undersigned shall remain subject to the restrictions contained in this lock-up

agreement. For purposes of this clause (j), Change of Control shall mean the consummation of any bond fide third party tender offer, merger,

amalgamation, consolidation, or other similar transaction the result of which is that any “person” (as defined in Section

13(d)(3) of the Exchange Act), or a group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange

Act) of a majority of total voting power of the voting shares of PubCo.

In addition, notwithstanding

the foregoing, this Letter Agreement shall not restrict the delivery of shares of PubCo Class A Common Stock to the undersigned upon (i)

exercise any options granted under any employee benefit plan of PubCo; provided that any shares of PubCo Class A Common Stock or

Restricted Shares acquired in connection with any such exercise will be subject to the restrictions set forth in this Letter Agreement,

or (ii) the exercise of warrants; provided that such shares of PubCo Class A Common Stock delivered to the undersigned in connection

with such exercise are subject to the restrictions set forth in this Letter Agreement. Notwithstanding the foregoing, this Letter Agreement

shall not restrict the transfer or withholding of securities or any securities convertible into securities to PubCo upon a vesting event

of PubCo’s securities or upon the exercise of options to purchase PubCo’s securities, in each case on a “cashless”

or “net exercise” basis or to cover tax obligations of the undersigned in connection with such vesting or exercise provided

that if the undersigned is required to file a report under Section 13 of the Exchange Act reporting a reduction in beneficial ownership

of securities during the Restriction Period, the undersigned shall include a statement in such schedule or report to the effect that the

purpose of such transfer was to cover tax withholding obligations of the undersigned in connection with such vesting or exercise.

Notwithstanding

the foregoing, after six (6) months, the undersigned, may sell, transfer or otherwise dispose of up to ten percent (10%) of the Restricted

Shares held by the undersigned (determined as of the Closing) in any thirty (30) consecutive calendar day period (a “Permitted

Leakout”); provided that such sales are effected through ordinary brokerage transactions on any national securities exchange

on which the PubCo Class A Common Stock is then listed.

The undersigned

acknowledges that the execution, delivery and performance of this Letter Agreement is a material inducement to the parties to the Business

Combination Agreement to enter into and consummate the Transactions and PubCo shall be entitled to specific performance of the undersigned’s

obligations hereunder. The undersigned hereby represents that the undersigned has the power and authority to execute, deliver and perform

this Letter Agreement, that the undersigned has received adequate consideration therefor and that the undersigned will indirectly benefit

from the consummation of the Transactions.

This Letter Agreement may

not be amended or otherwise modified in any respect without the written consent of each of PubCo and the undersigned. This Letter Agreement

shall be construed and enforced in accordance with the laws of the State of Delaware without regard to the principles of conflict of laws.

The undersigned hereby irrevocably submits to the exclusive jurisdiction of the Chancery Court of the State of Delaware (or, if the Chancery

Court of the State of Delaware does not have jurisdiction, a federal court sitting in Wilmington, Delaware) (or any appellate courts thereof),

for the purposes of any suit, action or proceeding arising out of or relating to this Letter Agreement, and hereby waives, and agrees

not to assert in any such suit, action or proceeding, any claim that (i) it is not personally subject to the jurisdiction of such court,

(ii) the suit, action or proceeding is brought in an inconvenient forum, or (iii) the venue of the suit, action or proceeding is improper.

The undersigned hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or

proceeding by receiving a copy thereof sent to PubCo at the address in effect for notices to it under the Business Combination Agreement

and agrees that such service shall constitute good and sufficient service of process and notice thereof. The undersigned hereby waives

any right to a trial by jury. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted

by law.

This Letter Agreement shall

be binding on successors and assigns of the undersigned with respect to the Restricted Shares and any such successor or assign shall enter

into a similar agreement for the benefit of PubCo.

This Letter Agreement may

be executed in two or more counterparts, all of which when taken together may be considered one and the same agreement.

*** SIGNATURE PAGE FOLLOWS***

IN WITNESS WHEREOF, the parties

hereto have caused this Agreement to be executed as of the date first written above.

Sponsor:

By:

Name:

Title:

By:

Name:

Title:

By:

Name:

Title:

Fist Choice Healthcare Solutions, Inc. Stockholders

By:

Name:

Title:

By:

Name:

Title:

By:

Name:

Title:

(Signature page to the Lock-up Agreement)

EX-10.4 — FORM OF REGISTRATION RIGHTS AGREEMENT

EX-10.4

Filename: ea029926201ex10-4.htm · Sequence: 6

Exhibit 10.4

FORM OF

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

THIS AMENDED AND RESTATED REGISTRATION RIGHTS

AGREEMENT (this “Agreement”) is entered into as of [●], 2026, by and among:

(i) Wellgevity 360, Inc., a Nevada corporation formerly known

as Westin Acquisition Corp. (“PubCo”);

(ii) Westin Investment Co. Ltd., a Cayman Islands exempted company

(the “Sponsor”);

(iii) the Persons listed on Schedule I hereto (other than the Sponsor)

that hold Registrable Securities immediately following the Closing as a result of their ownership of Parent Class B Ordinary Shares or

other securities covered by the Prior Registration Rights Agreement (each such Person, together with the Sponsor, a “SPAC Holder”

and, collectively, the “SPAC Holders”); and

(iv) the stockholders of First Choice Healthcare Solutions, Inc.

mutually agreed by Parent and the Company and listed on Schedule II hereto that receive shares of PubCo Common Stock pursuant to the

Business Combination Agreement (each, a “Company Holder” and, collectively, the “Company Holders”).

Each SPAC Holder and Company Holder, together

with any Person that hereafter becomes a party to this Agreement in accordance with Section 6.3, is referred to herein as a “Holder”

and, collectively, as the “Holders.” Capitalized terms used but not otherwise defined herein shall have the meanings ascribed

to such terms in the Business Combination Agreement.

RECITALS

WHEREAS, Westin Acquisition Corp., the Sponsor

and certain other investors entered into that certain Registration Rights Agreement, dated as of November 3, 2025 (as amended, supplemented

or otherwise modified prior to the date hereof, the “Prior Registration Rights Agreement”);

WHEREAS, Westin Acquisition Corp., First Choice

Healthcare Solutions, Inc., a Delaware corporation (the “Company”), and First Choice Acquisition Corp., a Delaware corporation

and a wholly owned subsidiary of Westin Acquisition Corp. (“Merger Sub”), entered into that certain Business Combination Agreement,

dated as of July 22, 2026 (as amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”);

WHEREAS, pursuant to the Business Combination

Agreement, prior to the Closing, Westin Acquisition Corp. will de-register as an exempted company incorporated under the laws of the Cayman

Islands and transfer by way of continuation out of the Cayman Islands and into the State of Nevada, domesticate as a Nevada corporation

and be renamed “Wellgevity 360, Inc.” (the “Domestication”);

WHEREAS, immediately following the Domestication,

Merger Sub will merge with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of PubCo;

WHEREAS, in connection with the consummation of

the Transactions, the Company Holders will receive shares of PubCo Common Stock pursuant to the Business Combination Agreement;

WHEREAS, the Sponsor and the other SPAC Holders

that are parties to the Prior Registration Rights Agreement hold a majority of the “Registrable Securities” thereunder and,

together with PubCo, desire to amend and restate the Prior Registration Rights Agreement in its entirety and accept the rights created

pursuant to this Agreement in lieu of the rights granted under the Prior Registration Rights Agreement; and

WHEREAS, PubCo and the Company Holders desire

to enter into this Agreement, pursuant to which PubCo will grant the Company Holders the registration rights set forth herein with respect

to their Registrable Securities.

NOW, THEREFORE, in consideration of the mutual

covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby

acknowledged, the parties agree as follows:

ARTICLE I

DEFINITIONS

The following capitalized terms used in this Agreement

have the following meanings:

“Adverse

Disclosure” means any public disclosure of material non-public information, which disclosure, in the good faith judgment of

the Board, after consultation with counsel to PubCo, (a) would be required to be made in any Registration Statement or Prospectus in order

for such Registration Statement or Prospectus not to contain a Misstatement, (b) would not be required to be made at such time if the

Registration Statement were not being filed or used, and (c) PubCo has a bona fide business purpose for not making such information public.

“Affiliate”

means, with respect to any Person, any other Person that directly or indirectly Controls, is Controlled by or is under common Control

with such Person; provided that no Holder shall be deemed an Affiliate of PubCo or any of its Subsidiaries solely by reason of such Holder’s

ownership of Registrable Securities.

“Agreement”

has the meaning set forth in the Preamble.

“Block

Trade” means an offering and/or sale of Registrable Securities by one or more Holders on a block trade or underwritten basis,

whether on a firm commitment or otherwise, without substantial marketing efforts prior to pricing, including a same-day trade, overnight

trade or similar transaction.

“Board”

means the board of directors of PubCo.

“Business

Combination Agreement” has the meaning set forth in the Recitals.

“Business

Day” has the meaning assigned to such term in the Business Combination Agreement.

“Closing”

has the meaning assigned to such term in the Business Combination Agreement.

“Closing

Date” has the meaning assigned to such term in the Business Combination Agreement.

“Commission”

means the United States Securities and Exchange Commission or any successor federal agency then administering the Securities Act or the

Exchange Act.

“Company

Holder” or “Company Holders” has the meaning set forth in the Preamble.

“Control”

means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person,

whether through ownership of voting securities, by contract or otherwise. The terms “Controlled,” “Controlling”

and “under common Control with” have correlative meanings.

“Demand

Registration” has the meaning set forth in Section 2.2.1.

“Demand

Takedown” has the meaning set forth in Section 2.1.6(a).

“Demanding

Holder” has the meaning set forth in Section 2.2.1.

“Domestication”

has the meaning set forth in the Recitals.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Form

S-1” means a registration statement on Form S-1 under the Securities Act or any successor form thereto.

“Form

S-3” means a registration statement on Form S-3 under the Securities Act or any similar short-form registration statement that

may be available to PubCo at the applicable time.

“Founder

Shares” means the shares of PubCo Common Stock issued upon the conversion of the Parent Class B Ordinary Shares in connection

with the Domestication.

“Governmental

Authority” means any federal, state, provincial, municipal, local or foreign government, governmental authority, regulatory

or administrative agency, commission, department, board, bureau, instrumentality, court, tribunal, arbitrator or self-regulatory organization,

including Nasdaq and the Commission.

“Holder”

or “Holders” has the meaning set forth in the Preamble; provided that a Person shall cease to be a Holder at such time as

such Person no longer holds any Registrable Securities.

“Law”

means any statute, law, ordinance, rule, regulation, directive, code, order, judgment, injunction, decree, writ, determination or other

requirement of any Governmental Authority.

“Lock-Up

Agreement” means any lock-up agreement entered into in connection with the Transactions, including each lock-up agreement entered

into substantially in the form attached as Exhibit F to the Business Combination Agreement, as the same may be amended, supplemented or

otherwise modified from time to time.

“Maximum

Number of Securities” has the meaning set forth in Section 2.2.4.

“Merger”

means the merger of Merger Sub with and into the Company pursuant to the Business Combination Agreement, with the Company surviving such

merger as a wholly owned Subsidiary of PubCo.

“Merger

Effective Time” has the meaning assigned to such term in the Business Combination Agreement.

“Merger Shares” means

the shares of PubCo Common Stock issued to the Company Holders pursuant to the Business Combination Agreement.

“Misstatement”

means an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement

or Prospectus or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

“Nasdaq”

means The Nasdaq Stock Market LLC.

“Parent”

means Westin Acquisition Corp., a Cayman Islands exempted company, prior to the Domestication.

“Parent

Class A Ordinary Shares” means, prior to the Domestication, the Class A ordinary shares, par value $0.0001 per share, of Parent.

“Parent

Class B Ordinary Shares” means, prior to the Domestication, the Class B ordinary shares, par value $0.0001 per share, of Parent.

“Parent

Rights” means, prior to the Domestication, the rights of Parent, each entitling the holder thereof to receive one-sixth (1/6)

of one Parent Class A Ordinary Share.

“Person”

means any individual, corporation, company, partnership, limited liability company, association, trust, joint venture, unincorporated

organization, Governmental Authority or other entity of any kind.

“Piggyback

Registration” has the meaning set forth in Section 2.3.1.

“Prior

Registration Rights Agreement” has the meaning set forth in the Recitals.

“Private

Placement Shares” means (a) the shares of PubCo Common Stock issued upon the conversion in connection with the Domestication

of the Parent Class A Ordinary Shares originally included in the private placement units issued by Parent in connection with its initial

public offering, (b) the shares of PubCo Common Stock issued or issuable in respect of the Parent Rights originally included in such private

placement units, and (c) any other shares of PubCo Common Stock issued or issuable upon the exercise, conversion or exchange of securities

originally issued as part of such private placement units.

“Prospectus”

means the prospectus included in any Registration Statement, including any preliminary prospectus, free writing prospectus or prospectus

supplement relating to the offering of Registrable Securities, and all amendments and supplements thereto and all material incorporated

by reference or deemed incorporated by reference therein.

“PubCo”

has the meaning set forth in the Preamble and includes any successor thereto.

“PubCo

Common Stock” means the common stock, par value $0.0001 per share, of PubCo.

“Register,”

“Registered” and “Registration” mean a registration effected by preparing and filing a registration statement

or similar document in compliance with the Securities Act and the applicable rules and regulations thereunder, and such registration statement

becoming effective.

“Registrable

Securities” means (a) any Founder Shares held by a SPAC Holder immediately following the Closing, (b) any Private Placement Shares

held by a SPAC Holder immediately following the Closing, (c) any Working Capital Loan Shares held by a SPAC Holder immediately following

the Closing, (d) any Merger Shares held by a Company Holder immediately following the Closing and (e) any other equity securities of PubCo

or any successor entity issued or issuable with respect to any security described in clauses (a) through (d) by way of stock dividend,

stock split, subdivision, combination, recapitalization, merger, consolidation, reorganization or similar transaction; provided, however,

that, as to any particular Registrable Security, such security shall cease to be a Registrable Security upon the earliest to occur of:

(i) a Registration Statement covering the sale or other disposition of such security having become effective under the Securities Act

and such security having been sold, transferred or otherwise disposed of pursuant to such Registration Statement; (ii) such security having

been sold pursuant to Rule 144; (iii) such security having been otherwise transferred and a new certificate or book-entry position not

bearing a legend restricting further transfer having been delivered or established by PubCo, and subsequent public distribution of such

security not requiring registration under the Securities Act; (iv) such security having ceased to be outstanding; or (v) such security

becoming eligible for sale by the applicable Holder pursuant to Rule 144 without volume or manner-of-sale restrictions and without the

requirement that PubCo comply with the current public information requirements under Rule 144(c)(1).

“Registration

Statement” means any registration statement filed by PubCo with the Commission in compliance with the Securities Act and the

rules and regulations promulgated thereunder for a public offering or resale of equity securities, or securities exercisable or exchangeable

for, or convertible into, equity securities, including the Prospectus, amendments and supplements thereto, all exhibits thereto and all

material incorporated by reference or deemed incorporated by reference therein; provided that a Registration Statement shall not include

a registration statement on Form S-4 or Form S-8, or any successor form thereto, or a registration statement covering only securities

proposed to be issued in exchange for securities or assets of another entity.

“Resale

Shelf Registration Statement” has the meaning set forth in Section 2.1.1.

“Rule

144” means Rule 144 promulgated under the Securities Act, or any successor rule thereto, as amended from time to time.

“Securities

Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Shelf

Registration” means a registration of securities pursuant to a Registration Statement filed with the Commission in accordance

with Rule 415 under the Securities Act.

“SPAC

Holder” or “SPAC Holders” has the meaning set forth in the Preamble.

“Sponsor”

means Westin Investment Co. Ltd., a Cayman Islands exempted company.

“Subsidiary”

means, with respect to any Person, any other Person of which a majority of the outstanding voting securities or other voting equity interests

are owned or Controlled, directly or indirectly, by such first Person, or with respect to which such first Person or any of its Subsidiaries

is a general partner or managing member.

“Transactions”

has the meaning assigned to such term in the Business Combination Agreement.

“Underwriter”

means a securities dealer that purchases any Registrable Securities as principal in an underwritten offering and not as part of such dealer’s

market-making activities.

“Underwritten

Demand Registration” means an underwritten public offering of Registrable Securities pursuant to a Demand Registration, as amended

or supplemented.

“Underwritten

Takedown” means an underwritten public offering of Registrable Securities pursuant to a Resale Shelf Registration Statement,

as amended or supplemented.

“Working

Capital Loan Shares” means the shares of PubCo Common Stock issued or issuable upon the conversion, exchange or exercise of any

units, rights or other securities issued upon conversion of any working capital loan made to Parent by the Sponsor, any Affiliate of the

Sponsor or any officer or director of Parent prior to the Closing.

ARTICLE II

REGISTRATION RIGHTS

2.1 Resale Shelf Registration Rights.

2.1.1 Registration Statement Covering Resale

of Registrable Securities.

Within thirty (30) calendar days following the

Closing Date, PubCo shall prepare and file, or cause to be prepared and filed, with the Commission a Registration Statement for a Shelf

Registration on Form S-1 or, if PubCo is then eligible to use Form S-3, on Form S-3 (the “Resale Shelf Registration Statement”),

in each case for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act registering the resale from

time to time by the Holders of all Registrable Securities. PubCo shall use commercially reasonable efforts to cause the Resale Shelf Registration

Statement to be declared effective as promptly as practicable after filing and, once effective, to keep the Resale Shelf Registration

Statement continuously effective and available for use until the date on which there are no longer any Registrable Securities outstanding.

If PubCo files the Resale Shelf Registration Statement on Form S-1, PubCo shall use commercially reasonable efforts to convert it to Form

S-3 as soon as practicable after PubCo becomes eligible to use Form S-3. PubCo’s obligations under this Section 2.1.1 shall be subject

to Section 3.2.

2.1.2 Notification and Distribution of Materials.

PubCo shall notify the Holders in writing of the

effectiveness of the Resale Shelf Registration Statement and shall furnish to each Holder, without charge, such number of copies of the

Resale Shelf Registration Statement, the Prospectus contained therein and such other documents as such Holder may reasonably request to

facilitate the disposition of its Registrable Securities in the manner described therein.

2.1.3 Amendments; Subsequent Shelf.

PubCo shall promptly prepare and file such amendments

and supplements to the Resale Shelf Registration Statement and Prospectus as may be necessary to keep the Resale Shelf Registration Statement

effective and in compliance with the Securities Act. If the Resale Shelf Registration Statement ceases to be effective while Registrable

Securities remain outstanding, PubCo shall use commercially reasonable efforts to cause it to become effective again or to file an additional

shelf registration statement covering all then-outstanding Registrable Securities. Any such additional shelf registration statement shall

be on Form S-3 to the extent PubCo is then eligible to use such form.

2.1.4 Rule 415 Cutback.

If the Commission informs PubCo that all Registrable

Securities cannot be registered for resale as a secondary offering on a single Registration Statement, PubCo shall use commercially reasonable

efforts to advocate with the Commission for registration of all Registrable Securities and, if nevertheless required, shall amend the

Resale Shelf Registration Statement or file one or more additional Registration Statements covering the maximum number of Registrable

Securities permitted by the Commission. Any reduction shall be allocated among the Holders on a pro rata basis based on the number of

Registrable Securities requested to be included, unless otherwise required by the Commission. PubCo shall use commercially reasonable

efforts to register any omitted Registrable Securities as promptly as permitted by the Commission.

2.1.5 Notice of Certain Events.

PubCo shall promptly notify the Holders in writing

of (a) the filing and effectiveness of the Resale Shelf Registration Statement and any amendment thereto, (b) any request by the Commission

for an amendment, supplement or additional information, (c) the issuance of any stop order or suspension of effectiveness and (d) the

occurrence of any event requiring the amendment or supplementation of the Prospectus so that it will not contain a Misstatement.

2.1.6 Underwritten Takedowns and Block Trades.

(a) Subject to the limitations in this Section 2.1.6, one or

more Holders holding Registrable Securities with an estimated aggregate market value of at least $[●] may request that PubCo effect

an Underwritten Takedown of all or a portion of their Registrable Securities (a “Demand Takedown”). PubCo shall promptly

notify the other Holders and shall use commercially reasonable efforts to include in such Underwritten Takedown the Registrable Securities

requested by such other Holders within five (5) Business Days after receipt of such notice, subject to customary underwriter cutbacks.

(b) PubCo shall not be required to effect more than three (3)

Underwritten Takedowns and Underwritten Demand Registrations, in the aggregate, during any twelve (12)-month period under this Agreement.

offering price of at least $[●]. PubCo shall use commercially reasonable efforts to facilitate such Block Trade as expeditiously

as practicable; provided that the requesting Holder shall use commercially reasonable efforts to work with PubCo and the underwriters

before making any public disclosure of the Block Trade. No notice to other Holders shall be required for a Block Trade unless the requesting

Holder elects to provide such notice.

(d) The requesting Holder or Holders shall have the right to

select the managing Underwriter or Underwriters for an Underwritten Takedown or Block Trade, subject to PubCo’s prior approval,

which shall not be unreasonably withheld, conditioned or delayed.

2.2 Demand Registration Rights.

2.2.1 Request for Registration.

At any time when there is no effective and usable

Resale Shelf Registration Statement available for the resale of all Registrable Securities, (a) SPAC Holders holding at least [●]%

of the Registrable Securities then held by all SPAC Holders or (b) Company Holders holding at least [●]% of the Registrable Securities

then held by all Company Holders may make a written demand that PubCo register all or part of their Registrable Securities under the Securities

Act (a “Demand Registration”). Each Holder initiating a Demand Registration is a “Demanding Holder.” A Demand

Registration shall specify the number of Registrable Securities proposed to be sold and the intended method of disposition. PubCo shall,

within five (5) Business Days after receipt of such demand, notify all other Holders, each of whom may request inclusion of its Registrable

Securities by written notice delivered within five (5) Business Days after receipt of PubCo’s notice.

2.2.2 Effective Registration.

A registration shall not count as a Demand Registration

until the applicable Registration Statement has been declared effective and PubCo has complied in all material respects with its obligations

hereunder; provided that a registration shall not count if the offering is prevented by a stop order or injunction that is not promptly

removed, unless the Demanding Holders elect to proceed after such stop order or injunction is removed.

2.2.3 Underwritten Offering.

If the Demanding Holders so elect, the offering

pursuant to a Demand Registration shall be an Underwritten Demand Registration. Each participating Holder shall enter into a customary

underwriting agreement and provide such representations, warranties and indemnities as are customary for selling stockholders; provided

that no Holder shall be required to make representations or warranties concerning PubCo or its business.

2.2.4 Reduction of Underwritten Offering.

If the managing Underwriter advises that the number

or dollar amount of securities requested to be included exceeds the largest number or dollar amount that can be sold without adversely

affecting the offering (the “Maximum Number of Securities”), PubCo shall include: (a) first, the Registrable Securities requested

by the Demanding Holders and other participating Holders, pro rata based on the number requested to be included; (b) second, securities

PubCo proposes to sell for its own account; and (c) third, other securities requested to be included pursuant to contractual registration

rights.

2.2.5 Withdrawal.

The Demanding Holders may withdraw a Demand Registration

at any time prior to effectiveness by written notice to PubCo. A withdrawn Demand Registration shall not count against any limitation

on Demand Registrations if the withdrawing Holders reimburse PubCo for all reasonable out-of-pocket expenses incurred in connection therewith,

unless the withdrawal results from material adverse information concerning PubCo that became known after the demand was made.

2.2.6 Limitations.

PubCo shall not be obligated to effect more than

three (3) Underwritten Takedowns and Underwritten Demand Registrations, in the aggregate, during any twelve (12)-month period under this

Agreement, or any Demand Registration with an estimated aggregate offering price of less than $[●]. PubCo may defer a Demand Registration

for up to sixty (60) consecutive days if the Board determines in good faith that the filing or use of the Registration Statement would

require Adverse Disclosure; provided that PubCo may not exercise such deferral right more than twice in any twelve (12)-month period or

for more than ninety (90) total days in any twelve (12)-month period.

2.3 Piggyback Registration Rights.

2.3.1 Piggyback Rights.

If PubCo proposes to file a Registration Statement

under the Securities Act with respect to an offering of equity securities for its own account or for the account of stockholders, other

than a registration statement on Form S-4 or Form S-8, a shelf registration pursuant to Section 2.1, a Block Trade or an offering solely

pursuant to a dividend reinvestment plan, PubCo shall give written notice to the Holders at least ten (10) days before the anticipated

filing date and offer each Holder the opportunity to include such number of Registrable Securities as it requests in writing within five

(5) days after receipt of such notice (a “Piggyback Registration”). PubCo shall use commercially reasonable efforts to cause

such Registrable Securities to be included on the same terms as the securities otherwise included in the offering.

2.3.2 Reduction of Offering.

If the managing Underwriter advises that the number

or dollar amount of securities requested to be included in a Piggyback Registration exceeds the Maximum Number of Securities, the securities

shall be included in the following order: (a) if the offering is for PubCo’s account, first, securities offered by PubCo; second,

Registrable Securities requested by the Holders, pro rata based on the number requested to be included; and third, securities requested

by other stockholders; or (b) if the offering is for the account of other stockholders, first, securities of the initiating stockholders;

second, Registrable Securities requested by the Holders, pro rata based on the number requested to be included; third, securities offered

by PubCo; and fourth, securities requested by other stockholders.

2.3.3 Withdrawal and Termination.

Any Holder may withdraw its Registrable Securities

from a Piggyback Registration at any time before execution of the underwriting agreement or, if no underwriting agreement is entered into,

before effectiveness. PubCo may withdraw or abandon any registration initiated by it without liability to any Holder, subject to payment

of Registration Expenses as provided herein.

2.4 Lock-Up Restrictions.

Notwithstanding anything to the contrary herein,

no Registration or offering pursuant to this Agreement shall relieve any Holder from, or otherwise modify, any restriction on transfer

applicable to such Holder under any Lock-Up Agreement. PubCo may include Registrable Securities subject to a Lock-Up Agreement in a Registration

Statement before the applicable lock-up expires, provided that no sale may be made in violation of such Lock-Up Agreement.

ARTICLE III

REGISTRATION PROCEDURES

3.1 Registration Procedures.

Whenever PubCo is required to effect the Registration

of any Registrable Securities pursuant to this Agreement, PubCo shall use commercially reasonable efforts to effect the Registration and

sale of such Registrable Securities in accordance with the intended method of disposition thereof as expeditiously as reasonably practicable

and, in connection therewith, PubCo shall:

3.1.1 prepare and file with the Commission the applicable Registration

Statement and use commercially reasonable efforts to cause it to become effective and remain effective for the period required by this

Agreement;

3.1.2 before filing a Registration Statement or Prospectus or any

amendment or supplement thereto, furnish to the participating Holders and their counsel copies of the documents proposed to be filed

sufficiently in advance to permit a reasonable review and consider in good faith any reasonable comments;

3.1.3 prepare and file such amendments and supplements as may be

necessary to keep the Registration Statement effective and the Prospectus current and in compliance with the Securities Act;

3.1.4 notify participating Holders promptly of effectiveness, stop

orders, Commission requests, the occurrence of a Misstatement and any suspension of the use of a Prospectus;

3.1.5 register or qualify the Registrable Securities under such

state securities or blue sky laws as the participating Holders reasonably request, except that PubCo shall not be required to qualify

generally to do business, subject itself to taxation or consent to general service of process in any jurisdiction where it is not otherwise

so subject;

3.1.6 enter into customary underwriting, placement agency, sales

or other agreements and take such other actions as are reasonably required to expedite or facilitate the disposition of Registrable Securities;

3.1.7 make available for inspection, subject to customary confidentiality

arrangements, such financial and other records and information as are reasonably necessary to permit customary due diligence by participating

Holders, Underwriters and their counsel and accountants;

3.1.8 obtain customary legal opinions and negative assurance letters

from counsel to PubCo and customary comfort letters from PubCo’s independent registered public accounting firm in connection with

an underwritten offering, in each case only to the extent customarily delivered in an offering of the applicable type;

3.1.9 cause senior executives of PubCo to participate in customary

marketing efforts and road shows for any underwritten offering, to the extent reasonably requested by the managing Underwriter;

3.1.10 cause all Registrable Securities included in a Registration

Statement to be listed on each securities exchange on which the PubCo Common Stock is then listed;

3.1.11 provide a transfer agent and registrar for the Registrable

Securities no later than the effective date of the applicable Registration Statement;

3.1.12 cooperate with the Holders and the managing Underwriter to

facilitate the timely preparation and delivery of book-entry positions or certificates not bearing restrictive legends, subject to applicable

Law;

3.1.13 otherwise comply with all applicable rules and regulations

of the Commission and make generally available to securityholders an earnings statement satisfying Section 11(a) of the Securities Act

and Rule 158 thereunder; and

3.1.14 in connection with an underwritten offering, agree not to

effect any public sale or distribution of PubCo Common Stock for such period, not to exceed ninety (90) days, as may be reasonably requested

by the managing Underwriter, subject to customary exceptions.

3.2 Suspension of Sales; Adverse Disclosure.

Upon receipt of written notice from PubCo that

a Registration Statement or Prospectus contains a Misstatement or that the use of such Registration Statement or Prospectus would require

Adverse Disclosure, each Holder shall immediately discontinue the disposition of Registrable Securities pursuant thereto until PubCo advises

that use may be resumed and, if directed by PubCo, shall return or destroy all non-permanent file copies of the affected Prospectus. PubCo

may suspend use of a Registration Statement for a period not to exceed sixty (60) consecutive days or ninety (90) total days in any twelve

(12)-month period; provided that PubCo shall promptly amend or supplement the Registration Statement or Prospectus as necessary to permit

the resumption of sales.

3.3 Registration Expenses.

All fees and expenses incident to PubCo’s

performance of or compliance with this Agreement (the “Registration Expenses”) shall be borne by PubCo, whether or not any

Registration Statement becomes effective, including registration and filing fees, printing expenses, fees and expenses of compliance with

securities or blue sky laws, FINRA fees, listing fees, fees and disbursements of counsel for PubCo, fees and expenses of PubCo’s

independent registered public accounting firm, transfer agent and registrar fees and the reasonable fees and expenses of one counsel selected

by the participating Holders holding a majority of the Registrable Securities included in the applicable offering, not to exceed $[●]

for any offering. Underwriting discounts, selling commissions, transfer taxes and similar selling expenses attributable to the sale of

a Holder’s Registrable Securities shall be borne by such Holder.

3.4 Holder Information.

Each Holder shall furnish to PubCo such information

regarding itself, the Registrable Securities held by it and the intended method of disposition as PubCo may reasonably request and as

is required to effect the Registration. PubCo may exclude a Holder’s Registrable Securities from a Registration Statement if such

Holder fails to provide requested information after receiving at least five (5) Business Days’ written notice, until such information

is provided.

3.5 Participation in Underwritten Offerings.

No Holder may participate in an underwritten offering

unless such Holder agrees to sell its Registrable Securities on the basis provided in the underwriting arrangements approved in accordance

with this Agreement and completes and executes all customary questionnaires, powers of attorney, custody agreements, underwriting agreements

and other documents reasonably required; provided that no Holder shall be required to agree to any indemnification or contribution obligation

in excess of the net proceeds received by such Holder from the offering.

3.6 Rule 144 Cooperation.

PubCo shall cooperate with any Holder and the

transfer agent to facilitate the removal of restrictive legends from Registrable Securities sold pursuant to an effective Registration

Statement or Rule 144, including by causing counsel to PubCo to deliver customary legal opinions, provided that the applicable Holder

supplies customary representations and supporting documentation reasonably requested by PubCo or its counsel.

ARTICLE IV

INDEMNIFICATION AND CONTRIBUTION

4.1 Indemnification by PubCo.

PubCo shall indemnify and hold harmless each Holder,

its officers, directors, managers, members, partners, stockholders and Affiliates, each Underwriter and each Person who Controls any such

Person, against any losses, claims, damages, liabilities and reasonable out-of-pocket expenses arising out of or based upon any Misstatement

contained in any Registration Statement or Prospectus, or any violation by PubCo of the Securities Act, the Exchange Act or applicable

state securities Laws in connection with the Registration; except to the extent that such loss arises from information furnished in writing

by such Holder expressly for use in the Registration Statement or Prospectus or from such Holder’s use of an outdated or defective

Prospectus after PubCo timely notified such Holder not to use it.

4.2 Indemnification by Holders.

Each selling Holder shall, severally and not jointly,

indemnify and hold harmless PubCo, its directors and officers, each other selling Holder, each Underwriter and each Person who Controls

any of the foregoing, against losses, claims, damages, liabilities and reasonable out-of-pocket expenses arising out of or based upon

any Misstatement contained in any Registration Statement or Prospectus, but only to the extent that such Misstatement was made in reliance

upon and in conformity with information furnished in writing by such Holder expressly for use therein. The liability of a Holder under

this Section 4.2 shall not exceed the net proceeds received by such Holder from the sale of Registrable Securities giving rise to the

claim, except in the case of fraud or willful misconduct.

4.3 Conduct of Indemnification Proceedings.

An indemnified party shall promptly notify the

indemnifying party in writing of any claim, but failure to give prompt notice shall not relieve the indemnifying party except to the extent

materially prejudiced. The indemnifying party may assume the defense with counsel reasonably satisfactory to the indemnified party. The

indemnified party may participate at its own expense, except that the indemnifying party shall pay the reasonable fees of one separate

counsel if there is an actual conflict of interest. No settlement may be entered into without the indemnified party’s consent unless

it includes an unconditional release and imposes no admission, injunctive relief or non-monetary obligation on the indemnified party.

4.4 Contribution.

If indemnification is unavailable or insufficient,

each indemnifying party shall contribute to the amount paid or payable in such proportion as is appropriate to reflect the relative fault

of PubCo and the applicable Holder, as well as any other relevant equitable considerations. No Holder shall be required to contribute

an amount exceeding the net proceeds received by it from the sale giving rise to the claim, except in the case of fraud or willful misconduct.

No Person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution

from a Person not guilty of such fraudulent misrepresentation.

4.5 Survival.

The obligations of the parties under this Article

IV shall survive the transfer of Registrable Securities, the termination of this Agreement and the completion of any offering.

ARTICLE V

RULE 144

5.1 Rule 144 Reporting.

With a view to making available to the Holders

the benefits of Rule 144, PubCo shall use commercially reasonable efforts to (a) make and keep public information available as required

by Rule 144, (b) file with the Commission in a timely manner all reports and other documents required of PubCo under the Securities Act

and Exchange Act and (c) furnish to any Holder, upon reasonable request, a written statement as to PubCo’s compliance with the reporting

requirements of Rule 144 and such other information as may reasonably be requested to permit the Holder to sell Registrable Securities

without registration.

ARTICLE VI

MISCELLANEOUS

6.1 Effectiveness; Amendment and Restatement.

This Agreement shall become effective upon the

Closing. Upon such effectiveness, the Prior Registration Rights Agreement shall be amended and restated in its entirety and shall thereafter

be of no further force or effect, and the rights and obligations of the parties thereto with respect to registration rights shall be governed

exclusively by this Agreement. If the Business Combination Agreement is terminated before the Closing, this Agreement shall be void ab

initio and the Prior Registration Rights Agreement shall remain in full force and effect.

6.2 Other Registration Rights.

PubCo represents and warrants that, as of the

date hereof, no Person other than a Holder has any right to require PubCo to register any securities of PubCo for sale or to include any

securities of PubCo in any Registration Statement filed by PubCo, other than pursuant to agreements disclosed in the Registration Statement.

From and after the Closing, PubCo shall not enter into any agreement that is inconsistent with, or that would materially impair, the rights

granted to the Holders under this Agreement. PubCo may grant additional registration rights that are pari passu with the rights granted

hereunder, provided that such rights do not adversely affect any Holder or reduce the number of Registrable Securities that may be included

in any Registration or offering pursuant to this Agreement.

6.3 Assignment; Joinder.

A Holder may assign its rights under this Agreement

in connection with a transfer of Registrable Securities to a permitted transferee; provided that such transferee, if not already a party,

executes and delivers to PubCo a joinder to this Agreement in form and substance reasonably satisfactory to PubCo. Upon delivery of such

joinder, the transferee shall be deemed a Holder for all purposes of this Agreement. PubCo may not assign its obligations without the

prior written consent of Holders holding a majority of the then-outstanding Registrable Securities, except to a successor in a merger,

consolidation or sale of substantially all of its assets that expressly assumes such obligations.

6.4 Notices.

All notices, requests, demands and other communications

under this Agreement shall be in writing and shall be deemed given when delivered personally, sent by nationally recognized overnight

courier, or transmitted by email (with confirmation of transmission), in each case to the addresses set forth below or to such other address

as a party may designate by notice:

(a) if to PubCo, to:

Wellgevity 360,

Inc.

[Address]

Attention: Kok Peng

Na, Chief Executive Officer

Email: kokpeng@ski.sg

with a copy (which shall not

constitute notice) to:

Sichenzia Ross Ference

Carmel LLP

1185 Avenue of the

Americas, 26th Floor

New York, New York

10036

Attention: Arthur

S. Marcus, Esq.

Email: amarcus@srfc.law

(b) if to the Sponsor or a SPAC Holder, to the address set forth on Schedule I;

with a copy (which shall not constitute

notice) to:

Celine & Partners PLLC

1345 Avenue of the Americas, 2nd Floor

New York, NY 10105

Attention: Hui Chen, Esq.

Email: hui.chen@alum.cardozo.yu.edu

6.5 Entire Agreement.

This Agreement, the Business Combination Agreement,

the Lock-Up Agreements and the other agreements expressly referenced herein constitute the entire agreement among the parties with respect

to the subject matter hereof and supersede all prior agreements and understandings relating thereto, including, upon the effectiveness

of this Agreement, the Prior Registration Rights Agreement.

6.6 Amendments and Waivers.

No amendment, modification or waiver of this Agreement

shall be effective unless in writing and signed by PubCo and Holders holding a majority of the then-outstanding Registrable Securities;

provided that any amendment, modification or waiver that disproportionately and adversely affects the rights of one category of Holders,

as compared with another category of Holders, shall also require the written consent of Holders holding a majority of the Registrable

Securities held by the adversely affected category. No waiver shall constitute a waiver of any subsequent breach or default.

6.7 Termination.

This Agreement shall terminate with respect to

a Holder when such Holder no longer holds any Registrable Securities. This Agreement shall terminate in its entirety on the date on which

no Registrable Securities remain outstanding; provided that Article IV, this Article VI and any accrued rights or obligations shall survive

such termination.

6.8 No Third-Party Beneficiaries.

Except for the indemnified parties under Article

IV, this Agreement is for the sole benefit of the parties and their permitted successors and assigns and is not intended to confer any

rights or remedies upon any other Person.

6.9 Severability.

If any provision of this Agreement is held invalid,

illegal or unenforceable, the remaining provisions shall remain in full force and effect, and the parties shall negotiate in good faith

a valid provision that most closely reflects the original intent.

6.10 Remedies.

Each party acknowledges that monetary damages

may be an inadequate remedy for a breach of this Agreement and that the other parties shall be entitled to specific performance, injunctive

relief and other equitable remedies without the necessity of posting a bond, in addition to any other remedies available at law or in

equity.

6.11 Governing Law; Jurisdiction.

This Agreement shall be governed by and construed

in accordance with the internal laws of the State of New York, without giving effect to choice-of-law principles that would require the

application of another jurisdiction’s laws. Each party irrevocably submits to the exclusive jurisdiction of the state and federal

courts located in New York County, New York, and waives any objection based on venue or forum non conveniens.

6.12 Waiver of Jury Trial.

EACH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES,

TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT

OR THE TRANSACTIONS CONTEMPLATED HEREBY.

6.13 Counterparts; Electronic Signatures.

This Agreement may be executed in counterparts,

each of which shall be deemed an original and all of which together shall constitute one instrument. Signatures delivered by electronic

transmission, including PDF and electronic signature platforms, shall be effective as originals.

6.14 Headings; Construction.

Headings are for convenience only and shall not

affect interpretation. Unless the context otherwise requires, words in the singular include the plural and vice versa, “including”

means “including without limitation,” references to Articles, Sections, Exhibits and Schedules are to this Agreement, and

references to laws include amendments and successor provisions.

6.15 Further Assurances.

Each party shall execute and deliver such additional

documents and take such further actions as may be reasonably necessary to carry out the provisions and purposes of this Agreement.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

IN WITNESS WHEREOF, the parties have executed

this Amended and Restated Registration Rights Agreement as of the date first written above.

PUBCO:

WELLGEVITY 360, INC.

By:

Name:

Title:

SPONSOR:

WESTIN INVESTMENT CO. LTD.

By:

Name:

Title:

[Signature Page to Amended and Restated Registration

Rights Agreement]

OTHER SPAC HOLDERS:

[NAME OF SPAC HOLDER]

By:

Name:

Title:

[Signature Page to Amended and Restated Registration

Rights Agreement]

COMPANY HOLDERS:

[NAME OF COMPANY HOLDER]

By:

Name:

Title:

[Signature Page to Amended and Restated Registration

Rights Agreement]

SPAC HOLDERS (INCLUDING THE SPONSOR)

SCHEDULE I

SPAC HOLDERS

Name

Address / Email

Type of Registrable Securities

Number of Registrable Securities

SCHEDULE II

COMPANY HOLDERS

Name

Address / Email

Type of Registrable Securities

Number of Registrable Securities

EX-10.5 — SHARE TRANSFER AGREEMENT, DATED AS OF JULY 25, 2026, BY AND BETWEEN WESTIN VENTURES HOLDINGS LTD. AND EU ASIA HOLIDAYS PTE. LTD

EX-10.5

Filename: ea029926201ex10-5.htm · Sequence: 7

Exhibit 10.5

SHARE TRANSFER AGREEMENT

This Share Transfer Agreement (this "Agreement")

is made and entered into as of July 25, 2026 (the "Effective Date"), by and between:

Transferor:

Westin Ventures Holdings Ltd.,

a British Virgin Islands Company ("Transferor");

and

Transferee:

EU Asia Holidays Pte. Ltd.,

a Singapore Registered Company (201317245C) ("Transferee").

The Transferor and the Transferee are collectively

referred to as the "Parties."

RECITALS

WHEREAS, the Transferor is the legal and

beneficial owner of all of the issued and outstanding shares of Westin Ventures Holdings Ltd., a company duly incorporated under the laws

of British Virgin Islands (the "Company");

WHEREAS, the Transferor desires to transfer,

assign and convey to the Transferee, and the Transferee desires to acquire, all of the Transferor's shares in the Company, upon the terms

and conditions set forth herein.

NOW, THEREFORE, the Parties agree as follows:

1. Transfer of Shares

The Transferor hereby sells, assigns, transfers

and conveys to the Transferee, and the Transferee hereby accepts and acquires, one hundred percent (100%) of the issued and outstanding

shares of the Company, together with all rights attaching thereto, free and clear of all liens, encumbrances, security interests and claims.

2. Purchase Price

The consideration for the transfer of the Shares

shall be US$1.00 and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged.

3. Representations of the Transferor

The Transferor represents and warrants that:

(a) the Transferor is the sole legal

and beneficial owner of the Shares;

(b) the Shares are fully paid and free

from all liens, charges, pledges, encumbrances and third-party rights;

to enter into this Agreement and transfer the Shares; and

(d) this Agreement constitutes a valid

and binding obligation of the Transferor.

4. Representations of the Transferee

The Transferee represents and warrants that:

(a) the Transferee has full legal capacity

and authority to enter into this Agreement; and

(b) the Transferee accepts the transfer

of the Shares subject to the Company's constitutional documents and applicable law.

5. Completion

Completion of the transfer shall take place on

the Effective Date, at which time:

the Transferor shall deliver any share certificate(s),

if applicable;

the Parties shall execute any share transfer forms

required by applicable law;

the Company shall update its register of members

to reflect the Transferee as the sole shareholder.

6. Further Assurances

Each Party agrees to execute such further documents

and take such further actions as may be reasonably required to give full effect to this Agreement.

7. Governing Law

This Agreement shall be governed by and construed

in accordance with the laws of the jurisdiction of incorporation of the Company.

8. Entire Agreement

This Agreement constitutes the entire agreement

between the Parties concerning the subject matter hereof and supersedes all prior understandings or agreements relating thereto.

9. Counterparts

This Agreement may be executed in counterparts,

each of which shall be deemed an original, and all counterparts together shall constitute one and the same instrument. Electronic signatures

and PDF copies shall be deemed originals.

IN WITNESS WHEREOF

The Parties have executed this Agreement as of

the Effective Date.

TRANSFEROR:

Mr. Kok Peng Na

Duly authorized signatory of Westin Ventures Holdings

Ltd.

Date: July 25, 2026

TRANSFEREE:

Mr. Hanjie Ong

Duly authorized signatory of EU Asia Holidays

Pte. Ltd.

Date: July 25, 2026

EX-99.1 — PRESS RELEASE, DATED AS OF JULY 22, 2026

EX-99.1

Filename: ea029926201ex99-1.htm · Sequence: 8

Exhibit 99.1

First Choice Healthcare Solutions, Inc. and Westin Acquisition Corp

Announce Definitive Business Combination Agreement to Create a Publicly Traded Healthcare and Wellness Company

Jul 22, 2026

Transaction Highlights

● Transaction expected to accelerate First Choice Healthcare

Solutions, Inc.’s strategic rebrand to Wellgevity 360, a next-generation healthcare and wellness platform focused on longevity,

preventative care, and personalized, biology-driven treatment solutions;

● Transaction values First Choice Healthcare at a pro forma

enterprise value of approximately $650 million;

● According to Global Wellness Institute, the United States’

fast-growing wellness economy is now valued at $2.1 trillion growing at an annual rate of 7.9% from 2019 to 2024;

● Wellness economy per capita spending in the US surpassed

the $6,000 threshold in 2024, reaching $6,293, while the sector now accounts for 7.33% of the nation’s GDP;

● First Choice Healthcare Solutions mission is to deliver

clinician-led end-to-end, whole-person care that integrates primary care, wellness, and longevity services to improve a patient’s

quality of life;

● Backed by an experienced management team spanning emerging

growth, healthcare services, and biopharmaceuticals;

● Post-combination company expected to trade on Nasdaq;

● Transaction expected to close in the fourth quarter of 2026,

subject to customary approvals and closing conditions.

New York and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- First

Choice Healthcare Solutions, Inc. (OTCQB: FCHS), a Delaware corporation (“First Choice” or the “Company”),

announced today that it has entered into an Agreement and Plan of Merger (the “Agreement”) with Westin Acquisition Corp. (Nasdaq:

WSTN, WSTNR, WSTNU) (“Westin”), a Cayman Islands exempted company and special purpose acquisition company, and First

Choice Acquisition Corp., a Delaware corporation (“Merger Sub”), pursuant to which, immediately prior to the closing

of the proposed business combination, Westin will domesticate from the Cayman Islands to the State of Nevada and continue as Wellgevity

360, Inc. (“PubCo”), following which Merger Sub will merge with and into the Company, with the Company surviving as

a wholly owned subsidiary of PubCo (the “Proposed Transaction”).

First Choice Healthcare Solutions, Inc. is engaged in providing healthcare

services through developing and operating functional health, longevity and regenerative medicine clinics and related healthcare businesses.

Expanding Footprint in the Wellness and Longevity Markets

The global wellness and longevity markets are experiencing unprecedented

expansion, driven by an aging global demographic and a profound consumer shift toward proactive health, anti-aging therapies, and personalized

medicine. First Choice delivers clinician-led, whole-person care by integrating primary care, advanced diagnostics, regenerative therapies,

medical weight loss, and hormone optimization. This Proposed Transaction positions the Company to scale its national footprint, enhance

its service offering and technological infrastructure, and meet the rising demand for life-improvement and preventive clinical services.

A Significant Market Opportunity

● According

to the Global Wellness Institute, the global wellness economy reached a record $6.8 trillion and is forecast to expand at a 7.6%

annual rate to approach $9.8 trillion by 2029;

● Millennials and Gen Z drive a "prejuvenation"

trend, shifting med-spas and aesthetics clinics into holistic longevity and screening centers;

● Genomics and nutraceuticals remain the largest revenue drivers,

while emerging technologies like biomarkers and senolytics are seeing the fastest growth as AI advances precision medicine

The Financial Model for Longevity Medicine may be a more Durable

Business

● Cash pay reduces insurance dependency

● Membership programs can create predictable recurring revenue

● High-income demographics with inelastic health spending

● The service ecosystem creates compounding revenue potential

per patient

Mr. Kok Peng Na, Chairman/CEO of Westin, said, “The merger

reflects our commitment to partnering with a company with an innovative healthcare platform, experienced management team and significant

growth potential. We believe the Company is well positioned to capitalize on the growing demand for primary care, wellness and regenerative

medicine services, and that this proposed transaction will provide the resources, public market access, and strategic flexibility needed

to support its next phase of growth.”

Mr. Lance Friedman, CEO of First Choice Healthcare Solutions, Inc., commented, “This

business combination marks a transformative milestone for First Choice as we capitalize on the accelerating demand for longevity and functional

medicine. By combining our clinical model with Westin's public market access, we expect to be able to scale our operations rapidly, invest

in cutting-edge health technologies, and expand our services to a broader patient base seeking to optimize their health span and lifespan.”

Transaction Overview

Pursuant to the Agreement, prior to the closing of the Proposed Transaction,

Westin will domesticate from the Cayman Islands to the State of Nevada (the “Domestication”), upon the Domestication

Effective Time, Westin will continue as a Nevada corporation (“PubCo”). Following the Domestication, Merger Sub, a

Delaware corporation and wholly owned subsidiary of PubCo, will merge with and into the Company, with the Company surviving the merger

as a wholly owned subsidiary of PubCo, in each case subject to the terms and conditions of the Agreement.

The Proposed Transaction implies a pre-money equity value of approximately

$650 million for the Company. Additional information regarding transaction proceeds, sources and uses of funds, and pro forma ownership

will be included in the registration statement and other transaction-related materials to be filed in connection with the Proposed Transaction.

The parties may also cooperate in connection with any additional financing arrangements sought in connection with the Proposed Transaction.

The Proposed Transaction, which has been approved by the boards of

directors of both Westin and the Company, is subject to regulatory approvals, the approvals by the shareholders of Westin and the Company,

respectively, and the satisfaction of certain other customary closing conditions, including, among others, a registration statement, of

which the proxy statement/prospectus forms a part, being declared effective by the U.S. Securities and Exchange Commission, and the approval

by Nasdaq of the listing application of the combined company.

The description of the Proposed Transaction contained herein is only

a summary and is qualified in its entirety by reference to the Agreement relating to the Proposed Transaction. A more detailed description

of the Proposed Transaction and a copy of the Agreement will be included in a Current Report on Form 8-K to be filed by Westin with the

SEC and will be available on the SEC’s website at www.sec.gov.

Advisors

Celine & Partners, PLLC and Ogier serve as the legal advisors to

Westin. Sichenzia Ross Ference Carmel LLP serves as the U.S. securities counsel to the Company. Geneva Capital Pte. Ltd. (GCCPL)

serves as the financial advisor to the Company.

About First Choice Healthcare Solutions, Inc.

First Choice Healthcare Solutions, Inc. is engaged in providing healthcare

services through developing and operating functional health, longevity and regenerative medicine clinics and related healthcare businesses.

About Westin Acquisition Corp.

Westin is a special purpose acquisition company incorporated as a Cayman

Islands exempted company and listed on the Nasdaq Stock Market under the symbols WSTN, WSTNR, and WSTNU. Westin was formed for the purpose

of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more

businesses. Westin’s strategy is to identify and partner with a business that can benefit from access to the public markets and

additional growth opportunities.

Important Additional Information Regarding the Proposed Transaction

Will Be Filed With the SEC

This press release relates to the proposed business combination between

Westin and the Company. This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or

exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be

unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Westin and the Company intend to file

a Registration Statement on Form F-4 with the SEC, which will include a document that serves as a prospectus and proxy statement, referred

to as a proxy statement/prospectus. A proxy statement/prospectus will be sent to all Westin shareholders. No offering of securities shall

be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption

therefrom. Westin and the Company will also file other documents regarding the proposed business combination with the SEC. This press

release does not contain all the information that should be considered concerning the proposed business combination and is not intended

to form the basis of any investment decision or any other decision in respect of the business combination. BEFORE MAKING ANY VOTING DECISION,

INVESTORS AND SECURITY HOLDERS OF WESTIN ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT

DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION AS THEY BECOME AVAILABLE BECAUSE THEY WILL

CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

Investors and security holders will be able to obtain free copies of

the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by

Westin and the Company through the website maintained by the SEC at www.sec.gov.

The documents filed by Westin and the Company with the SEC also may

be obtained free of charge upon written request to Westin Acquisition Corp., Suite 1165-L 3 Coleman Street #03-24, Singapore 179804.

Participants in the Solicitations

Westin, the Company and their respective directors, executive officers,

other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies from Westin’s

shareholders in connection with the proposed business combination. A list of the names of the directors, executive officers, other members

of management and employees of Westin and the Company, as well as information regarding their interests in the business combination, will

be contained in the Registration Statement on Form F-4 to be filed with the SEC by Westin and the Company. Additional information regarding

the interests of such potential participants in the solicitation process may also be included in other relevant documents when they are

filed with the SEC. You may obtain free copies of these documents from the sources indicated above.

Caution About Forward-Looking Statements

This press release may contain forward-looking statements within the

meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 that are based

on beliefs and assumptions and on information currently available to Westin and the Company. These forward-looking statements are based

on Westin’s and the Company’s expectations and beliefs concerning future events and involve risks and uncertainties that may

cause actual results to differ materially from current expectations. In some cases, you can identify forward-looking statements by words

such as “may,” “will,” “could,” “would,” “should,” “expect,” “intend,”

“plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,”

“potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural

of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking

statements contain these words. Any statements that refer to expectations, projections or other characterizations of future events or

circumstances, including projections of market opportunity and market share, the capability of the Company’s business plans, including

its plans to expand, the anticipated enterprise value of the combined company following the consummation of the proposed business combination,

anticipated benefits of the proposed business combination and expectations related to the terms and timing of the proposed business combination,

are also forward-looking statements.

Although each of Westin and the Company believes that it has a reasonable

basis for each forward-looking statement contained in this communication, each of Westin and the Company cautions you that these statements

are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. These factors

are difficult to predict accurately and may be beyond Westin’s and the Company’s control. In addition, there will be risks

and uncertainties described in the proxy statement/prospectus on Form F-4 relating to the proposed business combination, which is expected

to be filed by Westin and the Company with the SEC, and other documents filed by Westin, Westin or the Company from time to time with

the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to

differ materially from those expressed or implied in the forward-looking statements.

There may be additional risks that neither Westin nor the Company presently

know, or that Westin and the Company currently believe are immaterial, and that could also cause actual results to differ from those contained

in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard

these statements as a representation or warranty by Westin or the Company, their respective directors, officers or employees or any other

person that Westin or the Company will achieve their objectives and plans in any specified time frame, or at all. Forward-looking statements

in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible

for Westin or the Company to predict these events or how they may affect Westin or the Company. Except as required by law, neither Westin

nor the Company has any duty to, and does not intend to update or revise the forward-looking statements in this communication or elsewhere

after the date this communication is issued. In light of these risks and uncertainties, investors should keep in mind that results, events

or developments discussed in any forward-looking statement made in this communication may not occur.

Uncertainties and risk factors that could affect Westin’s and

the Company’s future performance and cause results to differ from the forward-looking statements in this release include, but are

not limited to: the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination;

the outcome of any legal proceedings that may be instituted against Westin or the Company, the combined company or others following the

announcement of the business combination; the inability to complete the business combination due to the failure to obtain approval of

the shareholders of Westin or to satisfy other conditions to closing; changes to the proposed structure of the business combination that

may be required or appropriate as a result of applicable laws or regulations; the ability to meet Nasdaq listing standards following the

consummation of the business combination; the risk that the business combination disrupts current plans and operations of Westin or the

Company as a result of the announcement and consummation of the business combination; the ability to recognize the anticipated benefits

of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and

manage growth profitably, maintain relationships with customers and retain its management and key employees; costs related to the business

combination; changes in applicable laws or regulations; Westin’s estimates of expenditures and profitability and underlying assumptions

with respect to shareholder redemptions and purchase price and other adjustments; changes in laws and regulations that impact the Company;

ability to enforce, protect and maintain intellectual property rights; and other risks and uncertainties set forth in the sections entitled

“Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Westin’s final prospectus relating

to its initial public offering and in subsequent filings with the SEC, including the Registration Statement on Form F-4 relating to the

business combination expected to be filed by Westin and the Company.

No Offer or Solicitation

This communication does not constitute an offer to sell or the solicitation

of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction

in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such

jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the

Securities Act, or an exemption therefrom.

For further queries, please contact:

Westin Acquisition Corp. Media Contact:

Bob Lau

bob.lau@genevagroup.com.sg

First Choice Healthcare Solutions, Inc. Contact

PCG Advisory

Kevin McGrath

+1-646-418-7002

kevin@pcgadvisory.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 14

v3.26.1

Cover

Jul. 22, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 22, 2026

Entity File Number

001-42926

Entity Registrant Name

Westin Acquisition Corp.

Entity Central Index Key

0002076192

Entity Tax Identification Number

00-0000000

Entity Incorporation, State or Country Code

Entity Address, Address Line One

Suite 1165-L

Entity Address, Address Line Two

3 Coleman Street #03-24

Entity Address, City or Town

Singapore

Entity Address, Country

Entity Address, Postal Zip Code

179804

City Area Code

+65

Local Phone Number

9488 4425

Written Communications

true

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one right entitling the holder to receive one-sixth (1/6) of one Class A ordinary share

Title of 12(b) Security

Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one right entitling the holder to receive one-sixth (1/6)

Trading Symbol

WSTNU

Security Exchange Name

NASDAQ

Class A ordinary shares, par value $0.0001 per share

Title of 12(b) Security

Class A ordinary shares, par value $0.0001 per share

Trading Symbol

WSTN

Security Exchange Name

NASDAQ

Rights, each entitling the holder to receive one-sixth (1/6) of one Class A ordinary share

Title of 12(b) Security

Rights, each entitling the holder to receive one-sixth (1/6) of one Class A ordinary share

Trading Symbol

WSTNR

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

ISO 3166-1 alpha-2 country code.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCountry

Namespace Prefix:

dei_

Data Type:

dei:countryCodeItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=wstn_UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareAndOneRightEntitlingHolderToReceiveOnesixth16OfOneClassOrdinaryShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=wstn_ClassOrdinarySharesParValue0.0001PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=wstn_RightsEachEntitlingHolderToReceiveOnesixth16OfOneClassOrdinaryShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: